Processing 00000000.tx.1: -Synuclein Membrane Interactions and Lipid Specificity* Euijung Jo, JoAnne McLaurin, Christopher M. 

Phrase: "-Synuclein Membrane Interactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "Lipid Specificity"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0037791:Specificity [Quantitative Concept]
   861   C1511884:Specificity [Quantitative Concept]
   789 E C0205369:Specific [Qualitative Concept]
   789 E C1552740:specific [Intellectual Product]

Phrase: "* Euijung Jo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022418:JO [Geographic Area]

Phrase: "JoAnne McLaurin,"

Phrase: "Christopher M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.2: Yip, Peter St. 

Phrase: "Yip,"

Phrase: "Peter St."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3272372:ST [Intellectual Product]
Processing 00000000.tx.3: George-Hyslop**, and Paul E. 

Phrase: "George-Hyslop"

Phrase: "*"

Phrase: "*,"

Phrase: "and"

Phrase: "Paul E."
Processing 00000000.tx.4: Fraser From the Centre for Research in Neurodegenerative Diseases, Laboratory Medicine and Pathobiology, Departments of Chemical Engineering and Biochemistry, Institute of Biomaterials and Biomedical Engineering, **Department of Medicine (Neurology), University Health Network, and Department of Medical Biophysics, University of Toronto, 6Queen's Park Crescent West, Toronto, Ontario M5S 3H2, Canada Received for publication, May 19,2000, and in revised form, July 26,2000  ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES With the discovery of missense mutations (A53T and A30P) in -synuclein (-Syn) in several families with early onset familial Parkinson's disease, -Syn aggregation and fibril formation have been thought to play a role in the pathogenesis of -synucleinopathies, such as Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy. 

Phrase: "Fraser From the Centre"

Phrase: "for Research"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035168:research [Research Activity]
  1000   C0242481:Research [Research Activity]

Phrase: "in Neurodegenerative Diseases,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0524851:Neurodegenerative Diseases [Disease or Syndrome]
   861   C0012634:Diseases [Disease or Syndrome]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]

Phrase: "Laboratory Medicine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013227:Medicine, NOS [Pharmacologic Substance]
   861   C0025118:Medicine [Biomedical Occupation or Discipline]

Phrase: "and"

Phrase: "Pathobiology,"

Phrase: "Departments of Chemical Engineering"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0868958:Engineering departments [Organization]
   737   C1704729:Department [Organization]

Phrase: "and"

Phrase: "Biochemistry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "Institute of Biomaterials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0021622:institute [Organization]
   790   C1272753:Institute [Idea or Concept]

Phrase: "and"

Phrase: "Biomedical Engineering,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0005539:Biomedical Engineering [Biomedical Occupation or Discipline]
   983 E C1552400:Biomedical Engineer [Professional or Occupational Group]
   861   C0014279:Engineering [Occupation or Discipline]
   861   C1879848:Biomedical [Biomedical Occupation or Discipline]
   827 E C0878517:Engineer [Professional or Occupational Group]

Phrase: "*"

Phrase: "*Department of Medicine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1704729:Department [Organization]

Phrase: "(Neurology"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: ")"

Phrase: ","

Phrase: "University Health Network,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1513822:Network [Professional or Occupational Group]
   827   C1705739:Network [Manufactured Object]
   827   C1882071:Network [Conceptual Entity]

Phrase: "and"

Phrase: "Department of Medical Biophysics,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0587450:Medical department [Health Care Related Organization]
   770   C1704729:Department [Organization]

Phrase: "University of Toronto,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "6Queen's Park Crescent West,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1705493:West [Spatial Concept]

Phrase: "Toronto,"

Phrase: "Ontario M5S 3H2,"

Phrase: "Canada"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006823:Canada [Geographic Area]

Phrase: "Received for publication,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0034036:Publication [Intellectual Product,Manufactured Object]
   790   C0034037:Publication [Occupational Activity]
   790   C1514756:Received [Qualitative Concept]
   790   C1704324:Publication [Intellectual Product]

Phrase: "May 19,"

Phrase: "2000,"

Phrase: "and in revised form,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1515981:And [Idea or Concept]
   770   C1522492:Form [Functional Concept]
   770   C1527075:Revised [Therapeutic or Preventive Procedure]

Phrase: "July 26,"

Phrase: "2000  ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0557061:Discussion [Therapeutic or Preventive Procedure]
   791   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES With the discovery of missense mutations"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   778   C0599155:Mutations, Missense [Genetic Function]
   748   C0026882:Mutations [Genetic Function]
   748   C1514811:Reference [Idea or Concept]
   748   C1706462:Reference [Conceptual Entity]
   748   C1880355:Discovery [Activity]
   714 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(A53T"

Phrase: "and"

Phrase: "A30P"

Phrase: ")"

Phrase: "in -synuclein (-Syn) in several families"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1336547:Synuclein Family [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "with early onset familial Parkinson's disease, -Syn aggregation"
Meta Candidates (Total=23; Excluded=6; Pruned=0; Remaining=17)
   850   C0679245:early disease [Temporal Concept]
   822   C0277558:Familial disease [Disease or Syndrome]
   822   C0332162:With onset [Qualitative Concept]
           Onset
   812   C0030567:Parkinson Disease [Disease or Syndrome]
   812   C1521736:Parkinson's Disease [Functional Concept]
   812   C1833334:Early-onset [Finding]
   812   C2681933:PARKINSON DISEASE [Gene or Genome]
   793   C0012634:Disease [Disease or Syndrome]
   793   C0015576:familial [Family Group]
   793   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0241888:Familial [Functional Concept]
   793   C0332287:With [Qualitative Concept]
   793   C0332621:Aggregation [Functional Concept]
   793   C0439168:% aggregation [Quantitative Concept]
   793   C1279919:Early [Temporal Concept]
   793   C1705690:With [Intellectual Product]
   787 E C0344339:family disease [Finding]
   737 E C1836721:MALS [Finding]
   737 E C3538764:MALS [Gene or Genome]
   737 E C3540595:MAL [Gene or Genome]
   721 E C0205418:Aggregate [Qualitative Concept]
   721 E C1704727:Family [Conceptual Entity]

Phrase: "and"

Phrase: "fibril formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "have"

Phrase: "been"

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a role in the pathogenesis of -synucleinopathies,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "such as Parkinson's disease,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]

Phrase: "dementia with Lewy bodies,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   865 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   770   C0011265:dementia [Mental or Behavioral Dysfunction]
   770   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "multiple system atrophy."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0037019:Multiple System Atrophy [Disease or Syndrome]
  1000   C0393571:Multiple System Atrophy [Disease or Syndrome]
   827   C0333641:Atrophy [Pathologic Function]
   827   C0439064:Multiple [Quantitative Concept]
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0151514:Atrophic [Disease or Syndrome]
   755 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.5: As previous reports have suggested that -Syn plays a role in lipid transport and synaptic membrane biogenesis, we investigated whether -Syn binds to a specific lipid ligand using thin layer chromatography overlay and examined the changes in its secondary structure using circular dichroism spectroscopy. 

Phrase: "As previous reports"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0684224:Reports [Intellectual Product]
   861   C0700287:reports [Health Care Activity]
   827 E C3273238:Report [Intellectual Product]

Phrase: "have"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that -Syn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a role in lipid transport"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "synaptic membrane biogenesis,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0596898:membrane biogenesis [Cell Function]
   827   C0005495:Biogenesis [Natural Phenomenon or Process]
   827   C0220781:Biogenesis [Biologic Function]
   734   C0039063:Synaptic membrane [Cell Component]

Phrase: "we"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "whether -Syn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "binds to a specific lipid ligand"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   783   C0023767:Lipid A [Immunologic Factor,Lipid]
   753   C0023688:Ligand [Chemical]
   753   C0023779:Lipid [Lipid]
   753   C0205369:Specific [Qualitative Concept]
   753   C1145667:Bind [Activity]
   753   C1167622:bind [Molecular Function]
   753   C1552740:specific [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "thin layer chromatography overlay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0444456:Overlay [Spatial Concept]
   812   C1706359:Overlay [Medical Device]
   756   C0008569:Thin Layer Chromatography [Laboratory Procedure]

Phrase: "and"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the changes in its secondary structure"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   773   C0025320:The change [Physiologic Function]
   753   C0392747:changes [Functional Concept]
   753   C0443172:changes [Quantitative Concept]
   719 E C1705241:Change [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "circular dichroism spectroscopy."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1519445:Spectroscopy, Circular Dichroism [Natural Phenomenon or Process]
   827   C0037812:spectroscopy [Laboratory Procedure]
   827   C2713504:Spectroscopy [Occupation or Discipline]
   827   C2984732:SPECTROSCOPY [Functional Concept]
   734   C0008813:Circular Dichroism [Laboratory Procedure]
Processing 00000000.tx.6: -Syn was found to bind to acidic phospholipid vesicles and this binding was significantly augmented by the presence of phosphatidylethanolamine, a neutral phospholipid. 

Phrase: "-Syn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "bind to acidic phospholipid vesicles"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0001128:Acidic [Chemical]
   760   C0031676:Phospholipid [Biologically Active Substance,Lipid]
   760   C0202177:Phospholipid [Laboratory Procedure]
   760   C0333262:VESICLES [Acquired Abnormality]
   760   C1145667:Bind [Activity]
   760   C1167622:bind [Molecular Function]
   726 E C1622418:vesicle [Cell Component]

Phrase: "and"

Phrase: "this binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "was"

Phrase: "significantly"

Phrase: "augmented by the presence of phosphatidylethanolamine,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0031618:Phosphatidyl ethanolamine [Biologically Active Substance,Lipid]
   753   C0205217:Augmented [Quantitative Concept]
   753   C0392148:Presence [Therapeutic or Preventive Procedure]
   753   C1450468:phosphatidylethanolamine [Lipid,Pharmacologic Substance]

Phrase: "a neutral phospholipid."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031676:Phospholipid [Biologically Active Substance,Lipid]
   861   C0202177:Phospholipid [Laboratory Procedure]
Processing 00000000.tx.7: We further examined the interaction of -Syn with lipids by in situ atomic force microscopy. 

Phrase: "We further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the interaction of -Syn with lipids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "by in situ atomic force microscopy."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   884   C0242849:Microscopy, Atomic Force [Laboratory Procedure]
           Force Microscopy
   804   C0026018:Microscopy [Laboratory Procedure]
   804   C0441722:Force [Phenomenon or Process]
   804   C0563538:Force [Phenomenon or Process]
   748 E C0729333:Dynamic [Functional Concept]
   733 E C0205288:Microscopic [Qualitative Concept]
   733   C0567415:Atom [Element, Ion, or Isotope]
   733   C1706222:Atom [Conceptual Entity]
Processing 00000000.tx.8: The association of soluble wild-type -Syn with planar lipid bilayers resulted in extensive bilayer disruption and the formation of amorphous aggregates and small fibrils. 

Phrase: "The association of soluble wild-type -Syn"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C3645563:Association type [Intellectual Product]
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]

Phrase: "with planar lipid bilayers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0023768:Lipid Bilayers [Cell Component]
   827   C0023779:Lipid [Lipid]

Phrase: "resulted in extensive bilayer disruption"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205231:Extensive [Qualitative Concept]
   760   C0332453:Disruption [Functional Concept]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "and"

Phrase: "the formation of amorphous aggregates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "small fibrils."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0225328:fibrils [Cell Component]
   827 E C1948066:Fibril [Physical Object]
Processing 00000000.tx.9: The A53T mutant -Syn disrupted the lipid bilayers in a similar fashion but at a slower rate. 

Phrase: "The A53T mutant -Syn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "disrupted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:Disrupted [Qualitative Concept]

Phrase: "the lipid bilayers in a similar fashion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0023768:Lipid Bilayers [Cell Component]
   774   C0023767:Lipid A [Immunologic Factor,Lipid]
   748   C0023779:Lipid [Lipid]

Phrase: "but at a slower rate."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0233535:but [Mental or Behavioral Dysfunction]
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]
   726   C0439834:Slow [Qualitative Concept]
Processing 00000000.tx.10: These results suggest that -Syn membrane interactions are physiologically important and the lipid composition of the cellular membranes may affect these interactions in vivo.  

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that -Syn membrane interactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1704675:Interaction [Functional Concept]

Phrase: "are"

Phrase: "physiologically important"

Phrase: "and"

Phrase: "the lipid composition of the cellular membranes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0486616:Composition [Clinical Attribute]
   748   C1555710:composition [Idea or Concept]

Phrase: "may"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "these interactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1704675:Interaction [Functional Concept]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.11: INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES -Synuclein (-Syn)1 belongs to a family of proteins including -, -, and -synucleins that are encoded in three different genes (1-7). 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES -Synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(-Syn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "belongs to a family of proteins"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   767   C1335532:Protein Family [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0015576:Family [Family Group]
   753   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1704727:Family [Conceptual Entity]

Phrase: "including -"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: ", -"

Phrase: ","

Phrase: "and -"

Phrase: "synucleins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synucleins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "are"

Phrase: "encoded in three different genes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0017337:Genes [Gene or Genome]
   760   C0205449:Three [Quantitative Concept]
   760   C0679058:encoded [Mental Process]
   760   C1705242:Different [Qualitative Concept]
   760   C2700640:Encoded [Activity]

Phrase: "(1-7"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3541329:1-7 [Gene or Genome]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.12: -Syn is expressed at high levels in the brain and enriched in neural synaptic terminals but its physiological function remains largely unknown. 

Phrase: "-Syn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "expressed at high levels"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0205250:High [Qualitative Concept]
   770   C0441889:Levels [Qualitative Concept]
   770   C1299351:High [Qualitative Concept]
   770   C2700149:HIGH [Intellectual Product]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "in the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "enriched in neural synaptic terminals"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   806   C0206181:Synaptic Terminals [Cell Component]
   770   C0027747:Nerve terminals [Cell Component]
   760   C0359583:enriched [Food]
   760   C0599851:Neural [Functional Concept]
   726   C0205088:Terminal [Temporal Concept]
   726   C1705314:Terminal [Manufactured Object]
   726   C1705315:Terminal [Spatial Concept]
   704 E C0027740:Nerve [Tissue]
   704 E C0027757:NERVE [Tissue]
   704 E C1280541:Nerve [Body Part, Organ, or Organ Component]

Phrase: "but"

Phrase: "its physiological function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "remains"

Phrase: "largely unknown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439673:Unknown [Qualitative Concept]
Processing 00000000.tx.13: It has been suggested that -Syn plays a role in neuronal plasticity because its expression in songbirds increased during learning (6). 

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that -Syn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a role in neuronal plasticity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "because"

Phrase: "its expression in songbirds"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "increased during learning"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0013621:learning [Educational Activity]
   790   C0023185:Learning [Mental Process]
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "(6"

Phrase: ")."
Processing 00000000.tx.14: A role in neuronal development and in synaptogenesis has been proposed since -Syn appears early in murine brain development and is redistributed from the cytosol to the nerve terminals where synaptosomes are located (8). 

Phrase: "A role in neuronal development"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "and in synaptogenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0597545:synaptogenesis [Organ or Tissue Function]
   790   C1515981:And [Idea or Concept]

Phrase: "has"

Phrase: "been"

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "since -Syn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "early in murine brain development"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C1160340:brain development [Organ or Tissue Function]
   760   C0006104:Brain [Body Part, Organ, or Organ Component]
   760   C0026809:Murine [Mammal]
   760   C0243107:development [Physiologic Function]
   760   C0591833:Murine [Organic Chemical,Pharmacologic Substance]
   760   C0678723:Development [Organism Function]
   760   C1269537:Brain [Body Part, Organ, or Organ Component]
   760   C1279919:Early [Temporal Concept]
   760   C1527148:Development [Functional Concept]

Phrase: "and"

Phrase: "is"

Phrase: "redistributed from the cytosol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1383501:Cytosol [Cell Component]

Phrase: "to the nerve terminals where synaptosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0039067:Synaptosomes [Cell Component]

Phrase: "are"

Phrase: "located"

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.15: The association of -Syn with neurodegeneration was identified by initial alanine to threonine mutation at codon 53(A53T) which was linked to an autosomal dominant, early-onset familial Parkinson's disease (PD) (9, 10). 

Phrase: "The association of -Syn with neurodegeneration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "identified by initial alanine"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0001898:Alanine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0205265:Initial [Temporal Concept]
   770   C0205396:Identified [Qualitative Concept]
   770   C1279901:Initial [Qualitative Concept]
   770   C1550043:Identified [Finding]
   770   C1551388:Identified [Functional Concept]
   770   C1555582:Initial [Idea or Concept]
   770   C1705685:INITIAL [Functional Concept]

Phrase: "to threonine mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "at codon 53"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0009221:Codon [Nucleotide Sequence]
   861   C1095825:Codon [Plant]

Phrase: "(A53T"

Phrase: ")"

Phrase: "which"

Phrase: "was"

Phrase: "linked to an autosomal dominant, early-onset familial Parkinson's disease"
Meta Candidates (Total=20; Excluded=1; Pruned=0; Remaining=19)
   797   C3489791:Parkinson Disease, Autosomal Dominant [Disease or Syndrome]
   775   C0814120:early disease onset [Disease or Syndrome]
   760   C0030567:Parkinson Disease [Disease or Syndrome]
   760   C0443147:Autosomal dominant [Intellectual Product]
   760   C1521736:Parkinson's Disease [Functional Concept]
   760   C1833334:Early-onset [Finding]
   760   C2681933:PARKINSON DISEASE [Gene or Genome]
   757   C0277558:Familial disease [Disease or Syndrome]
   757   C0277793:disease onset [Temporal Concept]
   757   C0679245:early disease [Temporal Concept]
   739   C0012634:Disease [Disease or Syndrome]
   739   C0015576:familial [Family Group]
   739   C0241888:Familial [Functional Concept]
   739   C0332162:Onset [Qualitative Concept]
   739   C0596142:autosomal [Cell Component]
   739   C1279919:Early [Temporal Concept]
   739   C1527180:Dominant [Functional Concept]
   722 E C0344339:disease family [Finding]
   706   C1517892:Link [Intellectual Product]
   706   C1704666:Link [Intellectual Product]

Phrase: "(PD) (9,"

Phrase: "10"

Phrase: ")."
Processing 00000000.tx.16: An additional missense mutation (A30P) was found in a second PD kindred (11) suggesting that the protein is of etiological significance. 

Phrase: "An additional missense mutation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0599155:Missense Mutation [Genetic Function]
   827   C0026882:Mutation [Genetic Function]
   827   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(A30P"

Phrase: ")"

Phrase: "was"

Phrase: "found in a second PD kindred"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   753   C0150312:Found [Quantitative Concept]
   753   C0205436:Second [Quantitative Concept]
   753   C0457385:Second [Temporal Concept]
   753   C0565930:/second [Quantitative Concept]
   753   C0598429:kindred [Qualitative Concept]
   753   C1561503:second [Idea or Concept]
   753   C1705190:Second [Qualitative Concept]
   719 E C0243095:Find [Finding]

Phrase: "(11"

Phrase: ")"

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is of etiological significance."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237881:Significance [Quantitative Concept]
   770   C0750502:Significance [Idea or Concept]
Processing 00000000.tx.17: In addition, the integral -Syn fragment, called non-A component, was found to be one of the major components of the insoluble fibrillar core of the Alzheimer's disease senile plaques (4, 12). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "the integral -Syn fragment,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332255:fragment [Functional Concept]
   827   C1708096:Fragment [Qualitative Concept]

Phrase: "called"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0679006:Call [Mental Process]
   966   C1947967:Call [Functional Concept]

Phrase: "non-A component,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0449432:Component [Manufactured Object]
   827   C1705248:Component [Conceptual Entity]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "one of the major components of the insoluble fibrillar core"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0205447:One [Quantitative Concept]

Phrase: "of the Alzheimer's disease senile plaques"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0333463:Senile Plaques [Acquired Abnormality]
           plaques
   812   C0392079:Senile [Finding]
   779 E C0011389:Plaque [Disease or Syndrome]
   779 E C0332461:Plaque [Finding]
   756 E C0231337:Old age [Finding]
   756 E C1999167:Old age [Population Group]

Phrase: "(4,"

Phrase: "12"

Phrase: ")."
Processing 00000000.tx.18: More recently, -Syn has been shown to be one of the principal components of Lewy bodies that are intracellular inclusions with fibrillar morphology and are the neuropathological characteristics of PD and dementia with Lewy bodies (13-19). 

Phrase: "More recently, -Syn"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0205172:More [Functional Concept]
   827   C0332185:Recently [Temporal Concept]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "one of the principal components of Lewy bodies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0205447:One [Quantitative Concept]

Phrase: "that"

Phrase: "are"

Phrase: "intracellular inclusions with fibrillar morphology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1512693:Inclusion [Qualitative Concept]

Phrase: "and"

Phrase: "are"

Phrase: "the neuropathological characteristics of PD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1521970:Characteristics [Qualitative Concept]

Phrase: "and"

Phrase: "dementia with Lewy bodies"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   865 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   770   C0011265:dementia [Mental or Behavioral Dysfunction]
   770   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: "(13-19"

Phrase: ")."
Processing 00000000.tx.19: Immunocytochemistry has revealed that -Syn-positive inclusions are present in astrocytic and oligodendroglial cells of PD-afflicted individuals (20, 21). 

Phrase: "Immunocytochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242349:Immunocytochemistry [Laboratory Procedure]

Phrase: "has"

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that -Syn-positive inclusions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1512693:Inclusion [Qualitative Concept]

Phrase: "are"

Phrase: "present in astrocytic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0150312:Present [Quantitative Concept]
   790   C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "oligodendroglial cells of PD-afflicted individuals"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   773   C0028944:Oligodendroglial cell [Cell]
   753   C0007634:Cells [Cell]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "(20,"

Phrase: "21"

Phrase: ")."
Processing 00000000.tx.20: -Syn is also a major component of the glial and neuronal inclusions of multiple system atrophy (22-25). 

Phrase: "-Syn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "also"

Phrase: "a major component of the glial"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0449432:Component [Manufactured Object]
   753   C1705248:Component [Conceptual Entity]

Phrase: "and"

Phrase: "neuronal inclusions of multiple system atrophy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1512693:Inclusion [Qualitative Concept]

Phrase: "(22-25"

Phrase: ")."
Processing 00000000.tx.21: Therefore, -Syn and its abnormal protein aggregation have been thought to play a role in the pathogenesis of these neurodegenerative diseases known as -synucleinopathies (26-28). 

Phrase: "Therefore, -Syn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "its abnormal protein aggregation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0332621:Aggregation [Functional Concept]
   827   C0439168:% aggregation [Quantitative Concept]
   755 E C0205418:Aggregate [Qualitative Concept]
   734   C0311448:Abnormal protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "have"

Phrase: "been"

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a role in the pathogenesis of these neurodegenerative diseases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0035820:Role [Social Behavior]
   742   C1705810:Role [Conceptual Entity]

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "as -synucleinopathies"

Phrase: "(26-28"

Phrase: ")."
Processing 00000000.tx.22: In order to understand their etiology and pathogenesis, it is crucial to identify the normal function of -Syn. 

Phrase: "In order to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "understand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162340:Understand [Mental Process]

Phrase: "their etiology"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:aetiology [Functional Concept]
  1000   C1314792:Aetiology [Functional Concept]
  1000   C1524003:Etiology [Conceptual Entity]

Phrase: "and"

Phrase: "pathogenesis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0543483:pathogenesis [Functional Concept]
  1000   C0699748:Pathogenesis [Pathologic Function]

Phrase: "it"

Phrase: "is"

Phrase: "crucial to"

Phrase: "identify"

Phrase: "the normal function of -Syn."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.23: The function of a protein is closely correlated with its three-dimensional structure, especially for proteins important in the pathogenesis of neurodegenerative diseases (29). 

Phrase: "The function of a protein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C0815043:function protein [Amino Acid, Peptide, or Protein]
   797   C1527118:Protein Function [Molecular Function]
   760   C0031843:function [Physiologic Function]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1705273:Function [Intellectual Product]

Phrase: "is"

Phrase: "closely"

Phrase: "correlated with its three-dimensional structure,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0450363:3-Dimensional [Spatial Concept]
   753   C0205449:Three [Quantitative Concept]
   753   C0678594:Structure [Spatial Concept]
   753   C1707520:Correlated [Qualitative Concept]

Phrase: "especially for proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "important in the pathogenesis of neurodegenerative diseases"

Phrase: "(29"

Phrase: ")."
Processing 00000000.tx.24: From a protein folding viewpoint, -Syn is a dynamic molecule whose secondary structure depends on its environment. 

Phrase: "From a protein folding viewpoint, -Syn"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   827   C0162847:protein folding [Molecular Function]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0185026:Folding [Therapeutic or Preventive Procedure]
   799   C0282411:Viewpoint [Intellectual Product]
   799   C1517320:From [Qualitative Concept]
   766 E C0332462:Fold [Spatial Concept]
   766 E C1880834:FOLD [Phenomenon or Process]

Phrase: "is"

Phrase: "a dynamic molecule"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0567416:Molecule [Substance]
   789 E C1521991:Molecular [Qualitative Concept]

Phrase: "whose secondary structure"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0162807:Secondary Structure [Spatial Concept]
   861   C0027627:secondary [Neoplastic Process]
   861   C0175668:Secondary [Temporal Concept]
   861   C0205436:Secondary [Quantitative Concept]
   861   C0678594:Structure [Spatial Concept]

Phrase: "depends on its environment."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0014406:Environment [Spatial Concept]
   770   C0725813:depend [Medical Device]
Processing 00000000.tx.25: For example, it has an unfolded random coil structure in aqueous solution (30), forms -helical structure upon binding to acidic phospholipid vesicles (31), and forms insoluble fibrils with a high -sheet content that resemble the filaments found in Lewy bodies (32). 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "it"

Phrase: "has"

Phrase: "an unfolded random coil structure in aqueous solution"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0678594:Structure [Spatial Concept]

Phrase: "(30"

Phrase: ")"

Phrase: ","

Phrase: "forms -helical structure upon binding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0678594:Structure [Spatial Concept]

Phrase: "to acidic phospholipid vesicles"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0333262:VESICLES [Acquired Abnormality]
   793 E C1622418:vesicle [Cell Component]
   743 E C0205378:Vesicular [Qualitative Concept]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "forms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "insoluble fibrils with a high -sheet"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0225328:fibrils [Cell Component]
   719 E C1948066:Fibril [Physical Object]

Phrase: "content"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0423896:Content [Mental Process]
  1000   C0456205:Content [Conceptual Entity]

Phrase: "that"

Phrase: "resemble"

Phrase: "the filaments"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   966   C0010851:Filament [Cell Component]
   916 E C1979891:Filamentous [Qualitative Concept]

Phrase: "found in Lewy bodies"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0085200:Lewy Bodies [Cell Component]
   770   C0150312:Found [Quantitative Concept]
   770   C0242821:bodies [Human]
   770   C1995017:Bodies [Cell Component]
   737 E C0243095:Find [Finding]
   737 E C0460148:Body [Anatomical Structure]
   737 E C1268086:Body [Anatomical Structure]

Phrase: "(32"

Phrase: ")."
Processing 00000000.tx.26: The human -Syn primary sequence (total 140residues) is well conserved among vertebrates, with rodent and zebra finch -Syn being 95and 87% identical to the human sequence (1, 4, 6, 33). 

Phrase: "The human -Syn primary sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   812   C0004793:Sequence [Nucleotide Sequence]
   812   C0162326:Sequence [Nucleotide Sequence]
   812   C0162327:Sequence [Nucleotide Sequence]
   812   C1519249:Sequence [Functional Concept]
   741 E C1548958:Sequential [Idea or Concept]
   741 E C1705294:Sequential [Qualitative Concept]

Phrase: "(total 140residues"

Phrase: ")"

Phrase: "is"

Phrase: "well conserved among vertebrates,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205170:Well [Qualitative Concept]
   770   C3146287:Well [Manufactured Object]

Phrase: "with rodent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035804:Rodent [Mammal]

Phrase: "and"

Phrase: "zebra finch -Syn"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0326833:Zebra finch [Bird]

Phrase: "being"

Phrase: "95and 87% identical to the human sequence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205280:Identical [Qualitative Concept]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "4,"

Phrase: "6,"

Phrase: "33"

Phrase: ")."
Processing 00000000.tx.27: The amino-terminal sequence (residues 7-87) contains a series of amphipathic -helical domains that may facilitate either membrane-protein or protein-protein interactions (Fig. 1). 

Phrase: "The amino-terminal sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0004793:Sequence [Nucleotide Sequence]
   827   C0162326:Sequence [Nucleotide Sequence]
   827   C0162327:Sequence [Nucleotide Sequence]
   827   C1519249:Sequence [Functional Concept]
   755 E C1548958:Sequential [Idea or Concept]
   755 E C1705294:Sequential [Qualitative Concept]

Phrase: "(residues 7-87"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C1709915:Residue [Conceptual Entity]
   793   C1882936:RESIDUE [Phenomenon or Process]
   743 E C1609982:Residual [Qualitative Concept]

Phrase: ")"

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "a series of amphipathic -helical domains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205549:Series [Quantitative Concept]
   753   C2348044:Series [Intellectual Product]

Phrase: "that"

Phrase: "may"

Phrase: "facilitate"

Phrase: "either membrane-protein"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0025252:Membrane Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0025255:Membrane [Tissue]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0596901:Membrane [Cell Component]
   827   C1706182:Membrane [Manufactured Object]
   755 E C0205287:Membranous [Qualitative Concept]

Phrase: "or"

Phrase: "protein-protein interactions"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0872079:Protein-Protein Interaction [Molecular Function]
           protein interaction
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C1704675:Interaction [Functional Concept]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.28: This region is composed of seven imperfect repeats of 11amino acids, which contain a 6-residue core with the consensus sequence KTKEGV (Fig. 1B; Ref. 33). 

Phrase: "This region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0017446:Region [Geographic Area]
  1000   C0205147:Region [Spatial Concept]
   928 E C0205276:Regional [Spatial Concept]
   928 E C1947913:Regional [Spatial Concept]

Phrase: "is"

Phrase: "composed of seven imperfect repeats of 11amino acids,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   744   C0001128:Acids [Chemical]
   744   C0205341:repeats [Functional Concept]
   744   C0205453:Seven [Quantitative Concept]
   744   C1705914:Repeats [Conceptual Entity]
   711 E C0202406:Acid [Laboratory Procedure]
   711 E C1547730:Repeat [Temporal Concept]

Phrase: "which"

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "a 6-residue core with the consensus sequence KTKEGV"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   742   C0444669:Core [Spatial Concept]
   742   C1167518:core [Cell Component]
   742   C1706352:Core [Medical Device]
   742   C1882467:Core [Manufactured Object]
   742   C3274653:Core [Body Substance]

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: "; Ref. 33"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1425988:REF [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.29: The central region of -Syn (residues 61-95) is very hydrophobic, and this internal fragment was initially isolated from Alzheimer's disease senile plaques (4). 

Phrase: "The central region of -Syn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(residues 61-95"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C1709915:Residue [Conceptual Entity]
   793   C1882936:RESIDUE [Phenomenon or Process]
   743 E C1609982:Residual [Qualitative Concept]

Phrase: ")"

Phrase: "is"

Phrase: "very hydrophobic,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0598629:Hydrophobic [Qualitative Concept]

Phrase: "and"

Phrase: "this internal fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332255:fragment [Functional Concept]
   861   C1708096:Fragment [Qualitative Concept]

Phrase: "was"

Phrase: "initially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205265:Initially [Temporal Concept]

Phrase: "isolated from Alzheimer's disease senile plaques"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   790   C0002395:Alzheimer's Disease [Disease or Syndrome]
   790   C0333463:Senile Plaques [Acquired Abnormality]
           plaques
   790   C1521724:Alzheimer's Disease [Pathologic Function]
   753   C0012634:Disease [Disease or Syndrome]
   753   C0205409:Isolated [Functional Concept]
   753   C0392079:Senile [Finding]
   753   C1548221:Isolated [Idea or Concept]
   719 E C0011389:Plaque [Disease or Syndrome]
   719 E C0332461:Plaque [Finding]
   719 E C0370215:Isolate [Substance]
   719 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "(4"

Phrase: ")."
Processing 00000000.tx.30: The carboxyl-terminal region is rich in glutamate residues and thus quite acidic. 

Phrase: "The carboxyl-terminal region"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   827   C0017446:Region [Geographic Area]
   827   C0205088:Terminal [Temporal Concept]
   827   C0205147:Region [Spatial Concept]
   827   C0596260:Carboxyl [Organic Chemical]
   827   C1705314:Terminal [Manufactured Object]
   827   C1705315:Terminal [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "is"

Phrase: "rich in glutamate residues"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0699759:Rich [Qualitative Concept]

Phrase: "and"

Phrase: "thus quite acidic."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0001128:Acidic [Chemical]
   755 E C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.31: These primary and secondary structure features of -Syn support a role for its interaction with lipid membranes. 

Phrase: "These primary"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205225:Primary [Qualitative Concept]
  1000   C0439631:Primary [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "secondary structure"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0162807:Secondary Structure [Spatial Concept]
   861   C0027627:secondary [Neoplastic Process]
   861   C0175668:Secondary [Temporal Concept]
   861   C0205436:Secondary [Quantitative Concept]
   861   C0678594:Structure [Spatial Concept]

Phrase: "features"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1521970:Feature [Qualitative Concept]
  1000   C1706388:Feature [Conceptual Entity]
  1000   C2346469:Feature [Qualitative Concept]
  1000   C2348519:Feature [Qualitative Concept]

Phrase: "of -Syn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "a role for its interaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "with lipid membranes."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0025255:Membranes [Tissue]
   827 E C0596901:Membrane [Cell Component]
   827 E C1706182:Membrane [Manufactured Object]
   777 E C0205287:Membranous [Qualitative Concept]
Processing 00000000.tx.32: View larger version (25K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(25K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.33: 1.  

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.34: Primary structure of human -synuclein. 

Phrase: "Primary structure of human -synuclein."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205225:Primary [Qualitative Concept]
   760   C0439631:Primary [Therapeutic or Preventive Procedure]
   760   C0678594:Structure [Spatial Concept]
Processing 00000000.tx.35: A, -synuclein contains three major regions including the NH2-terminal amphipathic -helical domains, the non-A component (NAC) of the insoluble fibrillar core of the Alzheimer's disease senile plaques, and the acidic COOH-terminal region. 

Phrase: "A, -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "three major regions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   793   C0017446:Region [Geographic Area]
   793   C0205147:Region [Spatial Concept]
   743 E C0205276:Regional [Spatial Concept]
   743 E C1947913:Regional [Spatial Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the NH2-terminal amphipathic -helical domains,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   771   C1880389:Domain [Functional Concept]
   771   C1883221:Domain [Conceptual Entity]
   771   C3541951:Domain [Intellectual Product]

Phrase: "the non-A component (NAC) of the insoluble fibrillar core"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0449432:Component [Manufactured Object]
   742   C1705248:Component [Conceptual Entity]

Phrase: "of the Alzheimer's disease senile plaques,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0333463:Senile Plaques [Acquired Abnormality]
           plaques
   812   C0392079:Senile [Finding]
   779 E C0011389:Plaque [Disease or Syndrome]
   779 E C0332461:Plaque [Finding]
   756 E C0231337:Old age [Finding]
   756 E C1999167:Old age [Population Group]

Phrase: "and"

Phrase: "the acidic COOH-terminal region."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   902   C1515860:Acidic Region [Amino Acid Sequence]
   812   C0017446:Region [Geographic Area]
   812   C0205147:Region [Spatial Concept]
   741 E C0205276:Regional [Spatial Concept]
   741 E C1947913:Regional [Spatial Concept]
Processing 00000000.tx.36: B, the amino acid sequence of the amphipathic -helical domains (residues 7-87) is aligned to show the 11-residue repeats containing the amino acids identical to the consensus sequence (underlined). 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "the amino acid sequence of the amphipathic -helical domains"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0002518:Amino Acid Sequence [Amino Acid Sequence]
   764   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   764   C2917660:Amino Acid [Pharmacologic Substance]
   742   C0001128:Acid [Chemical]
   742   C0004793:Sequence [Nucleotide Sequence]
   742   C0162326:Sequence [Nucleotide Sequence]
   742   C0162327:Sequence [Nucleotide Sequence]
   742   C0202406:Acid [Laboratory Procedure]
   742   C1519249:Sequence [Functional Concept]

Phrase: "(residues 7-87"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C1709915:Residue [Conceptual Entity]
   793   C1882936:RESIDUE [Phenomenon or Process]
   743 E C1609982:Residual [Qualitative Concept]

Phrase: ")"

Phrase: "is"

Phrase: "aligned"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1706765:Aligned [Quantitative Concept]
   966 E C2369992:Align [Pharmacologic Substance]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the 11-residue repeats"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0205341:repeats [Functional Concept]
   827   C1705914:Repeats [Conceptual Entity]
   793 E C1547730:Repeat [Temporal Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "identical to the consensus sequence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205280:Identical [Qualitative Concept]

Phrase: "(underlined"

Phrase: ")."
Processing 00000000.tx.37: Two missense mutations (A30P and A53T) associated with familial Parkinson's disease are indicated by arrows. 

Phrase: "Two missense mutations"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C0599155:Mutations, Missense [Genetic Function]
   827   C0026882:Mutations [Genetic Function]
   793 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(A30P"

Phrase: "and"

Phrase: "A53T"

Phrase: ")"

Phrase: "associated with familial Parkinson's disease"
Meta Candidates (Total=16; Excluded=6; Pruned=0; Remaining=10)
   806   C0030567:Parkinson Disease [Disease or Syndrome]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   806   C1521736:Parkinson's Disease [Functional Concept]
   806   C2681933:PARKINSON DISEASE [Gene or Genome]
   797   C0243083:associated disease [Pathologic Function]
   797   C0277558:Familial disease [Disease or Syndrome]
   762 E C0344339:disease family [Finding]
   760   C0012634:Disease [Disease or Syndrome]
   760   C0015576:familial [Family Group]
   760   C0241888:Familial [Functional Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]

Phrase: "are"

Phrase: "indicated by arrows."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0336721:arrows [Manufactured Object]
   790   C1444656:Indicated [Finding]
Processing 00000000.tx.38: There are a few lines of evidence suggesting that -Syn may play a role in lipid transport and synaptic membrane biogenesis. 

Phrase: "There"

Phrase: "are"

Phrase: "a few lines of evidence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0205132:lines [Spatial Concept]
   726 E C1550648:Line [Substance]
   726 E C1552960:Line [Quantitative Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that -Syn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "may"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a role in lipid transport"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "synaptic membrane biogenesis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0596898:membrane biogenesis [Cell Function]
   827   C0005495:Biogenesis [Natural Phenomenon or Process]
   827   C0220781:Biogenesis [Biologic Function]
   734   C0039063:Synaptic membrane [Cell Component]
Processing 00000000.tx.39: First of all, its amphipathic -helical domains of 11-residue repeats are reminiscent of those in the class A2 apolipoproteins, which carry lipid molecules by reversibly binding to them (34). 

Phrase: "First of all,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205435:First [Quantitative Concept]
   790   C1279901:First [Qualitative Concept]

Phrase: "its amphipathic -helical domains of 11-residue repeats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   711   C1880389:Domain [Functional Concept]
   711   C1883221:Domain [Conceptual Entity]
   711   C3541951:Domain [Intellectual Product]

Phrase: "are"

Phrase: "reminiscent of those in the class A2 apolipoproteins,"

Phrase: "which"

Phrase: "carry"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:Carry [Activity]
  1000   C0699809:carry [Finding]

Phrase: "lipid molecules by reversibly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0567416:molecules [Substance]

Phrase: "binding to them"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0243122:binding [Functional Concept]
   790   C1145667:Binding [Activity]
   790   C1167622:Binding [Molecular Function]

Phrase: "(34"

Phrase: ")."
Processing 00000000.tx.40: We and others have found that -Syn undergoes a major structural transition from random coil to -helical structure upon binding to lipid vesicles (31), supporting the possible role of -Syn in lipid binding and transport. 

Phrase: "We"

Phrase: "and"

Phrase: "others"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1955473:Others [Finding]
   966 E C0205394:Other [Qualitative Concept]

Phrase: "have"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that -Syn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "undergoes"

Phrase: "a major structural transition from random coil to -helical structure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0599156:Transition [Cell or Molecular Dysfunction]
   739   C2700061:Transition [Activity]

Phrase: "upon binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "to lipid vesicles"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0333262:VESICLES [Acquired Abnormality]
   827 E C1622418:vesicle [Cell Component]
   777 E C0205378:Vesicular [Qualitative Concept]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "supporting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0183683:Support [Medical Device]
   966   C1521721:Support [Conceptual Entity]

Phrase: "the possible role of -Syn in lipid binding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "transport."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005528:Transport, NOS [Cell Function]
  1000   C1317949:Transport [Manufactured Object]
  1000   C3495449:transport [Medical Device]
Processing 00000000.tx.41: Interestingly, one of the PD-linked point mutations (A30P) abolished the ability of -Syn to bind to the lipid vesicles (35), emphasizing the possibility that lipid binding is a normal function of -Syn. 

Phrase: "Interestingly,"

Phrase: "one of the PD-linked point mutations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205447:One [Quantitative Concept]

Phrase: "(A30P"

Phrase: ")"

Phrase: "abolished"

Phrase: "the ability of -Syn to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "bind to the lipid vesicles"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0023779:Lipid [Lipid]
   760   C0333262:VESICLES [Acquired Abnormality]
   760   C1145667:Bind [Activity]
   760   C1167622:bind [Molecular Function]
   726 E C1622418:vesicle [Cell Component]

Phrase: "(35"

Phrase: ")"

Phrase: ","

Phrase: "emphasizing"

Phrase: "the possibility"

Phrase: "that lipid binding"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1148636:Lipid Binding [Molecular Function]
   861   C0023779:Lipid [Lipid]
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "is"

Phrase: "a normal function of -Syn."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.42: Second, - and -synucleins were shown to be highly specific inhibitors of phospholipase D2 which hydrolyzes phosphatidylcholine to produce phosphatidic acid and diacylglycerol (36). 

Phrase: "Second, -"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0205436:Second [Quantitative Concept]
  1000   C0457385:Second [Temporal Concept]
  1000   C0565930:/second [Quantitative Concept]
  1000   C1561503:second [Idea or Concept]
  1000   C1705190:Second [Qualitative Concept]
   928 E C0027627:secondary [Neoplastic Process]
   928 E C0175668:Secondary [Temporal Concept]

Phrase: "and -"

Phrase: "synucleins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synucleins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "highly specific inhibitors of phospholipase D2"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   767   C0597220:phospholipase inhibitor [Pharmacologic Substance]
   753   C0243077:inhibitors [Chemical Viewed Functionally]
   719 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "which"

Phrase: "hydrolyzes"

Phrase: "phosphatidylcholine to"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1959616:Phosphatidyl choline [Biologically Active Substance,Lipid,Pharmacologic Substance]
   805 E C0031617:Lecithin [Biologically Active Substance,Lipid,Pharmacologic Substance]
   805 E C0885520:lecithin [Organic Chemical,Pharmacologic Substance]

Phrase: "produce"

Phrase: "phosphatidic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0031610:Phosphatidic Acid [Lipid]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "diacylglycerol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043791:Diacylglycerol [Biologically Active Substance,Lipid,Pharmacologic Substance]

Phrase: "(36"

Phrase: ")."
Processing 00000000.tx.43: This suggests that the level and modification of -Syn may affect phospholipase D2 activity, thereby modulating the cleavage of membrane lipids and membrane biogenesis (37). 

Phrase: "This"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0441889:Level [Qualitative Concept]
  1000   C0456079:Level [Classification]
  1000   C1547707:Level [Geographic Area]
  1000   C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "modification of -Syn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "may"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "phospholipase D2 activity,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   913   C1149838:phospholipase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0538283:phospholipase D2 [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1418642:PHOSPHOLIPASE D2 [Gene or Genome]

Phrase: "thereby"

Phrase: "modulating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:Modulating [Spatial Concept]

Phrase: "the cleavage of membrane lipids"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0010813:cleavage [Cell Function]
   760   C0596311:Cleavage [Phenomenon or Process]
   760   C1330957:cleavage [Cell Function]

Phrase: "and"

Phrase: "membrane biogenesis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0596898:membrane biogenesis [Cell Function]
   861   C0005495:Biogenesis [Natural Phenomenon or Process]
   861   C0220781:Biogenesis [Biologic Function]

Phrase: "(37"

Phrase: ")."
Processing 00000000.tx.44: Third, -Syn has been reported to co-localize with synaptic vesicles, suggesting its association with lipids (1, 38-40). 

Phrase: "Third, -Syn"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0205437:Third [Quantitative Concept]

Phrase: "has"

Phrase: "been"

Phrase: "reported to"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0684224:Reported [Intellectual Product]
   833   C0700287:Reported [Health Care Activity]
   833   C3496591:Reported [Clinical Attribute]
   799 E C3273238:Report [Intellectual Product]

Phrase: "co-localize with synaptic vesicles,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   806   C0039065:Synaptic Vesicles [Cell Component]
   760   C0333262:VESICLES [Acquired Abnormality]
   760   C0392752:localize [Spatial Concept]
   726 E C1622418:vesicle [Cell Component]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "its association with lipids"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "38-40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.45: Finally, it was recently reported that -Syn regulates the size of the presynaptic vesicular pools (41). 

Phrase: "Finally,"

Phrase: "it"

Phrase: "was"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that -Syn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "regulates"

Phrase: "the size of the presynaptic vesicular pools"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0456389:size [Spatial Concept]

Phrase: "(41"

Phrase: ")."
Processing 00000000.tx.46: In brief, when the expression of -Syn was suppressed with antisense oligonucleotide in primary hippocampal neuronal cultures, the number of synaptic vesicles was reduced significantly. 

Phrase: "In brief,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282927:brief [Qualitative Concept]
  1000   C1879313:Brief [Temporal Concept]

Phrase: "when"

Phrase: "the expression of -Syn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "suppressed with antisense oligonucleotide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0079925:antisense oligonucleotide [Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0028953:Oligonucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C1260953:Suppressed [Functional Concept]

Phrase: "in primary hippocampal neuronal cultures,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0010453:Cultures [Idea or Concept]
   779 E C0220814:culture [Functional Concept]
   779 E C0430400:Culture [Laboratory Procedure]
   779 E C2242979:Culture [Laboratory Procedure]

Phrase: "the number of synaptic vesicles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "was"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "significantly."
Processing 00000000.tx.47: This also suggests a role of -Syn in synaptic membrane biogenesis and/or vesicle fusion and budding. 

Phrase: "This also"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "a role of -Syn in synaptic membrane biogenesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and/or"

Phrase: "vesicle fusion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1326474:vesicle fusion [Cell Function]
   861   C0332466:Fusion [Functional Concept]
   861   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "budding."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1155616:budding [Cell Function]
   966 E C2700462:Bud [Plant]
   966 E C2945744:bud [Anatomical Structure]
Processing 00000000.tx.48: Given the evidence for -Syn involvement in lipid transport and turnover in synaptic terminals, we investigated the possibility of a specific lipid ligand for -Syn using thin layer chromatography (TLC) overlay and subsequent effect on secondary structure with circular dichroism (CD) spectroscopy. 

Phrase: "Given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "the evidence for -Syn involvement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332120:Evidence [Functional Concept]

Phrase: "in lipid transport"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0596846:Lipid Transport [Cell Function]
   861   C0005528:Transport, NOS [Cell Function]
   861   C1317949:Transport [Manufactured Object]
   861   C3495449:transport [Medical Device]

Phrase: "and"

Phrase: "turnover in synaptic terminals,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0031227:turnover [Quantitative Concept]
   770   C0243127:turnover [Functional Concept]
   770   C0443331:Turnover [Health Care Activity]

Phrase: "we"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "the possibility of a specific lipid ligand"

Phrase: "for -Syn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "thin layer chromatography (TLC) overlay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0444456:Overlay [Spatial Concept]
   812   C1706359:Overlay [Medical Device]
   756   C0008569:Thin Layer Chromatography [Laboratory Procedure]

Phrase: "and"

Phrase: "subsequent effect on secondary structure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "with circular dichroism (CD) spectroscopy."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1519445:Spectroscopy, Circular Dichroism [Natural Phenomenon or Process]
   827   C0037812:spectroscopy [Laboratory Procedure]
   827   C2713504:Spectroscopy [Occupation or Discipline]
   827   C2984732:SPECTROSCOPY [Functional Concept]
   734   C0008813:Circular Dichroism [Laboratory Procedure]
Processing 00000000.tx.49: -Syn was found to bind to acidic phospholipid vesicles and this binding was significantly augmented by the presence of phosphatidylethanolamine (PE), a neutral phospholipid. 

Phrase: "-Syn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "bind to acidic phospholipid vesicles"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0001128:Acidic [Chemical]
   760   C0031676:Phospholipid [Biologically Active Substance,Lipid]
   760   C0202177:Phospholipid [Laboratory Procedure]
   760   C0333262:VESICLES [Acquired Abnormality]
   760   C1145667:Bind [Activity]
   760   C1167622:bind [Molecular Function]
   726 E C1622418:vesicle [Cell Component]

Phrase: "and"

Phrase: "this binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "was"

Phrase: "significantly"

Phrase: "augmented by the presence of phosphatidylethanolamine (PE),"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0031618:Phosphatidyl ethanolamine [Biologically Active Substance,Lipid]
   753   C0205217:Augmented [Quantitative Concept]
   753   C0392148:Presence [Therapeutic or Preventive Procedure]
   753   C1450468:phosphatidylethanolamine [Lipid,Pharmacologic Substance]

Phrase: "a neutral phospholipid."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031676:Phospholipid [Biologically Active Substance,Lipid]
   861   C0202177:Phospholipid [Laboratory Procedure]
Processing 00000000.tx.50: The interaction of -Syn with lipids was further examined using in situ tapping mode atomic force microscopy (AFM). 

Phrase: "The interaction of -Syn with lipids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "in situ tapping mode atomic force microscopy (AFM)."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   845   C0242849:Microscopy, Atomic Force [Laboratory Procedure]
           Force Microscopy
   795   C0026018:Microscopy [Laboratory Procedure]
   795   C0441722:Force [Phenomenon or Process]
   795   C0563538:Force [Phenomenon or Process]
   740 E C0729333:Dynamic [Functional Concept]
   724 E C0205288:Microscopic [Qualitative Concept]
   724   C0567415:Atom [Element, Ion, or Isotope]
   724   C1706222:Atom [Conceptual Entity]
Processing 00000000.tx.51: The association of soluble wild-type -Syn with planar lipid bilayers resulted in extensive bilayer disruption with the concomitant formation of amorphous aggregates and small fibrils. 

Phrase: "The association of soluble wild-type -Syn"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C3645563:Association type [Intellectual Product]
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]

Phrase: "with planar lipid bilayers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0023768:Lipid Bilayers [Cell Component]
   827   C0023779:Lipid [Lipid]

Phrase: "resulted in extensive bilayer disruption"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205231:Extensive [Qualitative Concept]
   760   C0332453:Disruption [Functional Concept]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "with the concomitant formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "of amorphous aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205418:aggregates [Qualitative Concept]

Phrase: "and"

Phrase: "small fibrils."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0225328:fibrils [Cell Component]
   827 E C1948066:Fibril [Physical Object]
Processing 00000000.tx.52: Finally, we compared the wild-type and mutant (A53T) -Syn with regard to their comparative ability to interact with membranes. 

Phrase: "Finally,"

Phrase: "we"

Phrase: "compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "the wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "(A53T"

Phrase: ") -Syn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "with regard to their comparative ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0085732:Ability [Organism Attribute]
   755 E C1299581:Able [Finding]

Phrase: "interact with membranes."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C0025255:Membranes [Tissue]
   756 E C0596901:Membrane [Cell Component]
   756 E C1706182:Membrane [Manufactured Object]
   706 E C0205287:Membranous [Qualitative Concept]
Processing 00000000.tx.53: These in vitro studies are aimed at elucidating the physiological role of -Syn in the normal brain as well as the pathological role of the mutant -Syn in PD and related neurodegenerative diseases.  

Phrase: "These in vitro studies"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   983   C0681828:in vitro study [Research Activity]
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]
   734   C0021135:In Vitro [Intellectual Product]
   734   C1533691:in vitro [Qualitative Concept]
   734   C2827718:In Vitro [Functional Concept]

Phrase: "are"

Phrase: "aimed at elucidating"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   756   C1947946:Aim [Idea or Concept]
   756   C2948600:Aim [Pharmacologic Substance]
   756   C3540471:AIM [Gene or Genome]
   756   C3540472:AIM [Functional Concept]

Phrase: "the physiological role of -Syn in the normal brain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "as well as"

Phrase: "the pathological role of the mutant -Syn"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "in PD"

Phrase: "and"

Phrase: "related neurodegenerative diseases."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   901   C0524851:Neurodegenerative Diseases [Disease or Syndrome]
   827   C0012634:Diseases [Disease or Syndrome]
   755 E C1836721:MALS [Finding]
   755 E C3538764:MALS [Gene or Genome]
   755 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.54: EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Materials-- 1-Palmitoyl-2-oleoyl phosphatidylcholine (POPC), 1-palmitoyl-2-oleoyl phosphatidylserine (POPS), brain L--phosphatidylserine (PS), brain L--phosphatidylethanolamine (PE), lyso brain plasmalogen phosphatidylethanolamine (lyso-PE), liver L--phosphatidylinositol (PI), brain sphingomyelin (sphingomyelin), 1-palmitoyl-2-oleoyl phosphatidic acid (POPA), and cholesterol were purchased from Avanti Polar Lipids, Inc. 

Phrase: "EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0557061:Discussion [Therapeutic or Preventive Procedure]
   791   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "--"

Phrase: "1-Palmitoyl-2-oleoyl phosphatidylcholine (POPC),"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0044576:1-palmitoyl-2-oleoyl-phosphatidylcholine [Biologically Active Substance,Lipid]
   933   C0058325:1,2-oleoylphosphatidylcholine [Lipid]
   804   C1959616:Phosphatidyl choline [Biologically Active Substance,Lipid,Pharmacologic Substance]
   748 E C0031617:Lecithin [Biologically Active Substance,Lipid,Pharmacologic Substance]
   748 E C0885520:lecithin [Organic Chemical,Pharmacologic Substance]

Phrase: "1-palmitoyl-2-oleoyl phosphatidylserine (POPS),"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0031623:phosphatidylserine [Lipid]
   804   C0301704:Phosphatidyl serine [Lipid]

Phrase: "brain L--phosphatidylserine (PS),"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0031623:phosphatidylserine [Lipid]
   827   C0301704:Phosphatidyl serine [Lipid]

Phrase: "brain L--phosphatidylethanolamine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0031618:Phosphatidyl ethanolamine [Biologically Active Substance,Lipid]
   827   C1450468:phosphatidylethanolamine [Lipid,Pharmacologic Substance]

Phrase: "(PE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031618:Phosphatidyl ethanolamine [Biologically Active Substance,Lipid]
  1000   C1450468:phosphatidylethanolamine [Lipid,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "lyso brain plasmalogen phosphatidylethanolamine"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C0065389:lyso-phosphatidyl ethanolamine [Lipid]
   812   C0031618:Phosphatidyl ethanolamine [Biologically Active Substance,Lipid]
   812   C1450468:phosphatidylethanolamine [Lipid,Pharmacologic Substance]

Phrase: "(lyso-PE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031618:Phosphatidyl ethanolamine [Biologically Active Substance,Lipid]
   861   C1450468:phosphatidylethanolamine [Lipid,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "liver L--phosphatidylinositol (PI),"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0031621:Phosphatidyl Inositol [Biologically Active Substance,Lipid]
   827   C2348046:Phosphatidylinositol [Lipid]

Phrase: "brain sphingomyelin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0037906:Sphingomyelin [Biologically Active Substance,Lipid]

Phrase: "(sphingomyelin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037906:Sphingomyelin [Biologically Active Substance,Lipid]

Phrase: ")"

Phrase: ","

Phrase: "1-palmitoyl-2-oleoyl phosphatidic acid (POPA),"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0031610:Phosphatidic Acid [Lipid]
   799   C0001128:Acid [Chemical]
   799   C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "cholesterol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008377:Cholesterol [Biologically Active Substance,Steroid]

Phrase: "were"

Phrase: "purchased from Avanti Polar Lipids,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0023779:Lipids [Lipid]
   760   C0813983:polar [Quantitative Concept]
   760   C0869011:purchased [Activity]

Phrase: "Inc."
Processing 00000000.tx.55: (Birmingham, AL). 

Phrase: "(Birmingham,"

Phrase: "AL"

Phrase: ")."
Processing 00000000.tx.56: Poly(isobutyl methacrylate) was obtained from Aldrich. 

Phrase: "Poly(isobutyl methacrylate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0071441:poly(isobutyl methacrylate) [Organic Chemical]
   827   C0025601:methacrylate [Organic Chemical]
   827   C2828373:Methacrylate [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: ")"

Phrase: "was"

Phrase: "obtained from Aldrich."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]
Processing 00000000.tx.57: Monoclonal mouse anti--synuclein antibody (Synuclein-1) was from Transduction Laboratories (Lexington, KY). 

Phrase: "Monoclonal mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mouse [Mammal]
   861   C0025929:mouse [Mammal]
   861   C0026809:Mouse [Mammal]

Phrase: "anti"

Phrase: "--synuclein antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Synuclein-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "was from Transduction Laboratories"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0022877:Laboratories [Manufactured Object,Organization]
   770   C0043194:WAS [Disease or Syndrome]
   770   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1160185:transduction [Organism Function]
   770   C1421478:WAS [Gene or Genome]
   770   C1619828:Laboratories [Intellectual Product]
   737 E C3244292:laboratory [Functional Concept]

Phrase: "(Lexington,"

Phrase: "KY"

Phrase: ")."
Processing 00000000.tx.58: Horseradish peroxidase-conjugated goat anti-mouse IgG was from Bio-Rad. 

Phrase: "Horseradish peroxidase-conjugated goat anti-mouse IgG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   829   C0051979:anti-IgG [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "was from Bio-Rad."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0043194:WAS [Disease or Syndrome]
   770   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1421478:WAS [Gene or Genome]
Processing 00000000.tx.59: Foil-backed polygram silica gel G thin layer chromatography plates were from Macherey-Nagel (Germany). 

Phrase: "Foil-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1551385:Foil [Manufactured Object]
  1000   C1705857:Foil [Manufactured Object]

Phrase: "backed"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0004600:Back [Body Location or Region]
   966   C0205095:Back [Spatial Concept]
   966   C0460009:Back [Body Location or Region]
   966   C1995000:Back [Body Location or Region]

Phrase: "polygram silica gel G thin layer chromatography plates"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   793   C1139930:plates [Medical Device]
   760 E C0005971:Plate [Medical Device]
   760 E C3537155:Plate [Manufactured Object]

Phrase: "were from Macherey-Nagel"

Phrase: "(Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: ")."
Processing 00000000.tx.60: Expression and Purification of Recombinant -Synuclein-- Human -Syn cDNAs, both wild-type and a mutant (A53T), were subcloned into the plasmid pET-28a (Novagen), using NcoI and HindIII restriction sites. 

Phrase: "Expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "Purification of Recombinant -Synuclein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0243114:purification [Functional Concept]
   770   C1998793:Purification [Functional Concept]

Phrase: "--"

Phrase: "Human -Syn cDNAs,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "both wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "a mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "(A53T"

Phrase: ")"

Phrase: ","

Phrase: "were"

Phrase: "subcloned into the plasmid pET-28a"

Phrase: "(Novagen"

Phrase: ")"

Phrase: ","

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "NcoI"

Phrase: "and"

Phrase: "HindIII restriction sites."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   867   C1882940:Restriction Site [Nucleotide Sequence]
   827   C0205145:Sites [Spatial Concept]
   827   C0443288:Restriction [Functional Concept]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]
Processing 00000000.tx.61: -Syn was overexpressed in Escherichia coli BL21 (DE3) via an isopropyl-1-thio--D-galactopyranoside-inducible T7 promoter. 

Phrase: "-Syn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "overexpressed in Escherichia coli BL21"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0014834:Escherichia coli [Bacterium]
   760   C0014833:Escherichia [Bacterium]
   760   C0450615:BL21 [Body Location or Region]
   726   C1514559:overexpress [Genetic Function]

Phrase: "(DE3"

Phrase: ")"

Phrase: "via an isopropyl-1-thio"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1412102:THIO [Gene or Genome]

Phrase: "-"

Phrase: "-"

Phrase: "D-"

Phrase: "galactopyranoside-inducible T7 promoter."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.62: The bacterial pellet was resuspended in phosphate-buffered saline (PBS) containing 1mM phenylmethylsulfonyl fluoride. 

Phrase: "The bacterial pellet"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441436:Pellet [Manufactured Object]
   861   C0993610:Pellet [Biomedical or Dental Material]
   861   C1998480:Pellet [Quantitative Concept]

Phrase: "was"

Phrase: "resuspended in phosphate-buffered saline (PBS) containing 1mM phenylmethylsulfonyl fluoride."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   764   C0031493:Phenylmethylsulfonyl Fluoride [Organic Chemical,Pharmacologic Substance]
   762   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   742   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   742   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]
   742   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   742   C0031701:phosphate [Organophosphorus Compound]
   742   C0036082:Saline [Substance]
   742   C0332256:Containing [Functional Concept]
   742   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   742   C2700400:Containing [Activity]
Processing 00000000.tx.63: The bacterial suspension was then sonicated for 30s several times, boiled for 15min, and ultracentrifuged at 150,000g for 30min. 

Phrase: "The bacterial suspension"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0038960:Suspension [Biomedical or Dental Material]
   861   C1382107:Suspension [Substance]
   861   C1705537:Suspension [Functional Concept]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "sonicated for 30s several times,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0040223:times [Temporal Concept]
   760   C0227073:30S [Body Part, Organ, or Organ Component]
   760   C1632851:Times [Quantitative Concept]
   726 E C3541383:Time [Temporal Concept]

Phrase: "boiled for 15min,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0242301:Boil [Disease or Syndrome]
   756   C1546559:Boil [Intellectual Product]

Phrase: "and"

Phrase: "ultracentrifuged at 150,"

Phrase: "000g for 30min."
Processing 00000000.tx.64: The supernatant containing the heat-stable -Syn was dialyzed against 50mM Tris, pH 8.3,loaded onto a Q-Sepharose column (Amersham Pharmacia Biotech), and eluted with a 0-500 mM NaCl step gradient. 

Phrase: "The supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the heat-stable -Syn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "dialyzed against 50mM Tris,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   770   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   770   C0450400:50mm [Quantitative Concept]
   770   C0814229:TRI [Intellectual Product]

Phrase: "pH 8.3,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C0601906:PH 3 [Pharmacologic Substance]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "loaded onto a Q-Sepharose column"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   753   C0036681:Sepharose [Carbohydrate]
   753   C1185738:Column [Body Part, Organ, or Organ Component]
   753   C1706132:Column [Idea or Concept]
   753   C1708715:Loaded [Activity]
   719 E C1550025:Load [Idea or Concept]
   719 E C1704782:Load [Manufactured Object]

Phrase: "(Amersham Pharmacia Biotech"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0331955:Pharmacia [Health Care Related Organization]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "eluted with a 0-500 mM NaCl step gradient."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   742   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   742   C0439182:% gradient [Quantitative Concept]
   742   C0812409:Gradient [Quantitative Concept]
   742   C1261552:Step [Conceptual Entity]
   742   C1704379:Step [Functional Concept]
   742   C1705117:Step [Quantitative Concept]
   742   C1959973:% NaCl [Quantitative Concept]
   742   C2825408:Step [Manufactured Object]
Processing 00000000.tx.65: The eluents were desalted and concentrated on a Centricon-10 (Millipore) in 5mM phosphate buffer, pH 7.3.

Phrase: "The eluents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C3469601:Eluent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "were"

Phrase: "desalted"

Phrase: "and"

Phrase: "concentrated on a Centricon-10"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C1880165:Concentrated [Biomedical or Dental Material]
   726 E C1880310:Concentrate [Manufactured Object]
   726 E C2003864:Concentrate [Substance]

Phrase: "(Millipore"

Phrase: ")"

Phrase: "in 5mM phosphate buffer,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "pH 7.3."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C0601906:PH 3 [Pharmacologic Substance]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]
Processing 00000000.tx.66: Aliquots of each purification step were analyzed by SDS-polyacrylamide gel electrophoresis to confirm purity. 

Phrase: "Aliquots of each purification step"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1510844:Aliquot [Quantitative Concept]

Phrase: "were"

Phrase: "analyzed by SDS-polyacrylamide gel electrophoresis to"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   853   C0600209:SDS polyacrylamide gel electrophoresis [Laboratory Procedure,Research Activity]
   814   C0013862:Polyacrylamide Gel Electrophoresis [Laboratory Procedure]
   778   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   778   C0596607:Gel Electrophoresis [Laboratory Procedure]
   774 E C0972569:Electrophoresis Gel [Indicator, Reagent, or Diagnostic Aid]
   748   C0013855:Electrophoresis [Laboratory Procedure]
   748   C0017243:Gel [Biomedical or Dental Material]
   748   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   748   C0936012:Analyzed [Research Activity]
   748   C1382104:Gel [Substance]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "purity."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1882508:Purity [Quantitative Concept]
   928 E C2247561:PurE [Molecular Function]
Processing 00000000.tx.67: Protein concentration was determined by Lowry assay. 

Phrase: "Protein concentration"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0427716:Protein concentration [Laboratory Procedure]
  1000   C1304757:Protein concentration [Laboratory or Test Result]
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "was"

Phrase: "determined by Lowry assay."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0005507:Assay [Laboratory Procedure]
   770   C0243073:assay [Qualitative Concept]
   770   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.68: Binding of -Synuclein to Synthetic Phospholipid Vesicles-- Multilamellar vesicles (MLVs) of various phospholipids were prepared by suspending the dry phospholipid film in PBS, pH 7.3,and vortexing for 10min. 

Phrase: "Binding of -Synuclein to Synthetic Phospholipid Vesicles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "--"

Phrase: "Multilamellar vesicles (MLVs) of various phospholipids"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0333262:VESICLES [Acquired Abnormality]
   726 E C1622418:vesicle [Cell Component]

Phrase: "were"

Phrase: "prepared by suspending"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0038959:Suspending [Biomedical or Dental Material]
   790   C1705537:suspending [Functional Concept]
   756   C1521827:Prepare [Functional Concept]

Phrase: "the dry phospholipid film in PBS,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0086296:Film [Manufactured Object]
   744   C1561571:film [Biomedical or Dental Material]
   744   C1561572:film [Substance]

Phrase: "pH 7.3,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C0601906:PH 3 [Pharmacologic Substance]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "and"

Phrase: "vortexing for 10min."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0439648:vortexing [Spatial Concept]
   790   C0724378:vortexing [Organic Chemical,Pharmacologic Substance]
   756 E C2719416:Vortex [Pharmacologic Substance]
Processing 00000000.tx.69: Small unilamellar vesicles (SUVs) were subsequently prepared by sonicating MLVs using a probe sonicator for 10s several times with intermittent 30-s cooling period at 0C (42). 

Phrase: "Small unilamellar vesicles (SUVs)"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C1881413:Small Unilamellar Vesicles [Chemical Viewed Structurally]
   901   C1721092:Unilamellar Vesicles [Lipid]
   827   C0333262:VESICLES [Acquired Abnormality]
   827   C0700321:Small [Quantitative Concept]
   793 E C1622418:vesicle [Cell Component]
   743 E C0205378:Vesicular [Qualitative Concept]

Phrase: "were"

Phrase: "subsequently"

Phrase: "prepared by sonicating MLVs"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0333262:VESICLES [Acquired Abnormality]
   726   C1521827:Prepare [Functional Concept]
   726 E C1622418:vesicle [Cell Component]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a probe sonicator for 10s several times"

Phrase: "with intermittent 30-s cooling period"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   804   C0439531:/period [Temporal Concept]
   804   C1948053:Period [Temporal Concept]
   733 E C0332182:Periodic [Temporal Concept]
   733 E C1706381:PERIODIC [Intellectual Product]
   704 E C0031084:Periodicities [Temporal Concept]

Phrase: "at 0C"

Phrase: "(42"

Phrase: ")."
Processing 00000000.tx.70: -Syn (final concentration 0.2mg/ml) was mixed with MLVs or SUVs (final concentration 0.5-4 mg/ml) in 500l of PBS to give a 2.5:1 to 20:1 weight ratio of phospholipid to -Syn. 

Phrase: "-Syn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(final concentration 0.2mg/ml)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0439526:/mL [Quantitative Concept]

Phrase: "was"

Phrase: "mixed with MLVs"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0205430:Mixed [Functional Concept]
   770   C0333262:VESICLES [Acquired Abnormality]
   770   C3160715:Mixed [Finding]
   737 E C1421951:MIX [Gene or Genome]
   737 E C1622418:vesicle [Cell Component]
   737 E C1720722:Mix [Qualitative Concept]

Phrase: "or"

Phrase: "SUVs"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C1881413:Small Unilamellar Vesicles [Chemical Viewed Structurally]
   901   C1721092:Unilamellar Vesicles [Lipid]
   827   C0333262:VESICLES [Acquired Abnormality]
   827   C0700321:Small [Quantitative Concept]
   793 E C1622418:vesicle [Cell Component]
   743 E C0205378:Vesicular [Qualitative Concept]

Phrase: "(final concentration 0.5-4 mg/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0439269:mg% [Quantitative Concept]
   799   C1960952:mg % [Quantitative Concept]
   799   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "ml) in 500l of PBS to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0439526:/mL [Quantitative Concept]

Phrase: "give"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947971:Give [Functional Concept]

Phrase: "a 2.5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0450346:2 5 [Quantitative Concept]
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: ":"

Phrase: "1 to 20"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C2827734:1+ [Quantitative Concept]
   790   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1 weight ratio of phospholipid to -Syn."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C1271592:Phospholipid ratio [Laboratory Procedure]
   748   C0456603:Ratio [Quantitative Concept]
   748   C1547037:Ratio [Intellectual Product]
Processing 00000000.tx.71: The mixture was incubated for 2or 24h at 25C. 

Phrase: "The mixture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439962:Mixture [Substance]

Phrase: "was"

Phrase: "incubated for 2or 24h"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0456696:/24h [Temporal Concept]
   770   C1439852:Incubated [Laboratory Procedure]
   770   C1442770:24H [Temporal Concept]

Phrase: "at 25C."
Processing 00000000.tx.72: For MLVs containing -Syn, the dry phospholipid film was dispersed in -Syn solution, and the mixture was vortexed for 10min. 

Phrase: "For MLVs"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0333262:VESICLES [Acquired Abnormality]
   827 E C1622418:vesicle [Cell Component]
   777 E C0205378:Vesicular [Qualitative Concept]

Phrase: "containing -Syn,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0332256:Containing [Functional Concept]
   861   C2700400:Containing [Activity]

Phrase: "the dry phospholipid film"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0086296:Film [Manufactured Object]
   827   C1561571:film [Biomedical or Dental Material]
   827   C1561572:film [Substance]

Phrase: "was"

Phrase: "dispersed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332624:Dispersed [Spatial Concept]

Phrase: "in -Syn solution,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037633:Solution [Substance]
   827   C0525069:Solution [Biomedical or Dental Material]

Phrase: "and"

Phrase: "the mixture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439962:Mixture [Substance]

Phrase: "was"

Phrase: "vortexed for 10min."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0439648:vortexed [Spatial Concept]
   790   C0724378:vortexed [Organic Chemical,Pharmacologic Substance]
   756 E C2719416:Vortex [Pharmacologic Substance]
Processing 00000000.tx.73: For salt-dependent binding studies, the lipids were dispersed in 5mM phosphate buffer, pH 7.0,containing both -Syn and varying concentrations of NaCl (0-800 mM). 

Phrase: "For salt-dependent binding studies,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0947630:studies [Laboratory Procedure]
   779 E C0557651:Study [Manufactured Object]
   779 E C2603343:Study [Research Activity]

Phrase: "the lipids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023779:Lipids [Lipid]

Phrase: "were"

Phrase: "dispersed in 5mM phosphate buffer,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   760   C0031701:phosphate [Organophosphorus Compound]
   760   C0332624:Dispersed [Spatial Concept]
   760   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "pH 7.0,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "both -Syn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "varying concentrations of NaCl (0-800 mM"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0086045:Concentrations [Mental Process]
   714 E C1446561:Concentration [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.74: As a control, -Syn alone was dissolved in 5mM phosphate buffer containing 0,200,and 800mM NaCl. 

Phrase: "As a control, -Syn"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0243148:control [Qualitative Concept]
   812   C1550141:Control [Substance]
   812   C1882979:Control [Conceptual Entity]
   812   C2587213:Control [Functional Concept]
   812   C3274648:Control [Qualitative Concept]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "was"

Phrase: "dissolved in 5mM phosphate buffer"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   760   C0031701:phosphate [Organophosphorus Compound]
   760   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   726   C1549535:Dissolve [Functional Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0,"

Phrase: "200,"

Phrase: "and"

Phrase: "800mM NaCl."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]
Processing 00000000.tx.75: Circular Dichroism Spectroscopy-- CD spectra were recorded on a Jasco J-715 spectropolarimeter at room temperature. 

Phrase: "Circular Dichroism Spectroscopy"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1519445:Spectroscopy, Circular Dichroism [Natural Phenomenon or Process]
   827   C0037812:spectroscopy [Laboratory Procedure]
   827   C2713504:Spectroscopy [Occupation or Discipline]
   827   C2984732:SPECTROSCOPY [Functional Concept]
   734   C0008813:Circular Dichroism [Laboratory Procedure]

Phrase: "--"

Phrase: "CD spectra"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1883073:Spectrum [Quantitative Concept]
   793   C2827424:Spectrum [Conceptual Entity]
   734   C0008813:Circular Dichroism [Laboratory Procedure]

Phrase: "were"

Phrase: "recorded on a Jasco J-715 spectropolarimeter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C0034869:Record [Intellectual Product]

Phrase: "at room temperature."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]
Processing 00000000.tx.76: Incubated samples were placed in a 1-mm path length quartz cell to minimize the absorbance due to buffer components. 

Phrase: "Incubated samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "placed in a 1-mm path length quartz cell to"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   757   C1418486:MM-1 [Gene or Genome]
   739   C0007634:Cell [Cell]
   739   C0034387:Quartz [Inorganic Chemical]
   739   C0919386:PATH [Laboratory Procedure]
   739   C1269647:Cell [Cell]
   739   C1444754:Length [Quantitative Concept]
   739   C1704653:Cell [Medical Device]
   739   C1705483:Path [Intellectual Product]
   739   C1706316:LENGTH [Research Activity]
   739   C1948049:Cell [Spatial Concept]
   706   C0442504:Place [Spatial Concept]
   706   C1704765:Place [Functional Concept]
   706   C1882509:Place [Activity]
   706   C3496241:place [Disease or Syndrome]

Phrase: "minimize"

Phrase: "the absorbance due to buffer components."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1268822:Absorbance [Clinical Attribute]
   753   C2825050:Absorbance [Phenomenon or Process]
Processing 00000000.tx.77: Spectra were obtained from 195to 250nm, with a 0.5-nm step, 1-nm band width, and a speed of 20nm/min. 

Phrase: "Spectra"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1883073:Spectrum [Quantitative Concept]
   966   C2827424:Spectrum [Conceptual Entity]

Phrase: "were"

Phrase: "obtained from 195to 250nm,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]

Phrase: "with a 0.5-nm step,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C1261552:Step [Conceptual Entity]
   812   C1704379:Step [Functional Concept]
   812   C1705117:Step [Quantitative Concept]
   812   C2825408:Step [Manufactured Object]

Phrase: "1-nm band width,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   812   C0175723:Band [Medical Device]
   812   C0439645:Band [Spatial Concept]
   812   C0487742:Width [Quantitative Concept]
   812   C1521913:band [Cell Component]
   741 E C0332464:Wide [Spatial Concept]

Phrase: "and"

Phrase: "a speed of 20nm/min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0678536:Speed [Quantitative Concept]
Processing 00000000.tx.78: Three scans per sample were averaged. 

Phrase: "Three scans per sample"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0034606:Scan [Diagnostic Procedure]
   770   C0441633:Scan [Diagnostic Procedure]
   770   C2826292:SCAN [Finding]

Phrase: "were"

Phrase: "averaged."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1510992:Average [Quantitative Concept]
   966   C2825518:AVERAGE [Quantitative Concept]
Processing 00000000.tx.79: All spectra were corrected by subtracting background spectrum of the buffer or the lipid vesicles. 

Phrase: "All spectra"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1883073:Spectrum [Quantitative Concept]
   966   C2827424:Spectrum [Conceptual Entity]

Phrase: "were"

Phrase: "corrected by subtracting background spectrum of the buffer"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   744   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   744   C0205202:Corrected [Qualitative Concept]
   744   C1706907:Background [Conceptual Entity]
   744   C1883073:Spectrum [Quantitative Concept]
   744   C2827424:Spectrum [Conceptual Entity]
   711   C1719767:Subtract [Intellectual Product]
   711   C2348589:Subtract [Phenomenon or Process]
   711 E C2349182:Correct [Qualitative Concept]

Phrase: "or"

Phrase: "the lipid vesicles."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0333262:VESICLES [Acquired Abnormality]
   827 E C1622418:vesicle [Cell Component]
   777 E C0205378:Vesicular [Qualitative Concept]
Processing 00000000.tx.80: Extraction of Brain Lipids-- Cerebellum (0.5-1 g) or temporal cortex from human brain (non-diseased, 92yr-old male) was homogenized with a Polytron in 1.8ml of PBS. 

Phrase: "Extraction of Brain Lipids"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0185115:Extraction [Therapeutic or Preventive Procedure]
   770   C0684295:extraction [Laboratory Procedure]

Phrase: "--"

Phrase: "Cerebellum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007765:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1268981:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1707522:Cerebellum [Tissue]

Phrase: "(0.5-1 g)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439267:g% [Quantitative Concept]

Phrase: "or"

Phrase: "temporal cortex from human brain"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0039485:Temporal cortex [Body Part, Organ, or Organ Component]
   797   C1508538:Brain.temporal [Body Part, Organ, or Organ Component]
   760   C0007776:Cortex [Body Part, Organ, or Organ Component]
   760   C0442043:Temporal [Spatial Concept]
   760   C1176472:Cortex [Body Part, Organ, or Organ Component]
   760   C2362314:Temporal [Temporal Concept]
   760   C2700441:Cortex [Plant]

Phrase: "(non-diseased, 92yr-old male"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0024554:Male [Finding]
   804   C0086582:male [Population Group]
   804   C1706180:Male [Qualitative Concept]
   804   C1706428:Male [Qualitative Concept]
   804   C1706429:Male [Organism Attribute]

Phrase: ")"

Phrase: "was"

Phrase: "homogenized with a Polytron"

Phrase: "in 1.8ml"

Phrase: "of PBS."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0036082:Saline [Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
Processing 00000000.tx.81: Chloroform and methanol (2:1) were added to the brain homogenate to give a Folch partition, chloroform:methanol:water (PBS)=2:1:0.6. 

Phrase: "Chloroform"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008238:Chloroform [Hazardous or Poisonous Substance,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "and"

Phrase: "methanol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001963:Methanol [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "were"

Phrase: "added to the brain homogenate to"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0006104:Brain [Body Part, Organ, or Organ Component]
   753   C1269537:Brain [Body Part, Organ, or Organ Component]
   753   C1524062:Added [Functional Concept]
   719 E C1883712:Add [Functional Concept]

Phrase: "give"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947971:Give [Functional Concept]

Phrase: "a Folch partition,"

Phrase: "chloroform:methanol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0001963:Methanol [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   861   C0008238:Chloroform [Hazardous or Poisonous Substance,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: ":"

Phrase: "water"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
  1000   C0599638:WATER [Substance]
  1000   C1550678:Water [Inorganic Chemical]
   928 E C0443350:Watery [Qualitative Concept]

Phrase: "(PBS"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0036082:Saline [Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "=2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "0.6."
Processing 00000000.tx.82: The mixture was vortexed vigorously and allowed to separate in a separatory funnel. 

Phrase: "The mixture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439962:Mixture [Substance]

Phrase: "was"

Phrase: "vortexed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0439648:vortexed [Spatial Concept]
  1000   C0724378:vortexed [Organic Chemical,Pharmacologic Substance]
   966 E C2719416:Vortex [Pharmacologic Substance]

Phrase: "vigorously"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1690553:Vigorously [Qualitative Concept]

Phrase: "and"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "separate in a separatory funnel."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0443299:Separate [Spatial Concept]
Processing 00000000.tx.83: After 3h when both phases were clear, the lower phase was recovered and filtered. 

Phrase: "After 3h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442460:3H [Temporal Concept]

Phrase: "when"

Phrase: "both phases"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0585064:Phases [Temporal Concept]
  1000   C1067936:Phasis [Eukaryote]
   966 E C0205390:Phase [Temporal Concept]

Phrase: "were"

Phrase: "clear,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "the lower phase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205390:Phase [Temporal Concept]

Phrase: "was"

Phrase: "recovered"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0521108:recovered [Qualitative Concept]
   966 E C2004454:recover [Organism Function]

Phrase: "and"

Phrase: "filtered."
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   966   C0180860:Filter [Manufactured Object]
   966   C0581406:Filter [Medical Device]
   966   C1522664:Filter [Intellectual Product]
   966   C1704449:Filter [Conceptual Entity]
   966   C1704684:Filter [Medical Device]
   966   C1875155:FILTER [Medical Device]
   928 E C0080194:Strain [Injury or Poisoning]
   928 E C0442694:Straining [Physiologic Function]
   928 E C0456178:strain [Intellectual Product]
   928 E C1518614:Strain [Organism]
   928 E C2987481:Strain [Mental Process]
Processing 00000000.tx.84: The upper phase was re-extracted with theoretical lower phase (chloroform:methanol:water=86:14:1). 

Phrase: "The upper phase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205390:Phase [Temporal Concept]

Phrase: "was"

Phrase: "re-extracted with theoretical lower phase"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   753   C0185115:Extracted [Therapeutic or Preventive Procedure]
   753   C0205390:Phase [Temporal Concept]
   753   C0441994:Lower [Spatial Concept]
   753   C0871935:Theoretical [Idea or Concept]
   753   C1548802:Lower [Body Location or Region]
   753   C2003888:Lower [Activity]
   753   C2986904:RE [Idea or Concept]
   753   C3541890:EXTRACTED [Finding]
   719 E C2828366:Extract [Substance]

Phrase: "(chloroform:methanol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0001963:Methanol [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   861   C0008238:Chloroform [Hazardous or Poisonous Substance,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: ":"

Phrase: "water"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
  1000   C0599638:WATER [Substance]
  1000   C1550678:Water [Inorganic Chemical]
   928 E C0443350:Watery [Qualitative Concept]

Phrase: "=86"

Phrase: ":"

Phrase: "14"

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.85: The filtered lower phases were dried under a stream of nitrogen gas. 

Phrase: "The filtered lower phases"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0585064:Phases [Temporal Concept]
   827   C1067936:Phasis [Eukaryote]
   793 E C0205390:Phase [Temporal Concept]

Phrase: "were"

Phrase: "dried under a stream of nitrogen gas."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   778   C0301294:Nitrogen gas [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C0017110:Gas [Chemical Viewed Structurally]
   748   C0028158:Nitrogen [Element, Ion, or Isotope]
   748   C0442540:Stream [Natural Phenomenon or Process]
   748   C0596601:Gas [Sign or Symptom]
   748   C1512080:Dried [Qualitative Concept]
   748   C1550581:nitrogen [Human-caused Phenomenon or Process]
   748   C2827485:Dried [Body Substance]
   714 E C0011682:Dry [Natural Phenomenon or Process]
   714 E C0205222:Dry [Qualitative Concept]
Processing 00000000.tx.86: The resulting lipid films were dissolved in 0.4-4 ml of chloroform:methanol (2:1) and kept at 20C until use. 

Phrase: "The resulting lipid films"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0086296:Films [Manufactured Object]
   793 E C1561571:film [Biomedical or Dental Material]
   793 E C1561572:film [Substance]

Phrase: "were"

Phrase: "dissolved in 0.4-4 ml of chloroform:methanol"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0001963:Methanol [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   742   C0008238:Chloroform [Hazardous or Poisonous Substance,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   742   C0439526:/mL [Quantitative Concept]
   708   C1549535:Dissolve [Functional Concept]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "kept at 20C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0333118:Keep [Functional Concept]

Phrase: "until use."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]
Processing 00000000.tx.87: The final upper phase was lyophilized and dissolved in 200l of chloroform:methanol (2:1). 

Phrase: "The final upper phase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205390:Phase [Temporal Concept]

Phrase: "was"

Phrase: "lyophilized"

Phrase: "and"

Phrase: "dissolved in 200l of chloroform:methanol"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0001963:Methanol [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   753   C0008238:Chloroform [Hazardous or Poisonous Substance,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   719   C1549535:Dissolve [Functional Concept]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.88: Thin Layer Chromatography (TLC)-- Chloroform, methanol, and 0.25% KCl were combined at a ratio of 5:4:1 and used as a standard TLC running solvent. 

Phrase: "Thin Layer Chromatography"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0008569:Thin Layer Chromatography [Laboratory Procedure]
   827   C0008550:Chromatography [Laboratory Procedure]
   827   C0205168:Thin [Qualitative Concept]
   827   C0934502:Layer [Body Part, Organ, or Organ Component]
   827   C1522408:Layer [Qualitative Concept]
   827   C1561599:Layer [Intellectual Product]
   755 E C0039870:Thinness [Finding]
   727 E C0302647:chromatograph [Medical Device]

Phrase: "(TLC"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0008569:Thin Layer Chromatography [Laboratory Procedure]
   827   C0008550:Chromatography [Laboratory Procedure]
   827   C0205168:Thin [Qualitative Concept]
   827   C0934502:Layer [Body Part, Organ, or Organ Component]
   827   C1522408:Layer [Qualitative Concept]
   827   C1561599:Layer [Intellectual Product]
   755 E C0039870:Thinness [Finding]
   727 E C0302647:chromatograph [Medical Device]

Phrase: ")"

Phrase: "--"

Phrase: "Chloroform,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008238:Chloroform [Hazardous or Poisonous Substance,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "methanol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001963:Methanol [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "0.25% KCl"

Phrase: "were"

Phrase: "combined at a ratio of 5"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0205195:Combined [Qualitative Concept]
   753   C0456603:Ratio [Quantitative Concept]
   753   C1547037:Ratio [Intellectual Product]
   719 E C0336789:Combine [Manufactured Object]

Phrase: ":"

Phrase: "4"

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "and"

Phrase: "used as a standard TLC running solvent."
Meta Candidates (Total=17; Excluded=5; Pruned=0; Remaining=12)
   790   C0008569:Thin Layer Chromatography [Laboratory Procedure]
   742   C0008550:Chromatography [Laboratory Procedure]
   742   C0035953:Running [Daily or Recreational Activity]
   742   C0037638:Solvent [Indicator, Reagent, or Diagnostic Aid]
   742   C0205168:Thin [Qualitative Concept]
   742   C0934502:Layer [Body Part, Organ, or Organ Component]
   742   C1273517:used [Finding]
   742   C1442989:Standard [Qualitative Concept]
   742   C1522408:Layer [Qualitative Concept]
   742   C1561599:Layer [Intellectual Product]
   742   C2346414:Running [Finding]
   742   C2828392:Standard [Intellectual Product]
   708 E C0042153:use [Functional Concept]
   708 E C0457083:Use [Functional Concept]
   708 E C0600140:run [Finding]
   708 E C1704688:Run [Functional Concept]
   708 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.89: Human cerebellar lipid extracts along with phospholipid standards (2-15 g per lane) were applied to silica gel TLC plates and run until the solvent front was ~1 cm below the top of the plate. 

Phrase: "Human cerebellar lipid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0023779:Lipid [Lipid]

Phrase: "extracts along with phospholipid standards"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0031676:Phospholipid [Biologically Active Substance,Lipid]
   760   C0038137:standards [Intellectual Product]
   760   C0175675:Standards [Qualitative Concept]
   760   C0202177:Phospholipid [Laboratory Procedure]
   760   C2828366:Extract [Substance]
   726 E C1442989:Standard [Qualitative Concept]
   726 E C2828392:Standard [Intellectual Product]

Phrase: "(2-15 g per lane"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439267:g% [Quantitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "applied to silica gel TLC plates"
Meta Candidates (Total=17; Excluded=4; Pruned=0; Remaining=13)
   800   C0008569:Thin Layer Chromatography [Laboratory Procedure]
   770   C2936385:Silica Gel [Biomedical or Dental Material,Inorganic Chemical]
   767   C0008559:Gel Chromatography [Laboratory Procedure]
   744   C0008550:Chromatography [Laboratory Procedure]
   744   C0017243:Gel [Biomedical or Dental Material]
   744   C0037098:Silica [Biomedical or Dental Material,Inorganic Chemical]
   744   C0185125:Applied [Health Care Activity]
   744   C0205168:Thin [Qualitative Concept]
   744   C0934502:Layer [Body Part, Organ, or Organ Component]
   744   C1139930:plates [Medical Device]
   744   C1382104:Gel [Substance]
   744   C1522408:Layer [Qualitative Concept]
   744   C1561599:Layer [Intellectual Product]
   711 E C0005971:Plate [Medical Device]
   711 E C1632850:Apply [Functional Concept]
   711 E C1879355:Apply [Functional Concept]
   711 E C3537155:Plate [Manufactured Object]

Phrase: "and"

Phrase: "run until the solvent front"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0035953:run [Daily or Recreational Activity]
   760   C0600140:run [Finding]
   760   C1704688:Run [Functional Concept]
   760   C2346414:Run [Finding]

Phrase: "was ~"

Phrase: "1 cm below the top of the plate."
Processing 00000000.tx.90: After being air-dried, the TLC plate was cut in half, turning to twin plates, one for the detection of total lipids and the other for the overlay with -Syn. 

Phrase: "After"

Phrase: "being"

Phrase: "air-dried"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0001861:Air [Substance]
   861   C1512080:Dried [Qualitative Concept]
   861   C2827485:Dried [Body Substance]
   861   C3536832:Air [Inorganic Chemical,Pharmacologic Substance]
   827 E C0011682:Dry [Natural Phenomenon or Process]
   827 E C0205222:Dry [Qualitative Concept]
   777 E C0070924:AIRS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ","

Phrase: "the TLC plate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0005971:Plate [Medical Device]
   812   C1139930:plate [Medical Device]
   812   C3537155:Plate [Manufactured Object]
   756   C0008569:Thin Layer Chromatography [Laboratory Procedure]

Phrase: "was"

Phrase: "cut in half,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0000925:Cut [Injury or Poisoning]
   790   C1883724:CUT [Phenomenon or Process]
   790   C2825407:Half [Quantitative Concept]

Phrase: "turning to twin plates,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0041427:Twin [Family Group]
   770   C0205173:Twin [Functional Concept]
   770   C0541749:turning [Finding]
   770   C1139930:plates [Medical Device]
   737 E C0005971:Plate [Medical Device]
   737 E C1709743:Turn [Spatial Concept]
   737 E C3537155:Plate [Manufactured Object]

Phrase: "one for the detection of total lipids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205447:One [Quantitative Concept]

Phrase: "and"

Phrase: "the other for the overlay with -Syn."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0444456:Overlay [Spatial Concept]
   748   C1706359:Overlay [Medical Device]
Processing 00000000.tx.91: For total lipids, the TLC plate was sprayed with a mixture of 10% CuSO4H2O and 8% H3PO4 and heated for 5min at 170C (43). 

Phrase: "For total lipids,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0369610:Total lipids [Finding]
   861   C0023779:Lipids [Lipid]
   861   C0439175:% total [Quantitative Concept]
   861   C0439810:Total [Qualitative Concept]

Phrase: "the TLC plate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0005971:Plate [Medical Device]
   812   C1139930:plate [Medical Device]
   812   C3537155:Plate [Manufactured Object]
   756   C0008569:Thin Layer Chromatography [Laboratory Procedure]

Phrase: "was"

Phrase: "sprayed with a mixture of 10% CuSO4H2O"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   748   C0233601:sprayed [Mental or Behavioral Dysfunction]
   748   C0439962:Mixture [Substance]
   714 E C1704413:{Spray} [Quantitative Concept]
   714 E C2003858:Spray [Functional Concept]

Phrase: "and"

Phrase: "8% H3PO4"

Phrase: "and"

Phrase: "heated for 5min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0018837:Heat [Natural Phenomenon or Process]

Phrase: "at 170C"

Phrase: "(43"

Phrase: ")."
Processing 00000000.tx.92: To detect PE and PS, which contain amide groups, the TLC plate was alternatively sprayed with 0.5% ninhydrin (Sigma) in a mixture of 20ml of glacial acetic acid and 80ml of ethanol and heated for 5min at 110C. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "PE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031618:Phosphatidyl ethanolamine [Biologically Active Substance,Lipid]
  1000   C1450468:phosphatidylethanolamine [Lipid,Pharmacologic Substance]

Phrase: "and"

Phrase: "PS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031623:phosphatidylserine [Lipid]
  1000   C0301704:Phosphatidyl serine [Lipid]

Phrase: "which"

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "amide groups,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1552839:groups [Idea or Concept]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "the TLC plate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0005971:Plate [Medical Device]
   812   C1139930:plate [Medical Device]
   812   C3537155:Plate [Manufactured Object]
   756   C0008569:Thin Layer Chromatography [Laboratory Procedure]

Phrase: "was"

Phrase: "alternatively"

Phrase: "sprayed with 0.5% ninhydrin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   806   C0444499:0/5 [Quantitative Concept]
   760   C0028098:Ninhydrin [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   760   C0233601:sprayed [Mental or Behavioral Dysfunction]
   726 E C1704413:{Spray} [Quantitative Concept]
   726 E C2003858:Spray [Functional Concept]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "in a mixture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439962:Mixture [Substance]

Phrase: "of 20ml"

Phrase: "of glacial acetic acid"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0000983:Glacial Acetic Acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
           Acetic Acid
   901   C0000985:Acetic acid [Organic Chemical]
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]
   827   C0981805:ACETIC [Organic Chemical,Pharmacologic Substance]
   771 E C0148405:Vinegar [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "80ml of ethanol"

Phrase: "and"

Phrase: "heated for 5min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0018837:Heat [Natural Phenomenon or Process]

Phrase: "at 110C."
Processing 00000000.tx.93: Lipid Overlay with -Synuclein-- TLC plates were treated with poly(isobutyl methacrylate) to prevent silica loss and to orient the lipid head groups suitable for ligand binding (44). 

Phrase: "Lipid Overlay with -Synuclein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0444456:Overlay [Spatial Concept]
   770   C1706359:Overlay [Medical Device]

Phrase: "--"

Phrase: "TLC plates"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   812   C1139930:plates [Medical Device]
   779 E C0005971:Plate [Medical Device]
   779 E C3537155:Plate [Manufactured Object]
   756   C0008569:Thin Layer Chromatography [Laboratory Procedure]

Phrase: "were"

Phrase: "treated with poly(isobutyl methacrylate"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   862   C0071441:poly(isobutyl methacrylate) [Organic Chemical]
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   760   C0025601:methacrylate [Organic Chemical]
   760   C0032400:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0071360:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0747726:POLY [Conceptual Entity]
   760   C1522326:Treated [Functional Concept]
   760   C2828373:Methacrylate [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   726 E C1292734:TREAT [Functional Concept]

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "silica loss"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1517945:Loss [Quantitative Concept]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "orient"

Phrase: "the lipid head groups"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   827   C0018670:Head [Body Location or Region]
   827   C0441833:Group [Idea or Concept]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1281590:Head [Body Part, Organ, or Organ Component]
   827   C1552516:Group [Health Care Related Organization]
   827   C1552839:groups [Idea or Concept]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]
   827   C1706305:Head [Manufactured Object]
   771 E C0205096:Cephalic [Spatial Concept]

Phrase: "suitable for ligand binding"

Phrase: "(44"

Phrase: ")."
Processing 00000000.tx.94: To block nonspecific binding, plates were incubated in 0.6% gelatin with shaking for 1h at 37C. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "nonspecific binding,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0205370:Non-specific [Qualitative Concept]
   861   C0243122:binding [Functional Concept]
   861   C0750540:Nonspecific [Idea or Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "plates"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1139930:plates [Medical Device]
   966 E C0005971:Plate [Medical Device]
   966 E C3537155:Plate [Manufactured Object]

Phrase: "were"

Phrase: "incubated in 0.6% gelatin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0017237:Gelatin [Amino Acid, Peptide, or Protein,Biomedical or Dental Material,Pharmacologic Substance]
   760   C1145617:Gelatin [Food]
   760   C1439852:Incubated [Laboratory Procedure]

Phrase: "with shaking"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040822:Shaking [Sign or Symptom]
   966 E C1883023:Shake [Activity]

Phrase: "for 1h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: "at 37C."
Processing 00000000.tx.95: After a brief rinse with Tris-buffered saline (TBS), pH 7.6,the TLC plate was incubated with 2mg of -Syn in 7ml of TBS overnight at room temperature. 

Phrase: "After a brief rinse"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1701810:Rinse [Functional Concept]
   861   C1882955:Rinse [Activity]

Phrase: "with Tris-buffered saline (TBS),"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0041175:Tris Buffer [Organic Chemical,Pharmacologic Substance]
           TRIS
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0036082:Saline [Substance]
   827   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   827   C0814229:TRI [Intellectual Product]

Phrase: "pH 7.6,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "the TLC plate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0005971:Plate [Medical Device]
   812   C1139930:plate [Medical Device]
   812   C3537155:Plate [Manufactured Object]
   756   C0008569:Thin Layer Chromatography [Laboratory Procedure]

Phrase: "was"

Phrase: "incubated with 2mg of -Syn"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1439852:Incubated [Laboratory Procedure]

Phrase: "in 7ml"

Phrase: "of TBS"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0041175:Tris Buffer [Organic Chemical,Pharmacologic Substance]
           TRIS
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0036082:Saline [Substance]
   827   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   827   C0814229:TRI [Intellectual Product]

Phrase: "overnight at room temperature."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439583:Overnight [Temporal Concept]
Processing 00000000.tx.96: After rinsing with TBS, the TLC plate was incubated with monoclonal anti--synuclein antibody. 

Phrase: "After"

Phrase: "rinsing with TBS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1882955:Rinsing [Activity]

Phrase: "the TLC plate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0005971:Plate [Medical Device]
   812   C1139930:plate [Medical Device]
   812   C3537155:Plate [Manufactured Object]
   756   C0008569:Thin Layer Chromatography [Laboratory Procedure]

Phrase: "was"

Phrase: "incubated with monoclonal anti"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0746619:monoclonal [Finding]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "--synuclein antibody."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.97: After extensive washing, synuclein immunoreactivity was detected by peroxidase-conjugated goat anti-mouse antibody and visualized by enhanced chemiluminescence (Amersham Pharmacia Biotech). 

Phrase: "After extensive washing,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0441648:Washing [Activity]

Phrase: "synuclein immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597879:immunoreactivity [Molecular Function]

Phrase: "was"

Phrase: "detected by peroxidase-conjugated goat anti-mouse antibody"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   767   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   744   C0018019:goat [Mammal]
   744   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   744   C0025914:Mouse [Mammal]
   744   C0025929:mouse [Mammal]
   744   C0026809:Mouse [Mammal]
   744   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0442726:Detected [Finding]
   744   C0522529:Conjugated [Spatial Concept]
   744   C1265549:goat [Mammal]
   744   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]
   744   C1510458:Goat [Mammal]
   744   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "visualized by enhanced chemiluminescence"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0162524:Chemiluminescence [Natural Phenomenon or Process]
   770   C0234621:Visualized [Functional Concept]
   770   C1450278:Chemiluminescence [Natural Phenomenon or Process]
   770   C2349975:Enhanced [Activity]

Phrase: "(Amersham Pharmacia Biotech"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0331955:Pharmacia [Health Care Related Organization]

Phrase: ")."
Processing 00000000.tx.98: Atomic Force Microscopy-- Solution tapping mode atomic force microscopy images were acquired on a Digital Instruments Nanoscope IIIA MultiMode scanning probe microscope (Digital Instruments, Santa Barbara, CA) using 120-m oxide-sharpened silicon nitride V-shaped cantilevers installed in combination contact/tapping mode liquid flow cell. 

Phrase: "Atomic Force Microscopy"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0242849:Microscopy, Atomic Force [Laboratory Procedure]
           Force Microscopy
   827   C0026018:Microscopy [Laboratory Procedure]
   827   C0441722:Force [Phenomenon or Process]
   827   C0563538:Force [Phenomenon or Process]
   771 E C0729333:Dynamic [Functional Concept]
   755 E C0205288:Microscopic [Qualitative Concept]
   755   C0567415:Atom [Element, Ion, or Isotope]
   755   C1706222:Atom [Conceptual Entity]

Phrase: "--"

Phrase: "Solution tapping mode atomic force microscopy images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C1704254:Image [Intellectual Product]
   762   C1704922:Image [Entity]
   762   C3542466:Image [Intellectual Product]

Phrase: "were"

Phrase: "acquired on a Digital Instruments Nanoscope IIIA MultiMode scanning probe microscope"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   775   C0810473:Scanning Probe Microscope [Medical Device]
   738   C0034606:Scanning [Diagnostic Procedure]
   738   C0181839:Microscope [Medical Device]
   738   C0182400:Probe [Medical Device]
   738   C0348000:instruments [Medical Device]
   738   C0439661:Acquired [Temporal Concept]
   738   C0441633:Scanning [Diagnostic Procedure]
   738   C0442015:Digital [Intellectual Product]
   738   C1704681:Probe [Gene or Genome]
   738   C1706379:Microscope [Medical Device]
   738   C1883674:Digital [Qualitative Concept]
   738   C2347609:Probe [Chemical Viewed Functionally]
   738   C3245488:acquired [Intellectual Product]
   738   C3536729:Probe [Manufactured Object]
   704 E C1706701:Acquire [Activity]
   704 E C2826292:SCAN [Finding]

Phrase: "(Digital Instruments,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0348000:instruments [Medical Device]

Phrase: "Santa Barbara,"

Phrase: "CA)"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "120-m oxide-sharpened silicon nitride V-shaped cantilevers"

Phrase: "installed in combination contact/tapping mode liquid flow cell."
Meta Candidates (Total=19; Excluded=0; Pruned=0; Remaining=19)
   742   C0007634:Cell [Cell]
   742   C0205195:Combination [Qualitative Concept]
   742   C0302908:Liquid [Substance]
   742   C0332158:contact [Functional Concept]
   742   C0337611:Contact [Population Group]
   742   C0806140:Flow [Natural Phenomenon or Process]
   742   C1269647:Cell [Cell]
   742   C1304698:Liquid [Finding]
   742   C1513371:Mode [Functional Concept]
   742   C1546699:Liquid NOS [Intellectual Product]
   742   C1561501:Liquid NOS [Substance]
   742   C1704653:Cell [Medical Device]
   742   C1705415:Contact [Idea or Concept]
   742   C1705738:Mode [Quantitative Concept]
   742   C1947911:Combination [Physical Object]
   742   C1948049:Cell [Spatial Concept]
   742   C2347637:Mode [Quantitative Concept]
   742   C2348146:Mode [Quantitative Concept]
   708   C0034115:Tap [Health Care Activity]
Processing 00000000.tx.99: The AFM images were acquired using the E scanning head, which has a maximum lateral scan area of 14.6m14.6m. 

Phrase: "The AFM images"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   779   C1704254:Image [Intellectual Product]
   779   C1704922:Image [Entity]
   779   C3542466:Image [Intellectual Product]
   756   C0242849:Microscopy, Atomic Force [Laboratory Procedure]

Phrase: "were"

Phrase: "acquired"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0439661:Acquired [Temporal Concept]
  1000   C3245488:acquired [Intellectual Product]
   966 E C1706701:Acquire [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the E scanning head,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0018670:Head [Body Location or Region]
   827   C1281590:Head [Body Part, Organ, or Organ Component]
   827   C1706305:Head [Manufactured Object]
   771 E C0205096:Cephalic [Spatial Concept]

Phrase: "which"

Phrase: "has"

Phrase: "a maximum lateral scan area of 14.6m14.6m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0017446:Area [Geographic Area]
   742   C0205146:Area [Spatial Concept]
Processing 00000000.tx.100: All imaging was performed at tip scan rates from 1.25to 2Hz, using cantilever drive frequencies of ~8.9 kHz. 

Phrase: "All"

Phrase: "imaging"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0011923:Imaging [Diagnostic Procedure]
  1000   C0079595:Imaging [Diagnostic Procedure]
   966 E C1704254:Image [Intellectual Product]
   966 E C1704922:Image [Entity]
   966 E C3542466:Image [Intellectual Product]

Phrase: "was"

Phrase: "performed at tip scan rates"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   760   C0034606:Scan [Diagnostic Procedure]
   760   C0441633:Scan [Diagnostic Procedure]
   760   C0884358:Performed [Functional Concept]
   760   C1710425:Tip [Medical Device]
   760   C2826292:SCAN [Finding]
   760   C3282898:Tip [Qualitative Concept]
   726   C0871208:Rate [Activity]
   726   C1521828:Rate [Quantitative Concept]
   726 E C2947996:Perform [Pharmacologic Substance]

Phrase: "from 1.25to 2Hz,"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "cantilever"

Phrase: "drive"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013126:Drive [Mental Process]

Phrase: "frequencies of ~8.9 kHz."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0556965:kHz [Quantitative Concept]
Processing 00000000.tx.101: All images were captured as 512512pixel images and were low-pass filtered. 

Phrase: "All images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1704254:Image [Intellectual Product]
   966   C1704922:Image [Entity]
   966   C3542466:Image [Intellectual Product]

Phrase: "were"

Phrase: "captured as 512512pixel images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C1704254:Image [Intellectual Product]
   737   C1704922:Image [Entity]
   737   C3542466:Image [Intellectual Product]

Phrase: "and"

Phrase: "were"

Phrase: "low-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205251:low [Qualitative Concept]
  1000   C1299352:Low [Qualitative Concept]
  1000   C1550472:low [Idea or Concept]

Phrase: "pass"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2828386:Pass [Finding]

Phrase: "filtered."
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   966   C0180860:Filter [Manufactured Object]
   966   C0581406:Filter [Medical Device]
   966   C1522664:Filter [Intellectual Product]
   966   C1704449:Filter [Conceptual Entity]
   966   C1704684:Filter [Medical Device]
   966   C1875155:FILTER [Medical Device]
   928 E C0080194:Strain [Injury or Poisoning]
   928 E C0442694:Straining [Physiologic Function]
   928 E C0456178:strain [Intellectual Product]
   928 E C1518614:Strain [Organism]
   928 E C2987481:Strain [Mental Process]
Processing 00000000.tx.102: Feature size and volumes were calculated using the Digital Instruments Nanoscope software (version 4.21) and shareware image analysis program, NIH-Image (version 1.62). 

Phrase: "Feature size"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0456389:size [Spatial Concept]

Phrase: "and"

Phrase: "volumes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0449468:volumes [Quantitative Concept]
   966 E C1690016:% volume [Qualitative Concept]
   966 E C1705102:Volume [Intellectual Product]
   966 E C2700258:Volume [Laboratory Procedure]

Phrase: "were"

Phrase: "calculated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444686:Calculated [Functional Concept]
  1000   C1441506:Calculated [Activity]
  1000   C1443182:Calculated [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Digital Instruments Nanoscope software"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "(version 4.21"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0333052:Version [Functional Concept]
   827   C2607870:Version [Spatial Concept]

Phrase: ")"

Phrase: "and"

Phrase: "shareware image analysis program,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1709697:Program [Conceptual Entity]
   812   C2728259:Program [Pharmacologic Substance]
   812   C3484370:Program [Functional Concept]

Phrase: "NIH-Image"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1704254:Image [Intellectual Product]
   861   C1704922:Image [Entity]
   861   C3542466:Image [Intellectual Product]

Phrase: "(version 1.62"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0333052:Version [Functional Concept]
   827   C2607870:Version [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.103: In situ tapping mode atomic force microscopy experiments were performed by sequential addition of the solutions to the AFM fluid cell. 

Phrase: "In situ tapping mode atomic force microscopy experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   793   C0681814:Experiments [Research Activity]
   760 E C1706386:Experiment [Conceptual Entity]
   710 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "performed by sequential addition of the solutions"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   778   C1550369:Performed By [Qualitative Concept]
   748   C0037633:Solutions [Substance]
   748   C0884358:Performed [Functional Concept]
   748   C1548958:Sequential [Idea or Concept]
   748   C1705294:Sequential [Qualitative Concept]
   748   C1883712:Addition [Functional Concept]
   714 E C0525069:Solution [Biomedical or Dental Material]
   714 E C2947996:Perform [Pharmacologic Substance]

Phrase: "to the AFM fluid cell."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0007634:Cell [Cell]
   804   C1269647:Cell [Cell]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]
   717   C0242849:Microscopy, Atomic Force [Laboratory Procedure]
Processing 00000000.tx.104: Planar bilayers were formed by directly injecting ~500 l of the ~1 mg/ml POPC/POPS suspension into the AFM fluid cell, previously sealed against a piece of freshly cleaved mica and allowing the vesicles to fuse in situ. 

Phrase: "Planar bilayers"

Phrase: "were"

Phrase: "formed by directly"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0205431:Formed [Functional Concept]
   790   C1947931:Directly [Qualitative Concept]
   756 E C0348078:Form [Qualitative Concept]
   756 E C0376315:Form [Manufactured Object]
   756 E C1522492:Form [Functional Concept]

Phrase: "injecting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1720154:Inject [Functional Concept]

Phrase: "~500 l of the ~1 mg/ml POPC/POPS suspension"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   775   C2736830:500 mg/L [Quantitative Concept]
   757   C0439268:mg/L [Quantitative Concept]
   757   C1635169:mL/L [Quantitative Concept]

Phrase: "into the AFM fluid cell,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0007634:Cell [Cell]
   804   C1269647:Cell [Cell]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]
   717   C0242849:Microscopy, Atomic Force [Laboratory Procedure]

Phrase: "previously"

Phrase: "sealed against a piece of freshly cleaved mica"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   744   C0066503:Mica [Inorganic Chemical,Pharmacologic Substance]
   744   C0205242:Cleaved [Spatial Concept]
   744   C0333853:Cleaved [Cell]
   744   C1417162:MICA [Gene or Genome]
   744   C2982836:Piece [Quantitative Concept]
   711   C0036492:Seal [Mammal]
   711   C0325125:seal [Mammal]
   711   C1704637:Seal [Manufactured Object]

Phrase: "and"

Phrase: "allowing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowing [Social Behavior]

Phrase: "the vesicles to"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0333262:VESICLES [Acquired Abnormality]
   827 E C1622418:vesicle [Cell Component]
   777 E C0205378:Vesicular [Qualitative Concept]

Phrase: "fuse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0699952:fuse [Functional Concept]
  1000   C1414861:FUSE [Gene or Genome]
  1000   C1708111:Fuse [Manufactured Object]

Phrase: "in situ."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444498:In situ [Spatial Concept]
Processing 00000000.tx.105: The cell was flushed with neat buffer and reference tapping mode atomic force microscopy height and phase images were acquired in PBS, pH 7.4,to confirm formation of stable lipid bilayers. 

Phrase: "The cell"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "flushed with neat buffer"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0016382:flushed [Sign or Symptom]
   737 E C1696091:Flush [Functional Concept]

Phrase: "and"

Phrase: "reference tapping mode atomic force microscopy height"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   795   C0489786:Height [Organism Attribute]
   724 E C0205250:High [Qualitative Concept]
   724 E C1299351:High [Qualitative Concept]
   724 E C1522410:Highest [Qualitative Concept]
   724 E C2700149:HIGH [Intellectual Product]

Phrase: "and"

Phrase: "phase images"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205390:Phase [Temporal Concept]
   827   C1704254:Image [Intellectual Product]
   827   C1704922:Image [Entity]
   827   C3542466:Image [Intellectual Product]

Phrase: "were"

Phrase: "acquired in PBS,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   797   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   760   C0031701:phosphate [Organophosphorus Compound]
   760   C0036082:Saline [Substance]
   760   C0439661:Acquired [Temporal Concept]
   760   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   760   C3245488:acquired [Intellectual Product]
   751   C0860988:phosphate increased [Finding]
   726 E C1706701:Acquire [Activity]

Phrase: "pH 7.4,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "formation of stable lipid bilayers."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C1563744:lipid formation [Organism Function]
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]
Processing 00000000.tx.106: Approximately 500l of -Syn in PBS at 0.1mg/ml were injected directly into the AFM cell and imaging initiated 30min after the protein was introduced.  

Phrase: "Approximately 500l of -Syn in PBS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "at 0.1mg/ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439526:/mL [Quantitative Concept]

Phrase: "were"

Phrase: "injected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1720154:Inject [Functional Concept]

Phrase: "directly into the AFM cell"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   814   C0242849:Microscopy, Atomic Force [Laboratory Procedure]
           Force Microscopy
   748   C0007634:Cell [Cell]
   748   C0026018:Microscopy [Laboratory Procedure]
   748   C0441722:Force [Phenomenon or Process]
   748   C0563538:Force [Phenomenon or Process]
   748   C1269647:Cell [Cell]
   748   C1704653:Cell [Medical Device]
   748   C1947931:Directly [Qualitative Concept]
   748   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "imaging initiated 30min after the protein"

Phrase: "was"

Phrase: "introduced."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1292748:introduce [Functional Concept]
Processing 00000000.tx.107: RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Binding of -Syn to PS and PE Examined by TLC Overlay-- -Syn has been reported to bind to rat brain vesicles (35) and synthetic phospholipid membranes (31). 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   758   C1514811:Reference [Idea or Concept]
   758   C1706462:Reference [Conceptual Entity]

Phrase: "Binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "of -Syn to PS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "PE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031618:Phosphatidyl ethanolamine [Biologically Active Substance,Lipid]
  1000   C1450468:phosphatidylethanolamine [Lipid,Pharmacologic Substance]

Phrase: "Examined by TLC Overlay"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0008569:Thin Layer Chromatography [Laboratory Procedure]
   753   C0008550:Chromatography [Laboratory Procedure]
   753   C0205168:Thin [Qualitative Concept]
   753   C0332128:Examined [Finding]
   753   C0444456:Overlay [Spatial Concept]
   753   C0934502:Layer [Body Part, Organ, or Organ Component]
   753   C1522408:Layer [Qualitative Concept]
   753   C1561599:Layer [Intellectual Product]
   753   C1706359:Overlay [Medical Device]

Phrase: "-- -Syn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "bind to rat brain vesicles"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   806   C1882598:Rat Brain [Body Part, Organ, or Organ Component]
   760   C0006104:Brain [Body Part, Organ, or Organ Component]
   760   C0034693:Rat, NOS [Mammal]
   760   C0034721:Rat [Mammal]
   760   C0333262:VESICLES [Acquired Abnormality]
   760   C1145667:Bind [Activity]
   760   C1167622:bind [Molecular Function]
   760   C1269537:Brain [Body Part, Organ, or Organ Component]
   726 E C1622418:vesicle [Cell Component]

Phrase: "(35"

Phrase: ")"

Phrase: "and"

Phrase: "synthetic phospholipid membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0025255:Membranes [Tissue]
   793 E C0596901:Membrane [Cell Component]
   793 E C1706182:Membrane [Manufactured Object]
   743 E C0205287:Membranous [Qualitative Concept]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.108: This prompted us to apply TLC overlay to determine whether -Syn exhibits any specficity for a particular lipid extracted from human brain. 

Phrase: "This prompted"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0871157:prompted [Functional Concept]
   966 E C1602245:Prompt [Pharmacologic Substance]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "apply"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0185125:Apply [Health Care Activity]
  1000   C1632850:Apply [Functional Concept]
  1000   C1879355:Apply [Functional Concept]

Phrase: "TLC overlay to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0444456:Overlay [Spatial Concept]
   804   C1706359:Overlay [Medical Device]
   717   C0008569:Thin Layer Chromatography [Laboratory Procedure]

Phrase: "determine"

Phrase: "whether -Syn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "exhibits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "any specficity for a particular lipid"

Phrase: "extracted from human brain."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C0086418:Human [Human]
   770   C0185115:Extracted [Therapeutic or Preventive Procedure]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]
   770   C3541890:EXTRACTED [Finding]
   737 E C2828366:Extract [Substance]
Processing 00000000.tx.109: Total extracts obtained from either cerebellum or temporal cortex were separated on a TLC plate and incubated with purified -Syn. 

Phrase: "Total extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2828366:Extract [Substance]

Phrase: "obtained from either cerebellum"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0007765:Cerebellum [Body Part, Organ, or Organ Component]
   770   C1268981:Cerebellum [Body Part, Organ, or Organ Component]
   770   C1301820:Obtained [Functional Concept]
   770   C1707522:Cerebellum [Tissue]
   737 E C1706701:Obtain [Activity]

Phrase: "or"

Phrase: "temporal cortex"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039485:Temporal cortex [Body Part, Organ, or Organ Component]
   861   C0007776:Cortex [Body Part, Organ, or Organ Component]
   861   C0442043:Temporal [Spatial Concept]
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2362314:Temporal [Temporal Concept]
   861   C2700441:Cortex [Plant]

Phrase: "were"

Phrase: "separated on a TLC plate"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   814   C0008569:Thin Layer Chromatography [Laboratory Procedure]
   748   C0005971:Plate [Medical Device]
   748   C0008550:Chromatography [Laboratory Procedure]
   748   C0086972:Separated [Finding]
   748   C0205168:Thin [Qualitative Concept]
   748   C0443299:separated [Spatial Concept]
   748   C0687118:Separated [Functional Concept]
   748   C0934502:Layer [Body Part, Organ, or Organ Component]
   748   C1139930:plate [Medical Device]
   748   C1522408:Layer [Qualitative Concept]
   748   C1561599:Layer [Intellectual Product]
   748   C3537155:Plate [Manufactured Object]

Phrase: "and"

Phrase: "incubated with purified -Syn."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1439852:Incubated [Laboratory Procedure]
   770   C1998793:Purified [Functional Concept]
Processing 00000000.tx.110: Approximately 9-11 individual lipid bands were observed (Fig. 2A, lane 1) and only two showed any significant interaction with -Syn (Fig. 2B, lane 1). 

Phrase: "Approximately 9-11 individual lipid bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   799   C0175723:Bands [Medical Device]
   766 E C0439645:Band [Spatial Concept]
   766 E C1521913:band [Cell Component]

Phrase: "were"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "(Fig. 2A,"

Phrase: "lane 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "and"

Phrase: "only two"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205448:Two [Quantitative Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "any significant interaction with -Syn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704675:Interaction [Functional Concept]

Phrase: "(Fig. 2B,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: "lane 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.111: In order to identify these -Syn-binding lipids, commercially available lipids were run on TLC plates as references and overlaid with -Syn (Fig. 2, A and B, lanes 2-6). 

Phrase: "In order to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "identify"

Phrase: "these -Syn-binding lipids,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0023779:Lipids [Lipid]

Phrase: "commercially available lipids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0023779:Lipids [Lipid]

Phrase: "were"

Phrase: "run on TLC"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   884   C0008569:Thin Layer Chromatography [Laboratory Procedure]
   804   C0008550:Chromatography [Laboratory Procedure]
   804   C0205168:Thin [Qualitative Concept]
   804   C0934502:Layer [Body Part, Organ, or Organ Component]
   804   C1522408:Layer [Qualitative Concept]
   804   C1561599:Layer [Intellectual Product]
   733 E C0039870:Thinness [Finding]
   704 E C0302647:chromatograph [Medical Device]

Phrase: "plates as references"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0005971:Plate [Medical Device]
   790   C1139930:plate [Medical Device]
   790   C3537155:Plate [Manufactured Object]
   756   C1514811:Reference [Idea or Concept]
   756   C1706462:Reference [Conceptual Entity]

Phrase: "and"

Phrase: "overlaid with -Syn"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0444456:Overlay [Spatial Concept]
   756   C1706359:Overlay [Medical Device]

Phrase: "(Fig. 2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "lanes 2-6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.112: -Syn was found to bind to phosphatidylethanolamine (E.coli and brain PE), lyso-PE (brain lyso-PE), phosphatidylinositol (liver PI) and showed a detectable but much weaker interaction with phosphatidylserine (POPS and brain PS) (Fig. 2B). 

Phrase: "-Syn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "bind to phosphatidylethanolamine"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0031618:Phosphatidyl ethanolamine [Biologically Active Substance,Lipid]
   790   C1145667:Bind [Activity]
   790   C1167622:bind [Molecular Function]
   790   C1450468:phosphatidylethanolamine [Lipid,Pharmacologic Substance]

Phrase: "(E.coli"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014834:E coli [Bacterium]

Phrase: "and"

Phrase: "brain PE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031618:Phosphatidyl ethanolamine [Biologically Active Substance,Lipid]
   861   C1450468:phosphatidylethanolamine [Lipid,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "lyso-PE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031618:Phosphatidyl ethanolamine [Biologically Active Substance,Lipid]
   861   C1450468:phosphatidylethanolamine [Lipid,Pharmacologic Substance]

Phrase: "(brain lyso-PE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0031618:Phosphatidyl ethanolamine [Biologically Active Substance,Lipid]
   827   C1450468:phosphatidylethanolamine [Lipid,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "phosphatidylinositol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031621:Phosphatidyl Inositol [Biologically Active Substance,Lipid]
  1000   C2348046:Phosphatidylinositol [Lipid]

Phrase: "(liver PI"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031621:Phosphatidyl Inositol [Biologically Active Substance,Lipid]
   861   C2348046:Phosphatidylinositol [Lipid]

Phrase: ")"

Phrase: "and"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a detectable"

Phrase: "but"

Phrase: "much weaker interaction with phosphatidylserine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704675:Interaction [Functional Concept]

Phrase: "(POPS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031623:phosphatidylserine [Lipid]
  1000   C0301704:Phosphatidyl serine [Lipid]

Phrase: "and"

Phrase: "brain PS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031623:phosphatidylserine [Lipid]
   861   C0301704:Phosphatidyl serine [Lipid]

Phrase: ")"

Phrase: "(Fig. 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")."
Processing 00000000.tx.113: No interaction was observed for phosphatidylcholine (POPC), phosphatidic acid (POPA), sphingomyelin (brain sphingomyelin), or cholesterol (Fig. 2B). 

Phrase: "No interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704675:Interaction [Functional Concept]

Phrase: "was"

Phrase: "observed for phosphatidylcholine"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C1441672:Observed [Functional Concept]
   790   C1959616:Phosphatidyl choline [Biologically Active Substance,Lipid,Pharmacologic Substance]
   734 E C0031617:Lecithin [Biologically Active Substance,Lipid,Pharmacologic Substance]
   734 E C0885520:lecithin [Organic Chemical,Pharmacologic Substance]

Phrase: "(POPC"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1959616:Phosphatidyl choline [Biologically Active Substance,Lipid,Pharmacologic Substance]
   944 E C0031617:Lecithin [Biologically Active Substance,Lipid,Pharmacologic Substance]
   944 E C0885520:lecithin [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "phosphatidic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0031610:Phosphatidic Acid [Lipid]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "(POPA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0031610:Phosphatidic Acid [Lipid]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: ")"

Phrase: ","

Phrase: "sphingomyelin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037906:Sphingomyelin [Biologically Active Substance,Lipid]

Phrase: "(brain sphingomyelin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0037906:Sphingomyelin [Biologically Active Substance,Lipid]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "cholesterol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008377:Cholesterol [Biologically Active Substance,Steroid]

Phrase: "(Fig. 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")."
Processing 00000000.tx.114: Nonspecific immunoreactivity was not observed with similar TLC-separated lipids exposed to the anti-synuclein antibody alone (i.e. without prior incubation with recombinant -Syn) or with the secondary antibody (data not shown). 

Phrase: "Nonspecific immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597879:immunoreactivity [Molecular Function]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "observed with similar TLC-separated lipids"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   800   C0008569:Thin Layer Chromatography [Laboratory Procedure]
   744   C0008550:Chromatography [Laboratory Procedure]
   744   C0023779:Lipids [Lipid]
   744   C0086972:Separated [Finding]
   744   C0205168:Thin [Qualitative Concept]
   744   C0443299:separated [Spatial Concept]
   744   C0687118:Separated [Functional Concept]
   744   C0934502:Layer [Body Part, Organ, or Organ Component]
   744   C1441672:Observed [Functional Concept]
   744   C1522408:Layer [Qualitative Concept]
   744   C1561599:Layer [Intellectual Product]
   744   C2348205:Similar [Qualitative Concept]

Phrase: "exposed to the anti-synuclein antibody"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0332157:Exposed to [Clinical Attribute]
           Exposed
   783   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "(i.e."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "without prior incubation"

Phrase: "with recombinant -Syn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "or with the secondary antibody"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0027627:secondary [Neoplastic Process]
   760   C0175668:Secondary [Temporal Concept]
   760   C0205436:Secondary [Quantitative Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.115: It was surprising that -Syn did not bind to phosphatidic acid (PA) on TLC plate (Fig. 2, lane 6) since -Syn was reported to bind to the SUVs containing acidic phospholipids, such as PS, PI, and PA (31). 

Phrase: "It"

Phrase: "was"

Phrase: "surprising"

Phrase: "that -Syn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "bind to phosphatidic acid (PA)"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0031610:Phosphatidic Acid [Lipid]
   770   C0001128:Acid [Chemical]
   770   C0202406:Acid [Laboratory Procedure]
   770   C1145667:Bind [Activity]
   770   C1167622:bind [Molecular Function]

Phrase: "on TLC plate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0005971:Plate [Medical Device]
   812   C1139930:plate [Medical Device]
   812   C3537155:Plate [Manufactured Object]
   756   C0008569:Thin Layer Chromatography [Laboratory Procedure]

Phrase: "(Fig. 2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "lane 6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "since -Syn"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1711239:Since [Temporal Concept]

Phrase: "was"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "bind to the SUVs"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C1881413:Small Unilamellar Vesicles [Chemical Viewed Structurally]
   790   C1721092:Unilamellar Vesicles [Lipid]
   753   C0333262:VESICLES [Acquired Abnormality]
   753   C0700321:Small [Quantitative Concept]
   753   C1145667:Bind [Activity]
   753   C1167622:bind [Molecular Function]
   719 E C1622418:vesicle [Cell Component]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "acidic phospholipids,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0031676:Phospholipids [Biologically Active Substance,Lipid]
   827 E C0202177:Phospholipid [Laboratory Procedure]

Phrase: "such as PS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031623:phosphatidylserine [Lipid]
  1000   C0301704:Phosphatidyl serine [Lipid]

Phrase: "PI,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031621:Phosphatidyl Inositol [Biologically Active Substance,Lipid]
  1000   C2348046:Phosphatidylinositol [Lipid]

Phrase: "and"

Phrase: "PA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0031610:Phosphatidic Acid [Lipid]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.116: This discrepancy can be attributed to the physical properties of the TLC overlay method. 

Phrase: "This discrepancy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1290905:Discrepancy [Finding]

Phrase: "can"

Phrase: "be"

Phrase: "attributed to the physical properties of the TLC overlay method."
Meta Candidates (Total=24; Excluded=2; Pruned=0; Remaining=22)
   770   C0008569:Thin Layer Chromatography [Laboratory Procedure]
   753   C0597237:physical properties [Natural Phenomenon or Process]
   753   C1998468:Physical properties [Clinical Attribute]
   736   C0008550:Chromatography [Laboratory Procedure]
   736   C0025663:Method [Intellectual Product]
   736   C0031809:Physical [Health Care Activity]
   736   C0205168:Thin [Qualitative Concept]
   736   C0205485:Physical [Functional Concept]
   736   C0444456:Overlay [Spatial Concept]
   736   C0449851:Method [Functional Concept]
   736   C0871161:properties [Qualitative Concept]
           Property (attribute)
   736   C0871511:METHOD [Intellectual Product]
   736   C0934502:Layer [Body Part, Organ, or Organ Component]
   736   C1292721:properties [Functional Concept]
   736   C1509143:Physical [Finding]
   736   C1522408:Layer [Qualitative Concept]
   736   C1561599:Layer [Intellectual Product]
   736   C1706359:Overlay [Medical Device]
   703   C0449234:Attribute [Idea or Concept]
   703   C1704772:Attribute [Conceptual Entity]
   703   C1882133:Attribute [Qualitative Concept]
   703 E C1882134:Property [Conceptual Entity]
   703 E C2347695:Property [Entity]
Processing 00000000.tx.117: These findings suggest the possibility of some specificity of -Syn for particular lipids which may be relevant to its function. 

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "the possibility of some specificity of -Syn"

Phrase: "for particular lipids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023779:Lipids [Lipid]

Phrase: "which"

Phrase: "may"

Phrase: "be"

Phrase: "relevant to its function."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2347946:Relevant [Qualitative Concept]
Processing 00000000.tx.118: However, the overlay technique may not identify all -Syn binding lipids (e.g. phosphatidic acid) due to these technical constraints. 

Phrase: "However,"

Phrase: "the overlay technique"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0449851:Technique [Functional Concept]
   777 E C0025664:techniques [Intellectual Product]

Phrase: "may"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "identify"

Phrase: "all -Syn binding lipids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0023779:Lipids [Lipid]

Phrase: "("

Phrase: "e.g. phosphatidic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0031610:Phosphatidic Acid [Lipid]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: ")"

Phrase: "due to these technical constraints."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0443288:Constraint [Functional Concept]
   827   C2986806:Constraint [Occupational Activity]
Processing 00000000.tx.119: Significant binding of -Syn to brain PE was observed which may reflect a similar in vivo interaction. 

Phrase: "Significant binding of -Syn to brain PE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "which"

Phrase: "may"

Phrase: "reflect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "a similar in vivo interaction."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.120: View larger version (53K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(53K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.121: 2.  

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.122: Binding of -synuclein to specific lipids examined by TLC overlay. 

Phrase: "Binding of -synuclein to specific lipids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "examined by TLC overlay."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0008569:Thin Layer Chromatography [Laboratory Procedure]
   753   C0008550:Chromatography [Laboratory Procedure]
   753   C0205168:Thin [Qualitative Concept]
   753   C0332128:Examined [Finding]
   753   C0444456:Overlay [Spatial Concept]
   753   C0934502:Layer [Body Part, Organ, or Organ Component]
   753   C1522408:Layer [Qualitative Concept]
   753   C1561599:Layer [Intellectual Product]
   753   C1706359:Overlay [Medical Device]
Processing 00000000.tx.123: A, TLC plate stained to detect all the lipids. 

Phrase: "A,"

Phrase: "TLC plate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0005971:Plate [Medical Device]
   812   C1139930:plate [Medical Device]
   812   C3537155:Plate [Manufactured Object]
   756   C0008569:Thin Layer Chromatography [Laboratory Procedure]

Phrase: "stained"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C2986582:Stained [Qualitative Concept]
   966 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "all the lipids."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023779:Lipids [Lipid]
Processing 00000000.tx.124: B, TLC plate identical to A was probed for -synuclein binding using anti--synuclein antibody; 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "TLC plate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0005971:Plate [Medical Device]
   812   C1139930:plate [Medical Device]
   812   C3537155:Plate [Manufactured Object]
   756   C0008569:Thin Layer Chromatography [Laboratory Procedure]

Phrase: "identical to A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205280:Identical [Qualitative Concept]

Phrase: "was"

Phrase: "probed for -synuclein binding"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]
   737   C0182400:Probe [Medical Device]
   737   C1704681:Probe [Gene or Genome]
   737   C2347609:Probe [Chemical Viewed Functionally]
   737   C3536729:Probe [Manufactured Object]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "anti"

Phrase: "--synuclein antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.125: lane 1, total lipid extracts from temporal cortex; 

Phrase: "lane 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "total lipid extracts from temporal cortex"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0369610:total lipid [Finding]
   753   C0023779:Lipid [Lipid]
   753   C0439175:% total [Quantitative Concept]
   753   C0439810:Total [Qualitative Concept]
   719   C2828366:Extract [Substance]

Phrase: ";"
Processing 00000000.tx.126: lane 2, brain PE (upper band) and brain PS (lower); 

Phrase: "lane 2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "brain PE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031618:Phosphatidyl ethanolamine [Biologically Active Substance,Lipid]
   861   C1450468:phosphatidylethanolamine [Lipid,Pharmacologic Substance]

Phrase: "(upper band"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0175723:Band [Medical Device]
   861   C0439645:Band [Spatial Concept]
   861   C1521913:band [Cell Component]

Phrase: ")"

Phrase: "and"

Phrase: "brain PS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031623:phosphatidylserine [Lipid]
   861   C0301704:Phosphatidyl serine [Lipid]

Phrase: "(lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.127: lane 3, E.coli PE (upper) and POPS (lower); 

Phrase: "lane 3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "E.coli PE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0031618:Phosphatidyl ethanolamine [Biologically Active Substance,Lipid]
   827   C1450468:phosphatidylethanolamine [Lipid,Pharmacologic Substance]
   734   C0014834:E coli [Bacterium]

Phrase: "(upper"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1282910:Upper [Spatial Concept]

Phrase: ")"

Phrase: "and"

Phrase: "POPS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031623:phosphatidylserine [Lipid]
  1000   C0301704:Phosphatidyl serine [Lipid]

Phrase: "(lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.128: lane 4, lyso-PE; 

Phrase: "lane 4,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "lyso-PE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031618:Phosphatidyl ethanolamine [Biologically Active Substance,Lipid]
   861   C1450468:phosphatidylethanolamine [Lipid,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.129: lane 5, liver PI (upper) and brain sphingomyelin (lower); 

Phrase: "lane 5,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "liver PI"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031621:Phosphatidyl Inositol [Biologically Active Substance,Lipid]
   861   C2348046:Phosphatidylinositol [Lipid]

Phrase: "(upper"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1282910:Upper [Spatial Concept]

Phrase: ")"

Phrase: "and"

Phrase: "brain sphingomyelin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0037906:Sphingomyelin [Biologically Active Substance,Lipid]

Phrase: "(lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.130: lane 6, POPA (upper) and POPC (lower). 

Phrase: "lane 6,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "POPA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0031610:Phosphatidic Acid [Lipid]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "(upper"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1282910:Upper [Spatial Concept]

Phrase: ")"

Phrase: "and"

Phrase: "POPC"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1959616:Phosphatidyl choline [Biologically Active Substance,Lipid,Pharmacologic Substance]
   944 E C0031617:Lecithin [Biologically Active Substance,Lipid,Pharmacologic Substance]
   944 E C0885520:lecithin [Organic Chemical,Pharmacologic Substance]

Phrase: "(lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: ")."
Processing 00000000.tx.131: When these reference lipids were compared with the brain lipid extracts in parallel on a TLC plate, the location of purified brain PE (Fig. 2, lane 2,upper band) coincided with the upper band of the -Syn binding lipid bands from the brain lipid extracts (Fig. 2B, lane 1,upper band). 

Phrase: "When"

Phrase: "these reference lipids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023779:Lipids [Lipid]

Phrase: "were"

Phrase: "compared with the brain lipid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0006104:Brain [Body Part, Organ, or Organ Component]
   760   C0023779:Lipid [Lipid]
   760   C1269537:Brain [Body Part, Organ, or Organ Component]
   760   C1707455:Compared [Activity]

Phrase: "extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2828366:Extract [Substance]

Phrase: "in parallel on a TLC plate,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0150312:In [Quantitative Concept]
   744   C0332285:In [Spatial Concept]
   744   C2348042:Parallel [Qualitative Concept]
   744   C2826345:PARALLEL [Research Activity]

Phrase: "the location of purified brain PE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0450429:Location [Spatial Concept]
   753   C1515974:Location [Body Location or Region]

Phrase: "(Fig. 2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "lane 2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "upper band"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0175723:Band [Medical Device]
   861   C0439645:Band [Spatial Concept]
   861   C1521913:band [Cell Component]

Phrase: ")"

Phrase: "coincided with the upper band of the -Syn binding lipid bands"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   754   C1148636:Lipid Binding [Molecular Function]
   738   C0023779:Lipid [Lipid]
   738   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0175723:Band [Medical Device]
           Bands
   738   C0243122:binding [Functional Concept]
   738   C0439645:Band [Spatial Concept]
   738   C1145667:Binding [Activity]
   738   C1167622:Binding [Molecular Function]
   738   C1282910:Upper [Spatial Concept]
   738   C1521913:band [Cell Component]

Phrase: "from the brain lipid extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C2828366:Extract [Substance]

Phrase: "(Fig. 2B,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: "lane 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "upper band"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0175723:Band [Medical Device]
   861   C0439645:Band [Spatial Concept]
   861   C1521913:band [Cell Component]

Phrase: ")."
Processing 00000000.tx.132: The lower lipid band present in the brain lipid extracts ran similarly to purified PS, PI, and lyso-PE. 

Phrase: "The lower lipid band present in the brain lipid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0150312:Present [Quantitative Concept]
   742   C0449450:Present [Idea or Concept]

Phrase: "extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2828366:Extract [Substance]

Phrase: "ran similarly to purified PS,"

Phrase: "PI,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031621:Phosphatidyl Inositol [Biologically Active Substance,Lipid]
  1000   C2348046:Phosphatidylinositol [Lipid]

Phrase: "and"

Phrase: "lyso-PE."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031618:Phosphatidyl ethanolamine [Biologically Active Substance,Lipid]
   861   C1450468:phosphatidylethanolamine [Lipid,Pharmacologic Substance]
Processing 00000000.tx.133: In order to confirm that the -Syn-positive bands are PE and PS, the lipid samples on the TLC plate were examined using the ninhydrin reaction. 

Phrase: "In order to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "that"

Phrase: "the -Syn-positive bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0175723:Bands [Medical Device]
   793 E C0439645:Band [Spatial Concept]
   793 E C1521913:band [Cell Component]

Phrase: "are"

Phrase: "PE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031618:Phosphatidyl ethanolamine [Biologically Active Substance,Lipid]
  1000   C1450468:phosphatidylethanolamine [Lipid,Pharmacologic Substance]

Phrase: "and"

Phrase: "PS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031623:phosphatidylserine [Lipid]
  1000   C0301704:Phosphatidyl serine [Lipid]

Phrase: "the lipid samples on the TLC plate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   708   C0370003:Sample [Substance]
   708   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the ninhydrin reaction."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0443286:Reaction [Functional Concept]
   861   C1114821:Reaction [Clinical Attribute]
Processing 00000000.tx.134: This reaction is specific for amide and amine groups that are only found in PE and PS. 

Phrase: "This reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "is"

Phrase: "specific for amide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205369:Specific [Qualitative Concept]
   790   C1552740:specific [Intellectual Product]

Phrase: "and"

Phrase: "amine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0002508:Amine [Organic Chemical]
  1000   C1879694:Amine [Organic Chemical]

Phrase: "groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1552839:groups [Idea or Concept]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "that"

Phrase: "are"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "found in PE"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0031618:Phosphatidyl ethanolamine [Biologically Active Substance,Lipid]
   790   C0150312:Found [Quantitative Concept]
   790   C1450468:phosphatidylethanolamine [Lipid,Pharmacologic Substance]
   756 E C0243095:Find [Finding]

Phrase: "and"

Phrase: "PS."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031623:phosphatidylserine [Lipid]
  1000   C0301704:Phosphatidyl serine [Lipid]
Processing 00000000.tx.135: Both overlay positive bands and reference PS and PE were stained with ninhydrin, confirming that the overlay positive bands are PE and PS, respectively (data not shown). 

Phrase: "Both overlay positive bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0175723:Bands [Medical Device]
   793 E C0439645:Band [Spatial Concept]
   793 E C1521913:band [Cell Component]

Phrase: "and"

Phrase: "reference PS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031623:phosphatidylserine [Lipid]
   861   C0301704:Phosphatidyl serine [Lipid]

Phrase: "and"

Phrase: "PE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031618:Phosphatidyl ethanolamine [Biologically Active Substance,Lipid]
  1000   C1450468:phosphatidylethanolamine [Lipid,Pharmacologic Substance]

Phrase: "were"

Phrase: "stained with ninhydrin,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0028098:Ninhydrin [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   790   C2986582:Stained [Qualitative Concept]
   756 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "confirming"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirming [Qualitative Concept]
  1000   C0750484:confirming [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "that"

Phrase: "the overlay positive bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0175723:Bands [Medical Device]
   793 E C0439645:Band [Spatial Concept]
   793 E C1521913:band [Cell Component]

Phrase: "are"

Phrase: "PE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031618:Phosphatidyl ethanolamine [Biologically Active Substance,Lipid]
  1000   C1450468:phosphatidylethanolamine [Lipid,Pharmacologic Substance]

Phrase: "and"

Phrase: "PS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031623:phosphatidylserine [Lipid]
  1000   C0301704:Phosphatidyl serine [Lipid]

Phrase: "respectively"

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.136: Binding of -Syn to Phospholipid Vesicles-- In addition to the solid phase assay, we screened a variety of phospholipids for -Syn binding, using phospholipid liposomes. 

Phrase: "Binding of -Syn to Phospholipid Vesicles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "-"

Phrase: "-"

Phrase: "In addition to the solid phase assay,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "we"

Phrase: "screened"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0220908:screen [Health Care Activity]
   966   C1305399:screen [Functional Concept]
   966   C1705053:Screen [Medical Device]

Phrase: "a variety of phospholipids"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1883525:Variety [Conceptual Entity]
   770   C2346866:Variety [Conceptual Entity]

Phrase: "for -Syn binding,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "phospholipid liposomes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023828:Liposomes [Lipid]
Processing 00000000.tx.137: It has been reported that -Syn binds to SUVs containing acidic phospholipids, which results in an increased -helical conformation in -Syn (31). 

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that -Syn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "binds to SUVs"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   862   C1881413:Small Unilamellar Vesicles [Chemical Viewed Structurally]
   806   C1721092:Unilamellar Vesicles [Lipid]
   760   C0333262:VESICLES [Acquired Abnormality]
   760   C0700321:Small [Quantitative Concept]
   760   C1145667:Bind [Activity]
   760   C1167622:bind [Molecular Function]
   726 E C1622418:vesicle [Cell Component]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "acidic phospholipids,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0031676:Phospholipids [Biologically Active Substance,Lipid]
   827 E C0202177:Phospholipid [Laboratory Procedure]

Phrase: "which"

Phrase: "results in an increased -helical conformation in -Syn"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0026377:Conformation [Spatial Concept]
   744   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0205217:Increased [Quantitative Concept]
   744   C0442805:Increased [Functional Concept]
   744   C1274040:Result [Functional Concept]
   744   C1546471:Result [Idea or Concept]
   744   C2825142:Result [Finding]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.138: We report herein the following novel findings regarding the association of -Syn with lipids. 

Phrase: "We"

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "herein"

Phrase: "the following novel findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C2607943:findings [Functional Concept]
   827   C2926606:Findings [Clinical Attribute]
   827   C3539655:Findings [Intellectual Product]
   793 E C0037088:Finding [Sign or Symptom]
   793 E C0243095:Finding [Finding]
   793 E C2825141:Finding [Finding]

Phrase: "regarding"

Phrase: "the association of -Syn with lipids."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.139: (i) The binding of -Syn with acidic phospholipids is dose-dependent; 

Phrase: "(i)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "The binding of -Syn with acidic phospholipids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "dose-dependent"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1512045:Dose-dependent [Quantitative Concept]
   861   C0178602:Dose [Quantitative Concept]
   861   C0851827:Dependent [Qualitative Concept]
   861   C0869039:Dose [Quantitative Concept]
   861   C1114758:Dose # [Clinical Attribute]
   861   C1701901:Dependent [Qualitative Concept]
   861   C3244310:dependent [Functional Concept]

Phrase: ";"
Processing 00000000.tx.140: (ii) the extent of lipid binding depends rather on the availability of the phospholipids than on the size of lipid vesicles (SUVs versus MLVs); 

Phrase: "(ii"

Phrase: ")"

Phrase: "the extent of lipid binding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439792:Extent [Spatial Concept]

Phrase: "depends"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0725813:depend [Medical Device]

Phrase: "rather on the availability of the phospholipids"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   778   C0470187:Availability of [Functional Concept]
           Availability
   748   C0031676:Phospholipids [Biologically Active Substance,Lipid]
   714 E C0202177:Phospholipid [Laboratory Procedure]

Phrase: "than"

Phrase: "on the size"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0456389:size [Spatial Concept]

Phrase: "of lipid vesicles"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0333262:VESICLES [Acquired Abnormality]
   827 E C1622418:vesicle [Cell Component]
   777 E C0205378:Vesicular [Qualitative Concept]

Phrase: "(SUVs"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C1881413:Small Unilamellar Vesicles [Chemical Viewed Structurally]
   901   C1721092:Unilamellar Vesicles [Lipid]
   827   C0333262:VESICLES [Acquired Abnormality]
   827   C0700321:Small [Quantitative Concept]
   793 E C1622418:vesicle [Cell Component]
   743 E C0205378:Vesicular [Qualitative Concept]

Phrase: "versus"

Phrase: "MLVs"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0333262:VESICLES [Acquired Abnormality]
   827 E C1622418:vesicle [Cell Component]
   777 E C0205378:Vesicular [Qualitative Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.141: (iii) -Syn binding to phospholipid vesicles increases drastically when an acidic phospholipid is mixed with PE instead of PC; 

Phrase: "(iii"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439070:III [Intellectual Product]
  1000   C1705160:III [Qualitative Concept]

Phrase: ") -Syn binding"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "to phospholipid vesicles"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0333262:VESICLES [Acquired Abnormality]
   827 E C1622418:vesicle [Cell Component]
   777 E C0205378:Vesicular [Qualitative Concept]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "drastically"

Phrase: "when"

Phrase: "an acidic phospholipid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031676:Phospholipid [Biologically Active Substance,Lipid]
   861   C0202177:Phospholipid [Laboratory Procedure]

Phrase: "is"

Phrase: "mixed with PE"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0031618:Phosphatidyl ethanolamine [Biologically Active Substance,Lipid]
   790   C0205430:Mixed [Functional Concept]
   790   C1450468:phosphatidylethanolamine [Lipid,Pharmacologic Substance]
   790   C3160715:Mixed [Finding]
   756 E C1421951:MIX [Gene or Genome]
   756 E C1720722:Mix [Qualitative Concept]

Phrase: "instead of PC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540812:PC [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.142: and (iv) -Syn binding to acidic phospholipid (with PC or PE) vesicles is inversely proportional to the ionic strength. 

Phrase: "and ("

Phrase: "iv) -Syn binding to acidic phospholipid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C1148642:Phospholipid Binding [Molecular Function]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]

Phrase: "("

Phrase: "with PC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540812:PC [Gene or Genome]

Phrase: "or"

Phrase: "PE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031618:Phosphatidyl ethanolamine [Biologically Active Substance,Lipid]
  1000   C1450468:phosphatidylethanolamine [Lipid,Pharmacologic Substance]

Phrase: ")"

Phrase: "vesicles"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0333262:VESICLES [Acquired Abnormality]
   966 E C1622418:vesicle [Cell Component]
   916 E C0205378:Vesicular [Qualitative Concept]

Phrase: "is"

Phrase: "inversely proportional to the ionic strength."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205351:Proportional [Qualitative Concept]
Processing 00000000.tx.143: In the first instance, -Syn was incubated with POPC or POPC:POPS (1:1, w/w) SUVs. 

Phrase: "In the first instance, -Syn"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C0150312:In [Quantitative Concept]
   804   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0205435:First [Quantitative Concept]
   804   C0332285:In [Spatial Concept]
   804   C1279901:First [Qualitative Concept]
   804   C1550608:Instance [Idea or Concept]

Phrase: "was"

Phrase: "incubated with POPC"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C1439852:Incubated [Laboratory Procedure]
   790   C1959616:Phosphatidyl choline [Biologically Active Substance,Lipid,Pharmacologic Substance]
   734 E C0031617:Lecithin [Biologically Active Substance,Lipid,Pharmacologic Substance]
   734 E C0885520:lecithin [Organic Chemical,Pharmacologic Substance]

Phrase: "or"

Phrase: "POPC"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1959616:Phosphatidyl choline [Biologically Active Substance,Lipid,Pharmacologic Substance]
   944 E C0031617:Lecithin [Biologically Active Substance,Lipid,Pharmacologic Substance]
   944 E C0885520:lecithin [Organic Chemical,Pharmacologic Substance]

Phrase: ":"

Phrase: "POPS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031623:phosphatidylserine [Lipid]
  1000   C0301704:Phosphatidyl serine [Lipid]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "w/w) SUVs."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   884   C1881413:Small Unilamellar Vesicles [Chemical Viewed Structurally]
   840   C1721092:Unilamellar Vesicles [Lipid]
   804   C0333262:VESICLES [Acquired Abnormality]
   804   C0700321:Small [Quantitative Concept]
   771 E C1622418:vesicle [Cell Component]
   721 E C0205378:Vesicular [Qualitative Concept]
Processing 00000000.tx.144: CD spectroscopy was used to monitor changes in -Syn secondary structure upon binding to the lipid vesicles. 

Phrase: "CD spectroscopy"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1519445:Spectroscopy, Circular Dichroism [Natural Phenomenon or Process]
   827   C0037812:spectroscopy [Laboratory Procedure]
   827   C2713504:Spectroscopy [Occupation or Discipline]
   827   C2984732:SPECTROSCOPY [Functional Concept]
   734   C0008813:Circular Dichroism [Laboratory Procedure]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "monitor"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030695:monitor [Health Care Activity]
  1000   C0150369:monitor [Health Care Activity]
  1000   C0181904:Monitor [Medical Device]
  1000   C0596972:Monitor [Medical Device]
  1000   C1521743:Monitor [Professional or Occupational Group]
  1000   C1704646:Monitor [Manufactured Object]

Phrase: "changes in -Syn secondary structure upon binding"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0162807:Secondary Structure [Spatial Concept]
   748   C0027627:secondary [Neoplastic Process]
   748   C0175668:Secondary [Temporal Concept]
   748   C0205436:Secondary [Quantitative Concept]
   748   C0678594:Structure [Spatial Concept]

Phrase: "to the lipid vesicles."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0333262:VESICLES [Acquired Abnormality]
   827 E C1622418:vesicle [Cell Component]
   777 E C0205378:Vesicular [Qualitative Concept]
Processing 00000000.tx.145: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.146: 3A, the spectrum of -Syn in PBS, pH 7.3,showed a minimum ellipticity at 200nm, indicating a random coiled secondary structure. 

Phrase: "3A,"

Phrase: "the spectrum of -Syn in PBS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "pH 7.3,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C0601906:PH 3 [Pharmacologic Substance]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a minimum ellipticity at 200nm,"

Phrase: "indicating"

Phrase: "a random coiled secondary structure."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0162807:Secondary Structure [Spatial Concept]
   812   C0027627:secondary [Neoplastic Process]
   812   C0175668:Secondary [Temporal Concept]
   812   C0205436:Secondary [Quantitative Concept]
   812   C0678594:Structure [Spatial Concept]
Processing 00000000.tx.147: In the presence of POPC SUVs, the CD spectrum revealed a subtle shift toward -helical conformation. 

Phrase: "In the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of POPC SUVs,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   923   C1881413:Small Unilamellar Vesicles [Chemical Viewed Structurally]
   861   C1721092:Unilamellar Vesicles [Lipid]
   812   C0333262:VESICLES [Acquired Abnormality]
   812   C0700321:Small [Quantitative Concept]
   779 E C1622418:vesicle [Cell Component]
   729 E C0205378:Vesicular [Qualitative Concept]

Phrase: "the CD spectrum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1883073:Spectrum [Quantitative Concept]
   827   C2827424:Spectrum [Conceptual Entity]
   734   C0008813:Circular Dichroism [Laboratory Procedure]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "a subtle shift toward -helical conformation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0333051:Shift [Functional Concept]
   753   C2347509:Shift [Phenomenon or Process]
Processing 00000000.tx.148: In the presence of POPC/POPS SUVs, the spectrum clearly showed a typical -helical secondary structure with the characteristic minima at 208and 222nm. 

Phrase: "In the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of POPC/POPS SUVs,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   884   C1881413:Small Unilamellar Vesicles [Chemical Viewed Structurally]
   840   C1721092:Unilamellar Vesicles [Lipid]
   804   C0333262:VESICLES [Acquired Abnormality]
   804   C0700321:Small [Quantitative Concept]
   771 E C1622418:vesicle [Cell Component]
   721 E C0205378:Vesicular [Qualitative Concept]

Phrase: "the spectrum clearly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1883073:Spectrum [Quantitative Concept]
   861   C2827424:Spectrum [Conceptual Entity]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a typical -helical secondary structure with the characteristic minima"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   764   C0162807:Secondary Structure [Spatial Concept]
   742   C0027627:secondary [Neoplastic Process]
   742   C0175668:Secondary [Temporal Concept]
   742   C0205436:Secondary [Quantitative Concept]
   742   C0678594:Structure [Spatial Concept]

Phrase: "at 208and 222nm."
Processing 00000000.tx.149: The intensity of the -helicity increased as the concentration of POPC/POPS was increased from 0.5mg/ml (lipid:protein=2.5:1, w/w) to 2mg/ml (lipid:protein=10:1, w/w) (Fig. 3B). 

Phrase: "The intensity of the -helicity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0522510:Intensity [Qualitative Concept]

Phrase: "increased as the concentration of POPC/POPS"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0031623:phosphatidylserine [Lipid]
   748   C0086045:Concentration [Mental Process]
   748   C0205217:Increased [Quantitative Concept]
   748   C0301704:Phosphatidyl serine [Lipid]
   748   C0442805:Increased [Functional Concept]
   748   C1446561:Concentration [Quantitative Concept]
   748   C1959616:Phosphatidyl choline [Biologically Active Substance,Lipid,Pharmacologic Substance]

Phrase: "was"

Phrase: "increased from 0.5mg/ml (lipid"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0851043:Increased lipid [Finding]
   753   C0023779:Lipid [Lipid]
   753   C0205217:Increased [Quantitative Concept]
   753   C0439526:/mL [Quantitative Concept]
   753   C0442805:Increased [Functional Concept]

Phrase: ":"

Phrase: "protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "=2.5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0450346:2 5 [Quantitative Concept]
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: ":"

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "w/w) to 2mg/ml (lipid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1709500:%W/W [Quantitative Concept]
   790   C2919747:w/w [Quantitative Concept]

Phrase: ":"

Phrase: "protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "=10"

Phrase: ":"

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "w/w) (Fig. 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0450365:3b [Intellectual Product]
   812   C1706097:3B [Research Activity]

Phrase: ")."
Processing 00000000.tx.150: The spectrum did not change significantly when the POPC/POPS concentration was increased from 2to 4mg/ml, indicating that the binding of -Syn to POPC/POPS SUVs was saturated at a lipid concentration of 2mg/ml. 

Phrase: "The spectrum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1883073:Spectrum [Quantitative Concept]
  1000   C2827424:Spectrum [Conceptual Entity]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0392747:Change [Functional Concept]
  1000   C0443172:change [Quantitative Concept]
  1000   C1705241:Change [Quantitative Concept]

Phrase: "significantly"

Phrase: "when"

Phrase: "the POPC/POPS concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "was"

Phrase: "increased from 2to 4mg/ml,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205217:Increased [Quantitative Concept]
   760   C0439526:/mL [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]

Phrase: "indicating"

Phrase: "that"

Phrase: "the binding of -Syn to POPC/POPS SUVs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "saturated at a lipid concentration of 2mg/ml."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   767   C0023767:Lipid A [Immunologic Factor,Lipid]
   744   C0023779:Lipid [Lipid]
   744   C0086045:Concentration [Mental Process]
   744   C0439526:/mL [Quantitative Concept]
   744   C0522534:Saturated [Phenomenon or Process]
   744   C1446561:Concentration [Quantitative Concept]
   744   C1705188:SATURATED [Quantitative Concept]
Processing 00000000.tx.151: View larger version (13K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(13K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.152: 3.  

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.153: Changes in the secondary structure of -synuclein examined by CD spectroscopy. 

Phrase: "Changes in the secondary structure of -synuclein"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0392747:changes [Functional Concept]
   748   C0443172:changes [Quantitative Concept]
   714 E C1705241:Change [Quantitative Concept]

Phrase: "examined by CD spectroscopy."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C1519445:Spectroscopy, Circular Dichroism [Natural Phenomenon or Process]
   806   C0008813:Circular Dichroism [Laboratory Procedure]
   760   C0037812:spectroscopy [Laboratory Procedure]
   760   C0332128:Examined [Finding]
   760   C0596436:dichroism [Natural Phenomenon or Process]
   760   C1282913:Circular [Spatial Concept]
   760   C2713504:Spectroscopy [Occupation or Discipline]
   760   C2984732:SPECTROSCOPY [Functional Concept]
Processing 00000000.tx.154: A, -synuclein at 0.2mg/ml was examined in PBS () or in the presence of POPC SUVs (--) or POPC/POPS (1:1 wt/wt) SUVs () at 2mg/ml. 

Phrase: "A, -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "at 0.2mg/ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439526:/mL [Quantitative Concept]

Phrase: "was"

Phrase: "examined in PBS"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   797   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   760   C0031701:phosphate [Organophosphorus Compound]
   760   C0036082:Saline [Substance]
   760   C0332128:Examined [Finding]
   760   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "("

Phrase: ")"

Phrase: "or in the presence of POPC SUVs"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C1881413:Small Unilamellar Vesicles [Chemical Viewed Structurally]
   764   C1721092:Unilamellar Vesicles [Lipid]
   742   C0333262:VESICLES [Acquired Abnormality]
   742   C0392148:Presence [Therapeutic or Preventive Procedure]
   742   C0700321:Small [Quantitative Concept]
   742   C1959616:Phosphatidyl choline [Biologically Active Substance,Lipid,Pharmacologic Substance]
   708 E C1622418:vesicle [Cell Component]

Phrase: "("

Phrase: "-"

Phrase: "-"

Phrase: ")"

Phrase: "or"

Phrase: "POPC/POPS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031623:phosphatidylserine [Lipid]
   861   C0301704:Phosphatidyl serine [Lipid]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1 wt/wt) SUVs"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C1881413:Small Unilamellar Vesicles [Chemical Viewed Structurally]
   827   C1721092:Unilamellar Vesicles [Lipid]
   799   C0333262:VESICLES [Acquired Abnormality]
   799   C0700321:Small [Quantitative Concept]
   766 E C1622418:vesicle [Cell Component]
   716 E C0205378:Vesicular [Qualitative Concept]

Phrase: "("

Phrase: ")"

Phrase: "at 2mg/ml."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]
Processing 00000000.tx.155: B, -synuclein at 0.2mg/ml was examined with increasing weight ratios of lipid to protein; 

Phrase: "B, -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347469:/B [Quantitative Concept]

Phrase: "at 0.2mg/ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439526:/mL [Quantitative Concept]

Phrase: "was"

Phrase: "examined with increasing weight ratios of lipid"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   778   C0043094:increasing weight [Finding]
   748   C0005910:weight [Organism Attribute]
   748   C0023779:Lipid [Lipid]
   748   C0043100:Weight [Quantitative Concept]
   748   C0332128:Examined [Finding]
   748   C0442808:Increasing [Functional Concept]
   748   C0456603:Ratios [Quantitative Concept]
   748   C1305866:weight [Diagnostic Procedure]
   748   C1610540:*Ratios [Quantitative Concept]
   748   C1705104:Weight [Idea or Concept]
   714 E C1547037:Ratio [Intellectual Product]

Phrase: "to protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.156: -synuclein in PBS () or in the presence of POPC/POPS SUVs at 0.5mg/ml (1:2.5, protein:lipid) (--), 1mg/ml (1:5) (----), 2mg/ml (1:10) (--), and 4mg/ml (1:20) (). 

Phrase: "-synuclein in PBS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "("

Phrase: ")"

Phrase: "or in the presence of POPC/POPS SUVs"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   782   C1881413:Small Unilamellar Vesicles [Chemical Viewed Structurally]
   760   C1721092:Unilamellar Vesicles [Lipid]
   739   C0031623:phosphatidylserine [Lipid]
   739   C0301704:Phosphatidyl serine [Lipid]
   739   C0333262:VESICLES [Acquired Abnormality]
   739   C0392148:Presence [Therapeutic or Preventive Procedure]
   739   C0700321:Small [Quantitative Concept]
   739   C1959616:Phosphatidyl choline [Biologically Active Substance,Lipid,Pharmacologic Substance]
   706 E C1622418:vesicle [Cell Component]

Phrase: "at 0.5mg/ml (1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439526:/mL [Quantitative Concept]

Phrase: ":"

Phrase: "2.5,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0450346:2 5 [Quantitative Concept]
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: "protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ":"

Phrase: "lipid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023779:Lipid [Lipid]

Phrase: ")"

Phrase: "("

Phrase: "-"

Phrase: "-"

Phrase: ")"

Phrase: ","

Phrase: "1mg/ml (1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439526:/mL [Quantitative Concept]

Phrase: ":"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "("

Phrase: "-"

Phrase: "-"

Phrase: "-"

Phrase: "-"

Phrase: ")"

Phrase: ","

Phrase: "2mg/ml (1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439526:/mL [Quantitative Concept]

Phrase: ":"

Phrase: "10"

Phrase: ")"

Phrase: "("

Phrase: "-"

Phrase: "-"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "4mg/ml (1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439526:/mL [Quantitative Concept]

Phrase: ":"

Phrase: "20"

Phrase: ")"

Phrase: "("

Phrase: ")."
Processing 00000000.tx.157: Second, we examined the interaction of -Syn with SUVs in comparison to MLVs since the curvature of SUVs has been suggested to affect protein-lipid interactions (31). 

Phrase: "Second,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0205436:Second [Quantitative Concept]
  1000   C0457385:Second [Temporal Concept]
  1000   C0565930:/second [Quantitative Concept]
  1000   C1561503:second [Idea or Concept]
  1000   C1705190:Second [Qualitative Concept]
   928 E C0027627:secondary [Neoplastic Process]
   928 E C0175668:Secondary [Temporal Concept]

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the interaction of -Syn with SUVs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in comparison to MLVs"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0333262:VESICLES [Acquired Abnormality]
   827 E C1622418:vesicle [Cell Component]
   777 E C0205378:Vesicular [Qualitative Concept]

Phrase: "since"

Phrase: "the curvature of SUVs"

Phrase: "has"

Phrase: "been"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "protein-lipid interactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   896   C0872079:protein interaction [Molecular Function]
   793   C1704675:Interaction [Functional Concept]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.158: When preformed POPC/POPS MLVs at 2mg/ml were added to -Syn in PBS, the CD spectrum did not change significantly from its random coiled structure (Fig. 4). 

Phrase: "When"

Phrase: "preformed POPC/POPS MLVs at 2mg/ml"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0333262:VESICLES [Acquired Abnormality]
   711 E C1622418:vesicle [Cell Component]

Phrase: "were"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "to -Syn in PBS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "the CD spectrum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1883073:Spectrum [Quantitative Concept]
   827   C2827424:Spectrum [Conceptual Entity]
   734   C0008813:Circular Dichroism [Laboratory Procedure]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0392747:Change [Functional Concept]
  1000   C0443172:change [Quantitative Concept]
  1000   C1705241:Change [Quantitative Concept]

Phrase: "significantly from its random coiled structure"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   753   C0034656:RANDOM [Research Activity]
   753   C0439605:Random [Qualitative Concept]
   753   C0444764:coiled [Spatial Concept]
   753   C0678594:Structure [Spatial Concept]
   753   C1880115:COILED [Phenomenon or Process]
   719 E C1413568:COIL [Gene or Genome]
   719 E C1705946:Coil [Medical Device]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.159: This seemed to be due to the fact that only the outermost lipid bilayer is available for -Syn binding and the inner layers are inaccessible to -Syn, resulting in an actual concentration of the available lipids much less than 2mg/ml. 

Phrase: "This seemed to"

Phrase: "be due to the fact"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0678226:Due to [Functional Concept]
           due
   760   C2987476:Be [Conceptual Entity]
   760   C3146286:Due [Idea or Concept]

Phrase: "that only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "the outermost lipid bilayer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0023768:Lipid bilayer [Cell Component]
   827   C0023779:Lipid [Lipid]

Phrase: "is"

Phrase: "available for -Syn binding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0470187:Available [Functional Concept]

Phrase: "and"

Phrase: "the inner layers"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0934502:layers [Body Part, Organ, or Organ Component]
   827 E C1522408:Layer [Qualitative Concept]
   827 E C1561599:Layer [Intellectual Product]

Phrase: "are"

Phrase: "inaccessible to -Syn,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "resulting in an actual concentration of the available lipids much less"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   756   C0332294:Resulting in [Functional Concept]
   738   C0023779:Lipids [Lipid]
   738   C0086045:Concentration [Mental Process]
   738   C0237400:Actual [Qualitative Concept]
   738   C0470187:Available [Functional Concept]
           Availability of
   738   C0678226:resulting [Functional Concept]
   738   C1446561:Concentration [Quantitative Concept]
   704 E C1274040:Result [Functional Concept]
   704 E C1546471:Result [Idea or Concept]
   704 E C2825142:Result [Finding]

Phrase: "than 2mg/ml."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]
Processing 00000000.tx.160: In contrast, when POPC/POPS MLVs (2mg/ml) were made in PBS containing -Syn, the CD spectrum showed a characteristic -helical structure (Fig. 4), similar to the one obtained by adding POPC/POPS SUVs at 2mg/ml to -Syn in PBS. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "when"

Phrase: "POPC/POPS MLVs"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0333262:VESICLES [Acquired Abnormality]
   779 E C1622418:vesicle [Cell Component]
   729 E C0205378:Vesicular [Qualitative Concept]

Phrase: "(2mg/ml)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "were"

Phrase: "made in PBS"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   797   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   760   C0031701:phosphate [Organophosphorus Compound]
   760   C0036082:Saline [Substance]
   760   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   726   C1881534:Make [Functional Concept]

Phrase: "containing -Syn,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0332256:Containing [Functional Concept]
   861   C2700400:Containing [Activity]

Phrase: "the CD spectrum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1883073:Spectrum [Quantitative Concept]
   827   C2827424:Spectrum [Conceptual Entity]
   734   C0008813:Circular Dichroism [Laboratory Procedure]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a characteristic -helical structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0678594:Structure [Spatial Concept]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "similar to the one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similar [Qualitative Concept]

Phrase: "obtained by adding POPC/POPS SUVs"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   800   C1881413:Small Unilamellar Vesicles [Chemical Viewed Structurally]
   770   C1721092:Unilamellar Vesicles [Lipid]
   744   C0031623:phosphatidylserine [Lipid]
   744   C0301704:Phosphatidyl serine [Lipid]
   744   C0333262:VESICLES [Acquired Abnormality]
   744   C0700321:Small [Quantitative Concept]
   744   C1301820:Obtained [Functional Concept]
   744   C1959616:Phosphatidyl choline [Biologically Active Substance,Lipid,Pharmacologic Substance]
   711 E C1622418:vesicle [Cell Component]
   711 E C1706701:Obtain [Activity]
   711   C1883712:Add [Functional Concept]

Phrase: "at 2mg/ml to -Syn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in PBS."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0036082:Saline [Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
Processing 00000000.tx.161: Therefore, the extent of lipid binding was dependent on the availability of lipids rather than on the size of the vesicles (SUVs versus MLVs). 

Phrase: "Therefore,"

Phrase: "the extent of lipid binding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439792:Extent [Spatial Concept]

Phrase: "was"

Phrase: "dependent on the availability of lipids"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0851827:Dependent [Qualitative Concept]
   753   C1701901:Dependent [Qualitative Concept]
   753   C3244310:dependent [Functional Concept]

Phrase: "rather than on the size of the vesicles"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   744   C0333262:VESICLES [Acquired Abnormality]
   744   C0456389:size [Spatial Concept]
   711 E C1622418:vesicle [Cell Component]

Phrase: "(SUVs"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C1881413:Small Unilamellar Vesicles [Chemical Viewed Structurally]
   901   C1721092:Unilamellar Vesicles [Lipid]
   827   C0333262:VESICLES [Acquired Abnormality]
   827   C0700321:Small [Quantitative Concept]
   793 E C1622418:vesicle [Cell Component]
   743 E C0205378:Vesicular [Qualitative Concept]

Phrase: "versus"

Phrase: "MLVs"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0333262:VESICLES [Acquired Abnormality]
   827 E C1622418:vesicle [Cell Component]
   777 E C0205378:Vesicular [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.162: The A53T mutant -Syn was also examined by CD in all the experiments in order to compare the secondary structure of the mutant with the wild-type -Syn. 

Phrase: "The A53T mutant -Syn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "also"

Phrase: "examined by CD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0008813:Circular Dichroism [Laboratory Procedure]
   770   C0332128:Examined [Finding]
   770   C0596436:dichroism [Natural Phenomenon or Process]
   770   C1282913:Circular [Spatial Concept]

Phrase: "in all"

Phrase: "the experiments in order to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0681814:Experiments [Research Activity]
   726 E C1706386:Experiment [Conceptual Entity]

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "the secondary structure of the mutant"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0162807:Secondary Structure [Spatial Concept]
   753   C0027627:secondary [Neoplastic Process]
   753   C0175668:Secondary [Temporal Concept]
   753   C0205436:Secondary [Quantitative Concept]
   753   C0678594:Structure [Spatial Concept]

Phrase: "with the wild-type -Syn."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1883559:Wild Type [Organism Attribute]
Processing 00000000.tx.163: CD spectra of A53T mutant (Fig. 4B) were similar to the wild-type (Fig. 4A) in all conditions, suggesting that the average secondary structure of A53T -Syn upon lipid binding is similar to the wild-type. 

Phrase: "CD spectra of A53T mutant"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1883073:Spectrum [Quantitative Concept]
   719   C2827424:Spectrum [Conceptual Entity]

Phrase: "(Fig. 4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")"

Phrase: "were"

Phrase: "similar to the wild-type"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2348205:Similar [Qualitative Concept]

Phrase: "(Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")"

Phrase: "in all conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the average secondary structure of A53T -Syn"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0162807:Secondary Structure [Spatial Concept]
   748   C0027627:secondary [Neoplastic Process]
   748   C0175668:Secondary [Temporal Concept]
   748   C0205436:Secondary [Quantitative Concept]
   748   C0678594:Structure [Spatial Concept]

Phrase: "upon lipid binding"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1148636:Lipid Binding [Molecular Function]
   861   C0023779:Lipid [Lipid]
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "is"

Phrase: "similar to the wild-type."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2348205:Similar [Qualitative Concept]
Processing 00000000.tx.164: View larger version (12K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(12K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.165: 4.  

Phrase: "4."
Processing 00000000.tx.166: CD spectra of -synuclein bound to the preformed MLVs versus -synuclein incorporated into MLVs. 

Phrase: "CD spectra of -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "bound to the preformed MLVs"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0332297:bound [Spatial Concept]
   753   C0333262:VESICLES [Acquired Abnormality]
   753   C1145667:Bound [Activity]
   753   C1167622:Bound [Molecular Function]
   753   C1689898:% bound [Quantitative Concept]
   753   C2349209:Bound [Conceptual Entity]
   719 E C1622418:vesicle [Cell Component]

Phrase: "versus -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "incorporated into MLVs."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0333262:VESICLES [Acquired Abnormality]
   737 E C1622418:vesicle [Cell Component]
Processing 00000000.tx.167: -Synuclein at 0.2mg/ml was examined in PBS () or in the presence of POPC/POPS MLVs (--) at 2mg/ml. 

Phrase: "-Synuclein at 0.2mg/ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "examined in PBS"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   797   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   760   C0031701:phosphate [Organophosphorus Compound]
   760   C0036082:Saline [Substance]
   760   C0332128:Examined [Finding]
   760   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "("

Phrase: ")"

Phrase: "or in the presence of POPC/POPS MLVs"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   742   C0031623:phosphatidylserine [Lipid]
   742   C0301704:Phosphatidyl serine [Lipid]
   742   C0333262:VESICLES [Acquired Abnormality]
   742   C0392148:Presence [Therapeutic or Preventive Procedure]
   742   C1959616:Phosphatidyl choline [Biologically Active Substance,Lipid,Pharmacologic Substance]
   708 E C1622418:vesicle [Cell Component]

Phrase: "("

Phrase: "-"

Phrase: "-"

Phrase: ")"

Phrase: "at 2mg/ml."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]
Processing 00000000.tx.168: Alternatively, -synuclein was incorporated into POPC/POPS MLVs by making MLVs (2mg/ml) in PBS containing -synuclein (0.2mg/ml) (). 

Phrase: "Alternatively, -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "incorporated into POPC/POPS MLVs"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0031623:phosphatidylserine [Lipid]
   753   C0301704:Phosphatidyl serine [Lipid]
   753   C0333262:VESICLES [Acquired Abnormality]
   753   C1959616:Phosphatidyl choline [Biologically Active Substance,Lipid,Pharmacologic Substance]
   719 E C1622418:vesicle [Cell Component]

Phrase: "by making MLVs"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0333262:VESICLES [Acquired Abnormality]
   793 E C1622418:vesicle [Cell Component]
   743 E C0205378:Vesicular [Qualitative Concept]

Phrase: "(2mg/ml) in PBS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439526:/mL [Quantitative Concept]

Phrase: "containing -synuclein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0332256:Containing [Functional Concept]
   861   C2700400:Containing [Activity]

Phrase: "(0.2mg/ml) ("
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439526:/mL [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.169: A, wild-type -synuclein. 

Phrase: "A,"

Phrase: "wild-type -synuclein."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1883559:Wild Type [Organism Attribute]
Processing 00000000.tx.170: B, A53T mutant -synuclein. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "A53T mutant -synuclein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.171: Third, we examined if -Syn binds to PE-containing vesicles because -Syn was found to bind to PE on TLC plate. 

Phrase: "Third,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205437:Third [Quantitative Concept]

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "if -Syn"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0750557:If [Qualitative Concept]

Phrase: "binds to PE-containing vesicles"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   760   C0031618:Phosphatidyl ethanolamine [Biologically Active Substance,Lipid]
   760   C0332256:Containing [Functional Concept]
   760   C0333262:VESICLES [Acquired Abnormality]
   760   C1145667:Bind [Activity]
   760   C1167622:bind [Molecular Function]
   760   C1450468:phosphatidylethanolamine [Lipid,Pharmacologic Substance]
   760   C2700400:Containing [Activity]
   726 E C1622418:vesicle [Cell Component]

Phrase: "because -Syn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "bind to PE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0031618:Phosphatidyl ethanolamine [Biologically Active Substance,Lipid]
   790   C1145667:Bind [Activity]
   790   C1167622:bind [Molecular Function]
   790   C1450468:phosphatidylethanolamine [Lipid,Pharmacologic Substance]

Phrase: "on TLC plate."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0005971:Plate [Medical Device]
   812   C1139930:plate [Medical Device]
   812   C3537155:Plate [Manufactured Object]
   756   C0008569:Thin Layer Chromatography [Laboratory Procedure]
Processing 00000000.tx.172: PE itself cannot form stable vesicles due to its tendency to form a hexagonal phase (45). 

Phrase: "PE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031618:Phosphatidyl ethanolamine [Biologically Active Substance,Lipid]
  1000   C1450468:phosphatidylethanolamine [Lipid,Pharmacologic Substance]

Phrase: "itself"

Phrase: "cannot"

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "stable vesicles due to its tendency to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0333262:VESICLES [Acquired Abnormality]
   714 E C1622418:vesicle [Cell Component]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "a hexagonal phase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205390:Phase [Temporal Concept]

Phrase: "(45"

Phrase: ")."
Processing 00000000.tx.173: Therefore, SUVs of an equimolar mixture of PC and PE as well as 100% PE dispersed in buffer were examined for -Syn binding. 

Phrase: "Therefore,"

Phrase: "SUVs of an equimolar mixture of PC"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C1881413:Small Unilamellar Vesicles [Chemical Viewed Structurally]
   764   C1721092:Unilamellar Vesicles [Lipid]
   742   C0333262:VESICLES [Acquired Abnormality]
   742   C0700321:Small [Quantitative Concept]
   708 E C1622418:vesicle [Cell Component]

Phrase: "and"

Phrase: "PE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031618:Phosphatidyl ethanolamine [Biologically Active Substance,Lipid]
  1000   C1450468:phosphatidylethanolamine [Lipid,Pharmacologic Substance]

Phrase: "as well as"

Phrase: "100% PE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031618:Phosphatidyl ethanolamine [Biologically Active Substance,Lipid]
   861   C1450468:phosphatidylethanolamine [Lipid,Pharmacologic Substance]

Phrase: "dispersed in buffer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   790   C0332624:Dispersed [Spatial Concept]

Phrase: "were"

Phrase: "examined for -Syn binding."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0243122:binding [Functional Concept]
   770   C0332128:Examined [Finding]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]
Processing 00000000.tx.174: -Syn did not undergo a conformational change in the presence of PC/PE SUVs or PE suspension (data not shown). 

Phrase: "-Syn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "undergo"

Phrase: "a conformational change in the presence of PC/PE SUVs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0301641:Conformational change [Molecular Function]
   736   C0392747:Change [Functional Concept]
   736   C0443172:change [Quantitative Concept]
   736   C1705241:Change [Quantitative Concept]

Phrase: "or"

Phrase: "PE suspension"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0038960:Suspension [Biomedical or Dental Material]
   861   C1382107:Suspension [Substance]
   861   C1705537:Suspension [Functional Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.175: Although PE suspension and PC/PE SUVs did not cause an increase in the -helicity of -Syn, PE in the presence of all acidic phospholipids caused an appreciable increase in its -helicity (Fig. 5). 

Phrase: "Although"

Phrase: "PE suspension"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0038960:Suspension [Biomedical or Dental Material]
   861   C1382107:Suspension [Substance]
   861   C1705537:Suspension [Functional Concept]

Phrase: "and"

Phrase: "PC/PE SUVs"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   884   C1881413:Small Unilamellar Vesicles [Chemical Viewed Structurally]
   840   C1721092:Unilamellar Vesicles [Lipid]
   804   C0333262:VESICLES [Acquired Abnormality]
   804   C0700321:Small [Quantitative Concept]
   771 E C1622418:vesicle [Cell Component]
   721 E C0205378:Vesicular [Qualitative Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "an increase in the -helicity of -Syn,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "PE in the presence of all acidic phospholipids"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0031618:Phosphatidyl ethanolamine [Biologically Active Substance,Lipid]
   744   C1450468:phosphatidylethanolamine [Lipid,Pharmacologic Substance]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "an appreciable increase in its -helicity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.176: Surprisingly, PA and PI did not induce a significant conformational change in -Syn when presented with PC (Fig. 5). 

Phrase: "Surprisingly,"

Phrase: "PA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0031610:Phosphatidic Acid [Lipid]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "PI"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031621:Phosphatidyl Inositol [Biologically Active Substance,Lipid]
  1000   C2348046:Phosphatidylinositol [Lipid]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "a significant conformational change in -Syn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "when"

Phrase: "presented with PC (Fig. 5"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0349966:Fig [Food]
   760   C0449450:Presented [Idea or Concept]
   760   C1337208:FIG [Food]
   760   C3540812:PC [Gene or Genome]
   726 E C0150312:Present [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.177: In contrast, when PA and PI were combined with PE (1:1, w/w), the -helicity of -Syn increased significantly (Fig. 5), indicating its increased interaction with PE/PA (and PE/PI) vesicles. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "when"

Phrase: "PA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0031610:Phosphatidic Acid [Lipid]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "PI"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031621:Phosphatidyl Inositol [Biologically Active Substance,Lipid]
  1000   C2348046:Phosphatidylinositol [Lipid]

Phrase: "were"

Phrase: "combined with PE"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0031618:Phosphatidyl ethanolamine [Biologically Active Substance,Lipid]
   790   C0205195:Combined [Qualitative Concept]
   790   C1450468:phosphatidylethanolamine [Lipid,Pharmacologic Substance]
   756 E C0336789:Combine [Manufactured Object]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "w/w),"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709500:%W/W [Quantitative Concept]
  1000   C2919747:w/w [Quantitative Concept]

Phrase: "the -helicity of -Syn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "significantly"

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "indicating"

Phrase: "its increased interaction with PE/PA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1704675:Interaction [Functional Concept]

Phrase: "("

Phrase: "and"

Phrase: "PE/PI"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031621:Phosphatidyl Inositol [Biologically Active Substance,Lipid]
   861   C2348046:Phosphatidylinositol [Lipid]

Phrase: ")"

Phrase: "vesicles."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0333262:VESICLES [Acquired Abnormality]
   966 E C1622418:vesicle [Cell Component]
   916 E C0205378:Vesicular [Qualitative Concept]
Processing 00000000.tx.178: Therefore, PE seems to help the lipid vesicles to bind to -Syn possibly by providing a monolayer negative curvature strain to the vesicles, which can be relieved by -Syn binding. 

Phrase: "Therefore,"

Phrase: "PE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031618:Phosphatidyl ethanolamine [Biologically Active Substance,Lipid]
  1000   C1450468:phosphatidylethanolamine [Lipid,Pharmacologic Substance]

Phrase: "seems"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "help"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018896:Help [Social Behavior]
  1000   C1552861:help [Idea or Concept]

Phrase: "the lipid vesicles to"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0333262:VESICLES [Acquired Abnormality]
   793 E C1622418:vesicle [Cell Component]
   743 E C0205378:Vesicular [Qualitative Concept]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "to -Syn possibly by providing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "a monolayer negative curvature strain to the vesicles,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0080194:Strain [Injury or Poisoning]
   744   C0456178:strain [Intellectual Product]
   744   C1518614:Strain [Organism]
   744   C2987481:Strain [Mental Process]

Phrase: "which"

Phrase: "can"

Phrase: "be"

Phrase: "relieved by -Syn binding."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0332303:Relieved by [Functional Concept]
   770   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]
   770   C1301771:Relieved [Qualitative Concept]
   737 E C1301676:relieve [Functional Concept]
Processing 00000000.tx.179: Alternatively, since PE has a smaller hydration shell than PC, it might allow closer protein-membrane contact, as proposed for protein kinase C (46). 

Phrase: "Alternatively,"

Phrase: "since"

Phrase: "PE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031618:Phosphatidyl ethanolamine [Biologically Active Substance,Lipid]
  1000   C1450468:phosphatidylethanolamine [Lipid,Pharmacologic Substance]

Phrase: "has"

Phrase: "a smaller hydration shell than PC,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0222041:Shell [Body Part, Organ, or Organ Component]
   753   C1948022:Shell [Qualitative Concept]

Phrase: "it"

Phrase: "might"

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "closer protein-membrane contact,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0332158:contact [Functional Concept]
   812   C0337611:Contact [Population Group]
   812   C1705415:Contact [Idea or Concept]

Phrase: "as"

Phrase: "proposed for protein kinase C"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   862   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   844 E C1259877:kinase c protein [Amino Acid, Peptide, or Protein,Enzyme]
   806   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   797   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   797   C1168438:Protein C [Laboratory Procedure]
   797   C1418943:PROTEIN C [Gene or Genome]
   797   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1441414:PROPOSED [Idea or Concept]
   760   C1553874:Proposed [Qualitative Concept]
   760   C1578820:Proposed [Idea or Concept]

Phrase: "(46"

Phrase: ")."
Processing 00000000.tx.180: View larger version (14K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(14K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.181: 5.  

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.182: Changes in the secondary structure of -synuclein in the presence of PE-containing acidic lipid vesicles. 

Phrase: "Changes in the secondary structure of -synuclein"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0392747:changes [Functional Concept]
   748   C0443172:changes [Quantitative Concept]
   714 E C1705241:Change [Quantitative Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of PE-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031618:Phosphatidyl ethanolamine [Biologically Active Substance,Lipid]
  1000   C1450468:phosphatidylethanolamine [Lipid,Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "acidic lipid vesicles."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0333262:VESICLES [Acquired Abnormality]
   793 E C1622418:vesicle [Cell Component]
   743 E C0205378:Vesicular [Qualitative Concept]
Processing 00000000.tx.183: -Synuclein at 0.2mg/ml was examined in PBS () or incorporated into POPC/POPA (1:1, w/w, 2mg/ml) MLVs (--) or brain PE/POPA MLVs (). 

Phrase: "-Synuclein at 0.2mg/ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "examined in PBS"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   797   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   760   C0031701:phosphate [Organophosphorus Compound]
   760   C0036082:Saline [Substance]
   760   C0332128:Examined [Finding]
   760   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "("

Phrase: ")"

Phrase: "or"

Phrase: "incorporated into POPC/POPA"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   806   C0031610:Phosphatidic Acid [Lipid]
   760   C0001128:Acid [Chemical]
   760   C0202406:Acid [Laboratory Procedure]
   760   C1959616:Phosphatidyl choline [Biologically Active Substance,Lipid,Pharmacologic Substance]
   704 E C0031617:Lecithin [Biologically Active Substance,Lipid,Pharmacologic Substance]
   704 E C0885520:lecithin [Organic Chemical,Pharmacologic Substance]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "w/w,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709500:%W/W [Quantitative Concept]
  1000   C2919747:w/w [Quantitative Concept]

Phrase: "2mg/ml) MLVs"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0333262:VESICLES [Acquired Abnormality]
   779 E C1622418:vesicle [Cell Component]
   729 E C0205378:Vesicular [Qualitative Concept]

Phrase: "("

Phrase: "-"

Phrase: "-"

Phrase: ")"

Phrase: "or"

Phrase: "brain PE/POPA MLVs"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   799   C0333262:VESICLES [Acquired Abnormality]
   766 E C1622418:vesicle [Cell Component]
   716 E C0205378:Vesicular [Qualitative Concept]

Phrase: "("

Phrase: ")."
Processing 00000000.tx.184: Spectra obtained using PI vesicles were essentially identical to PA vesicles (data not shown). 

Phrase: "Spectra"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1883073:Spectrum [Quantitative Concept]
   966   C2827424:Spectrum [Conceptual Entity]

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "PI vesicles"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0333262:VESICLES [Acquired Abnormality]
   827 E C1622418:vesicle [Cell Component]
   777 E C0205378:Vesicular [Qualitative Concept]

Phrase: "were"

Phrase: "essentially identical to PA vesicles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205280:Identical [Qualitative Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.185: Fourth, since -Syn binding to PC/PS vesicles was thought to be electrostatic, we investigated the influence of ionic strength on -Syn association with PC/PS and PE/PS vesicles (Ref. 31, Fig. 6). 

Phrase: "Fourth,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205438:Fourth [Quantitative Concept]
  1000   C1706303:Fourth [Qualitative Concept]

Phrase: "since -Syn binding"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   827   C1711239:Since [Temporal Concept]

Phrase: "to PC/PS vesicles"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0333262:VESICLES [Acquired Abnormality]
   793 E C1622418:vesicle [Cell Component]
   743 E C0205378:Vesicular [Qualitative Concept]

Phrase: "was"

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "electrostatic,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0376534:electrostatic [Natural Phenomenon or Process]

Phrase: "we"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "the influence of ionic strength on -Syn association"

Phrase: "with PC/PS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031623:phosphatidylserine [Lipid]
   861   C0301704:Phosphatidyl serine [Lipid]

Phrase: "and"

Phrase: "PE/PS vesicles"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0333262:VESICLES [Acquired Abnormality]
   793 E C1622418:vesicle [Cell Component]
   743 E C0205378:Vesicular [Qualitative Concept]

Phrase: "(Ref. 31,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450355:31 [Intellectual Product]
   861   C1425988:REF [Gene or Genome]

Phrase: "Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.186: The -helicity of -Syn was greatest at 0mM NaCl and decreased with increasing NaCl concentration, indicating that the electrostatic interaction between -Syn and PC/PS vesicles was inhibited by salt. 

Phrase: "The -helicity of -Syn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "greatest at 0mM NaCl"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0205393:Greatest [Quantitative Concept]
   737 E C0549177:Great [Quantitative Concept]
   737 E C1704243:Great [Quantitative Concept]

Phrase: "and"

Phrase: "decreased with increasing NaCl concentration,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   760   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   760   C0086045:Concentration [Mental Process]
   760   C0205216:Decreased [Quantitative Concept]
   760   C0392756:Decreased [Qualitative Concept]
   760   C0442797:decreased [Qualitative Concept]
   760   C0442808:Increasing [Functional Concept]
   760   C1446561:Concentration [Quantitative Concept]
   760   C1959973:% NaCl [Quantitative Concept]
   726 E C0547047:Decrease [Quantitative Concept]

Phrase: "indicating"

Phrase: "that"

Phrase: "the electrostatic interaction between -Syn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "PC/PS vesicles"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0333262:VESICLES [Acquired Abnormality]
   793 E C1622418:vesicle [Cell Component]
   743 E C0205378:Vesicular [Qualitative Concept]

Phrase: "was"

Phrase: "inhibited by salt."
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   790   C0036140:Salt [Chemical Viewed Structurally]
   790   C0037494:Salt [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   790   C0206136:Salt [Food,Inorganic Chemical]
   790   C0311403:Inhibited [Qualitative Concept]
   718 E C0018790:arrested [Disease or Syndrome]
   718 E C0237477:Arrest [Temporal Concept]
   718 E C0392351:arrest [Governmental or Regulatory Activity]
   718 E C0521111:Retarded [Qualitative Concept]
   718 E C1537053:salty [Qualitative Concept]
Processing 00000000.tx.187: PE/PS vesicles were more resistant to the salt-induced inhibition of -Syn binding to the vesicles than PC/PS. 

Phrase: "PE/PS vesicles"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0333262:VESICLES [Acquired Abnormality]
   793 E C1622418:vesicle [Cell Component]
   743 E C0205378:Vesicular [Qualitative Concept]

Phrase: "were"

Phrase: "more resistant to the salt-induced inhibition of -Syn binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0332325:Resistant to [Functional Concept]
           Resistant
   739   C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "to the vesicles"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0333262:VESICLES [Acquired Abnormality]
   966 E C1622418:vesicle [Cell Component]
   916 E C0205378:Vesicular [Qualitative Concept]

Phrase: "than PC/PS."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031623:phosphatidylserine [Lipid]
   861   C0301704:Phosphatidyl serine [Lipid]
Processing 00000000.tx.188: The extent of -Syn binding to PE/PS vesicles was significantly greater than its binding to PC/PS vesicles at 100-400 mM NaCl which includes a physiological salt concentration (Fig. 6). 

Phrase: "The extent of -Syn binding to PE/PS vesicles"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   762   C1148644:phosphatidylethanolamine binding [Molecular Function]
   762   C1323272:phosphatidylserine binding [Molecular Function]
   742   C0243122:binding [Functional Concept]
   742   C1145667:Binding [Activity]
   742   C1167622:Binding [Molecular Function]

Phrase: "was"

Phrase: "significantly greater than its binding"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   806   C0439093:Greater Than [Quantitative Concept]
   760   C0443228:greater [Quantitative Concept]
   760   C1704243:Greater [Quantitative Concept]
   726 E C0549177:Great [Quantitative Concept]

Phrase: "to PC/PS vesicles"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0333262:VESICLES [Acquired Abnormality]
   793 E C1622418:vesicle [Cell Component]
   743 E C0205378:Vesicular [Qualitative Concept]

Phrase: "at 100-400 mM NaCl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C1959973:% NaCl [Quantitative Concept]

Phrase: "which"

Phrase: "includes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:Includes [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "a physiological salt concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.189: This result confirms the specific binding of -Syn to PE, as shown by TLC overlay. 

Phrase: "This result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "confirms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "the specific binding of -Syn to PE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "as"

Phrase: "shown by TLC overlay."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0008569:Thin Layer Chromatography [Laboratory Procedure]
   753   C0008550:Chromatography [Laboratory Procedure]
   753   C0205168:Thin [Qualitative Concept]
   753   C0444456:Overlay [Spatial Concept]
   753   C0934502:Layer [Body Part, Organ, or Organ Component]
   753   C1522408:Layer [Qualitative Concept]
   753   C1561599:Layer [Intellectual Product]
   753   C1706359:Overlay [Medical Device]
   719   C1547282:Show [Intellectual Product]
Processing 00000000.tx.190: View larger version (10K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(10K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.191: 6.  

Phrase: "6."
Processing 00000000.tx.192: Ionic strength dependence of -synuclein binding to acidic lipid vesicles. 

Phrase: "Ionic strength dependence of -synuclein binding to acidic lipid vesicles."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   757   C1148636:Lipid Binding [Molecular Function]
   739   C0243122:binding [Functional Concept]
   739   C1145667:Binding [Activity]
   739   C1167622:Binding [Molecular Function]
   722   C1752728:ion binding [Molecular Function]
Processing 00000000.tx.193: -Synuclein (0.2mg/ml) was incorporated into MLVs in 5mM phosphate buffer containing 0,100,200,400,and 800mM NaCl. 

Phrase: "-Synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(0.2mg/ml)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439526:/mL [Quantitative Concept]

Phrase: "was"

Phrase: "incorporated into MLVs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0333262:VESICLES [Acquired Abnormality]
   737 E C1622418:vesicle [Cell Component]

Phrase: "in 5mM phosphate buffer"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0,"

Phrase: "100,"

Phrase: "200,"

Phrase: "400,"

Phrase: "and"

Phrase: "800mM NaCl."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]
Processing 00000000.tx.194: The minimum ellipticity at 222nm was taken as a measure of -helicity. 

Phrase: "The minimum ellipticity at 222nm"

Phrase: "was"

Phrase: "taken as a measure of -helicity."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0079809:Measure [Quantitative Concept]
   753   C0242485:Measure [Functional Concept]
   753   C1883727:Taken [Conceptual Entity]
   719 E C1515187:Take [Health Care Activity]
Processing 00000000.tx.195: The solid line () represents brain PE/brain PS (1:1 wt/wt) MLVs at 2mg/ml and the dashed line (----) represents POPC/brain PS MLVs. 

Phrase: "The solid line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: "("

Phrase: ")"

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "brain PE/brain PS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0031623:phosphatidylserine [Lipid]
   812   C0301704:Phosphatidyl serine [Lipid]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1 wt/wt) MLVs at 2mg/ml"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0333262:VESICLES [Acquired Abnormality]
   711 E C1622418:vesicle [Cell Component]

Phrase: "and"

Phrase: "the dashed line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: "("

Phrase: "-"

Phrase: "-"

Phrase: "-"

Phrase: "-"

Phrase: ")"

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "POPC/brain PS MLVs."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   804   C0333262:VESICLES [Acquired Abnormality]
   771 E C1622418:vesicle [Cell Component]
   721 E C0205378:Vesicular [Qualitative Concept]
Processing 00000000.tx.196: Disruption of Acidic Phospholipid Bilayer by -Syn-- Based on the results on the binding of -Syn to acidic phospholipid vesicles, the interaction of -Syn with planar supported bilayers of POPC/POPS (1:1) prepared by in situ vesicle fusion to mica was examined by in situ AFM. 

Phrase: "Disruption of Acidic Phospholipid Bilayer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332453:Disruption [Functional Concept]

Phrase: "by -Syn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "-"

Phrase: "-"

Phrase: "Based on the results"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737 E C1880279:Base [Biomedical or Dental Material]
   737   C2825142:Result [Finding]

Phrase: "on the binding of -Syn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "to acidic phospholipid vesicles,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0333262:VESICLES [Acquired Abnormality]
   793 E C1622418:vesicle [Cell Component]
   743 E C0205378:Vesicular [Qualitative Concept]

Phrase: "the interaction of -Syn with planar supported bilayers of POPC/POPS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "prepared by in situ vesicle fusion"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0444498:In situ [Spatial Concept]
   790   C1326474:vesicle fusion [Cell Function]
   753   C0332466:Fusion [Functional Concept]
   753   C0333262:Vesicle [Acquired Abnormality]
   753   C1293131:Fusion [Therapeutic or Preventive Procedure]
   753   C1622418:vesicle [Cell Component]
   719   C1521827:Prepare [Functional Concept]

Phrase: "to mica"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0066503:Mica [Inorganic Chemical,Pharmacologic Substance]
  1000   C1417162:MICA [Gene or Genome]

Phrase: "was"

Phrase: "examined by in situ AFM."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   814   C0242849:Microscopy, Atomic Force [Laboratory Procedure]
           Force Microscopy
   778   C0444498:In situ [Spatial Concept]
   748   C0026018:Microscopy [Laboratory Procedure]
   748   C0332128:Examined [Finding]
   748   C0441722:Force [Phenomenon or Process]
   748   C0563538:Force [Phenomenon or Process]
Processing 00000000.tx.197: The addition of -Syn at 0.1mg/ml in PBS buffer resulted in the gradual formation and expansion of bilayer holes over the course of several hours (Fig. 7). 

Phrase: "The addition of -Syn at 0.1mg/ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in PBS buffer"

Phrase: "resulted in the gradual formation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C0439833:Gradual [Qualitative Concept]
   760   C1522492:Formation [Functional Concept]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "and"

Phrase: "expansion of bilayer holes"

Phrase: "over the course"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750729:Course [Temporal Concept]

Phrase: "of several hours"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]

Phrase: "(Fig. 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.198: Close inspection of the bilayer and the defect sites revealed the presence of small aggregates and putative fibrils lying against the exposed mica surface (Fig. 7C, arrows). 

Phrase: "Close inspection of the bilayer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0199219:Inspection [Functional Concept]

Phrase: "and"

Phrase: "the defect sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205145:Sites [Spatial Concept]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "the presence of small aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "putative fibrils"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0225328:fibrils [Cell Component]
   827 E C1948066:Fibril [Physical Object]

Phrase: "lying against the exposed mica surface"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0038846:Lying [Spatial Concept]
   753   C0066503:Mica [Inorganic Chemical,Pharmacologic Substance]
   753   C0205148:Surface [Spatial Concept]
   753   C0332157:Exposed [Clinical Attribute]
   753   C0600261:Lying [Individual Behavior]
   753   C1417162:MICA [Gene or Genome]

Phrase: "(Fig. 7C,"

Phrase: "arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:arrows [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.199: The aggregates with a width of 2-3 nm and a thickness of ~2 nm are likely aggregated -Syn or possibly -Syn-lipid complexes (Fig. 7B, inset). 

Phrase: "The aggregates with a width of 2-3 nm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0205418:aggregates [Qualitative Concept]

Phrase: "and"

Phrase: "a thickness of ~2 nm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0312860:NM [Cell Function]

Phrase: "are"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "aggregated -Syn"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0332621:Aggregated [Functional Concept]
   827 E C0205418:Aggregate [Qualitative Concept]

Phrase: "or"

Phrase: "possibly -Syn-lipid complexes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C1704241:Complexes [Chemical Viewed Structurally]
   779 E C0439855:Complex [Qualitative Concept]

Phrase: "(Fig. 7B,"

Phrase: "inset"

Phrase: ")."
Processing 00000000.tx.200: While intermittent contact AFM height imaging provides details on surface topography, phase imaging measures the relative phase shift between the applied and detected tip oscillation during imaging, providing information related to specific adhesive interactions between the scanning tip and the sample surface (47-50). 

Phrase: "While"

Phrase: "intermittent contact AFM height"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   799   C0489786:Height [Organism Attribute]
   727 E C0205250:High [Qualitative Concept]
   727 E C1299351:High [Qualitative Concept]
   727 E C1522410:Highest [Qualitative Concept]
   727 E C2700149:HIGH [Intellectual Product]

Phrase: "imaging"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0011923:Imaging [Diagnostic Procedure]
  1000   C0079595:Imaging [Diagnostic Procedure]
   966 E C1704254:Image [Intellectual Product]
   966 E C1704922:Image [Entity]
   966 E C3542466:Image [Intellectual Product]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "details on surface topography,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1522508:Details [Qualitative Concept]
   737 E C1561567:detail [Functional Concept]

Phrase: "phase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205390:Phase [Temporal Concept]

Phrase: "imaging"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0011923:Imaging [Diagnostic Procedure]
  1000   C0079595:Imaging [Diagnostic Procedure]
   966 E C1704254:Image [Intellectual Product]
   966 E C1704922:Image [Entity]
   966 E C3542466:Image [Intellectual Product]

Phrase: "measures"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079809:Measure [Quantitative Concept]
  1000   C0242485:Measure [Functional Concept]
  1000   C1879489:Measures [Functional Concept]

Phrase: "the relative phase shift between the applied"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0205390:Phase [Temporal Concept]
   748   C0333051:Shift [Functional Concept]
   748   C2347509:Shift [Phenomenon or Process]

Phrase: "and"

Phrase: "detected tip oscillation during imaging,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0695434:oscillation [Therapeutic or Preventive Procedure]

Phrase: "providing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1999230:Provide [Activity]

Phrase: "information"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1533716:Information [Idea or Concept]
   928 E C3242430:informational [Idea or Concept]

Phrase: "related to specific adhesive interactions"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   760   C0001516:Adhesive [Manufactured Object]
   760   C0205369:Specific [Qualitative Concept]
   760   C0439849:Related [Qualitative Concept]
   760   C0445223:Related [Finding]
   760   C1552740:specific [Intellectual Product]
   760   C2982905:Adhesive [Manufactured Object]
   726 E C0163712:Relate [Organic Chemical]
   726   C1704675:Interaction [Functional Concept]

Phrase: "between the scanning tip"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1710425:Tip [Medical Device]
   861   C3282898:Tip [Qualitative Concept]

Phrase: "and"

Phrase: "the sample surface"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205148:Surface [Spatial Concept]

Phrase: "(47-50"

Phrase: ")."
Processing 00000000.tx.201: Phase images collected simultaneously with the topographical images acquired by in situ tapping mode AFM revealed variations in phase image contrast between the intact lipid bilayers and these aggregates, which confirms that the aggregates are not simply lipid artifacts. 

Phrase: "Phase images"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205390:Phase [Temporal Concept]
   827   C1704254:Image [Intellectual Product]
   827   C1704922:Image [Entity]
   827   C3542466:Image [Intellectual Product]

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "simultaneously with the topographical images"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0521115:simultaneously [Temporal Concept]
   726   C1704254:Image [Intellectual Product]
   726   C1704922:Image [Entity]
   726   C3542466:Image [Intellectual Product]

Phrase: "acquired by in situ tapping mode AFM revealed variations"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   775   C0242849:Microscopy, Atomic Force [Laboratory Procedure]
           Force Microscopy
   756   C0444498:In situ [Spatial Concept]
   738   C0026018:Microscopy [Laboratory Procedure]
   738   C0205419:variations [Qualitative Concept]
   738   C0439661:Acquired [Temporal Concept]
   738   C0441722:Force [Phenomenon or Process]
   738   C0443289:Revealed [Qualitative Concept]
   738   C0563538:Force [Phenomenon or Process]
   738   C1513371:Mode [Functional Concept]
   738   C1705738:Mode [Quantitative Concept]
   738   C2347637:Mode [Quantitative Concept]
   738   C2348146:Mode [Quantitative Concept]
   738   C3245488:acquired [Intellectual Product]
   704   C0034115:Tap [Health Care Activity]
   704 E C1706701:Acquire [Activity]

Phrase: "in phase image contrast"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C0444701:Phase contrast [Laboratory Procedure]
   827   C1979874:Contrast [Qualitative Concept]

Phrase: "between the intact lipid bilayers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0023768:Lipid Bilayers [Cell Component]
   827   C0023779:Lipid [Lipid]

Phrase: "and"

Phrase: "these aggregates,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205418:aggregates [Qualitative Concept]

Phrase: "which"

Phrase: "confirms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "that"

Phrase: "the aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205418:aggregates [Qualitative Concept]

Phrase: "are"

Phrase: "not simply lipid artifacts."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0085089:Artifacts [Human-caused Phenomenon or Process]
   812   C0699801:artifacts [Manufactured Object]
   779 E C1879740:ARTIFACT [Phenomenon or Process]
Processing 00000000.tx.202: View larger version (69K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(69K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.203: 7.  

Phrase: "7."
Processing 00000000.tx.204: AFM of lipid bilayer disrupted by wild-type -synuclein. 

Phrase: "AFM of lipid bilayer"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0242849:Microscopy, Atomic Force [Laboratory Procedure]
           Force Microscopy
   753   C0026018:Microscopy [Laboratory Procedure]
   753   C0441722:Force [Phenomenon or Process]
   753   C0563538:Force [Phenomenon or Process]

Phrase: "disrupted by wild-type -synuclein."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C1883559:Wild Type [Organism Attribute]
   760   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0332307:Type [Qualitative Concept]
   760   C0332454:Disrupted [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.205: A, POPC/POPS (1:1) bilayer. 

Phrase: "A,"

Phrase: "POPC/POPS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031623:phosphatidylserine [Lipid]
   861   C0301704:Phosphatidyl serine [Lipid]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "bilayer."
Processing 00000000.tx.206: B, 30min after adding the wild-type -synuclein at 0.1mg/ml in PBS. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "30min after adding"

Phrase: "the wild-type -synuclein at 0.1mg/ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in PBS."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0036082:Saline [Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
Processing 00000000.tx.207: The wild-type -Syn aggregates are shown in the zoomed height image (inset size 750750nm). 

Phrase: "The wild-type -Syn aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0205418:aggregates [Qualitative Concept]

Phrase: "are"

Phrase: "shown in the zoomed height image"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0489786:Height [Organism Attribute]
   753   C1704254:Image [Intellectual Product]
   753   C1704922:Image [Entity]
   753   C3542466:Image [Intellectual Product]
   719   C1547282:Show [Intellectual Product]

Phrase: "(inset size 750750nm"

Phrase: ")."
Processing 00000000.tx.208: C, 9h post-addition. 

Phrase: "C,"

Phrase: "9h post-addition."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1883712:Addition [Functional Concept]
   755 E C1524062:Additional [Functional Concept]
Processing 00000000.tx.209: The arrows indicate protein aggregates and putative fibrils. 

Phrase: "The arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:arrows [Manufactured Object]

Phrase: "indicate"

Phrase: "protein aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205418:aggregates [Qualitative Concept]

Phrase: "and"

Phrase: "putative fibrils."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0225328:fibrils [Cell Component]
   827 E C1948066:Fibril [Physical Object]
Processing 00000000.tx.210: Scale bar is 2m. 

Phrase: "Scale bar"

Phrase: "is"

Phrase: "2m."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3171718:2M [Quantitative Concept]
Processing 00000000.tx.211: To investigate whether there is any difference in lipid binding associated with the A53T mutant -Syn, we employed in situ AFM to examine the A53T -Syn binding to supported planar bilayers of POPC/POPS. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "whether"

Phrase: "there"

Phrase: "is"

Phrase: "any difference in lipid binding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1705241:*Difference [Quantitative Concept]
   760   C1705242:Difference [Qualitative Concept]

Phrase: "associated with the A53T mutant -Syn,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   753   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0596988:Mutant [Cell or Molecular Dysfunction]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "we"

Phrase: "employed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0557351:Employed [Finding]
   966 E C0457083:Employ [Functional Concept]

Phrase: "in situ AFM to"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   861   C0242849:Microscopy, Atomic Force [Laboratory Procedure]
           Force Microscopy
   799   C0026018:Microscopy [Laboratory Procedure]
   799   C0441722:Force [Phenomenon or Process]
   799   C0563538:Force [Phenomenon or Process]
   743 E C0729333:Dynamic [Functional Concept]
   727 E C0205288:Microscopic [Qualitative Concept]
   727   C0567415:Atom [Element, Ion, or Isotope]
   727   C1706222:Atom [Conceptual Entity]

Phrase: "examine"

Phrase: "the A53T -Syn binding to supported planar bilayers of POPC/POPS."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   754   C1323272:phosphatidylserine binding [Molecular Function]
   754   C1660266:phosphatidylcholine binding [Molecular Function]
   738   C0243122:binding [Functional Concept]
   738   C1145667:Binding [Activity]
   738   C1167622:Binding [Molecular Function]
Processing 00000000.tx.212: As in the case of the wild-type -Syn, extended duration in situ AFM revealed the gradual expansion of bilayer defects (Fig. 8). 

Phrase: "As in the case of the wild-type -Syn,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   764   C1883559:Wild Type [Organism Attribute]
   742   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0332307:Type [Qualitative Concept]
   742   C0445392:Wild [Intellectual Product]
   742   C0868928:Case [Functional Concept]
   742   C1547052:*Type [Quantitative Concept]
   742   C1706255:CASE [Medical Device]
   742   C1706256:Case [Conceptual Entity]

Phrase: "extended duration in situ AFM"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   845   C0242849:Microscopy, Atomic Force [Laboratory Procedure]
           Force Microscopy
   795   C0026018:Microscopy [Laboratory Procedure]
   795   C0441722:Force [Phenomenon or Process]
   795   C0563538:Force [Phenomenon or Process]
   740 E C0729333:Dynamic [Functional Concept]
   724 E C0205288:Microscopic [Qualitative Concept]
   724   C0567415:Atom [Element, Ion, or Isotope]
   724   C1706222:Atom [Conceptual Entity]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "the gradual expansion of bilayer defects"

Phrase: "(Fig. 8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.213: The rate of bilayer disruption was qualitatively slower in the case of the A53T -Syn mutant, which suggests that the mutant may be less effective in membrane binding and membrane disruption. 

Phrase: "The rate of bilayer disruption"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]

Phrase: "was"

Phrase: "qualitatively slower in the case of the A53T -Syn mutant,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   706   C0439834:Slow [Qualitative Concept]

Phrase: "which"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "may"

Phrase: "be"

Phrase: "less effective in membrane binding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280519:effective [Qualitative Concept]
   760   C1704419:Effective [Qualitative Concept]

Phrase: "and"

Phrase: "membrane disruption."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332453:Disruption [Functional Concept]
Processing 00000000.tx.214: We did not find any aggregated materials on the surface of the bilayers for both the wild-type and A53T mutant -Syn. 

Phrase: "We"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "find"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243095:Find [Finding]

Phrase: "any aggregated materials on the surface of the bilayers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0520510:Materials [Substance]

Phrase: "for both"

Phrase: "the wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "A53T mutant -Syn."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.215: However, we observed that the morphology of the A53T mutant -Syn aggregates was different from the wild-type. 

Phrase: "However,"

Phrase: "we"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "that"

Phrase: "the morphology of the A53T mutant -Syn aggregates"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0332437:Morphology [Qualitative Concept]
   744   C0543482:morphology [Spatial Concept]
   744   C0700329:Morphology, NOS [Finding]
   744   C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "was"

Phrase: "different from the wild-type."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1705242:Different [Qualitative Concept]
Processing 00000000.tx.216: The wild-type -Syn tended to form elongated aggregates with a width on the order of 2-3 nm and a thickness of ~2 nm (Fig. 7B, inset) whereas the A53T mutant -Syn formed small ellipsoidal aggregates with a dimension of 431.5nm (Fig. 8D, inset). 

Phrase: "The wild-type -Syn"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "tended"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "elongated aggregates with a width"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205418:aggregates [Qualitative Concept]

Phrase: "on the order"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1705175:Order [Intellectual Product]
  1000   C1705176:Order [Qualitative Concept]
  1000   C1705177:Order [Classification]
  1000   C1705178:Order [Activity]
  1000   C1882348:Order [Qualitative Concept]

Phrase: "of 2-3 nm"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0312860:NM [Cell Function]
   734   C1519042:2-3 [Research Activity]

Phrase: "and"

Phrase: "a thickness of ~2 nm (Fig. 7B,"

Phrase: "inset"

Phrase: ")"

Phrase: "whereas"

Phrase: "the A53T mutant -Syn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "formed"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0205431:Formed [Functional Concept]
   966 E C0348078:Form [Qualitative Concept]
   966 E C0376315:Form [Manufactured Object]
   966 E C1522492:Form [Functional Concept]

Phrase: "small ellipsoidal aggregates with a dimension of 431.5nm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0205418:aggregates [Qualitative Concept]

Phrase: "(Fig. 8D,"

Phrase: "inset"

Phrase: ")."
Processing 00000000.tx.217: View larger version (188K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(188K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.218: 8.  

Phrase: "8."
Processing 00000000.tx.219: AFM of lipid bilayer disrupted by A53T mutant -synuclein. 

Phrase: "AFM of lipid bilayer"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0242849:Microscopy, Atomic Force [Laboratory Procedure]
           Force Microscopy
   753   C0026018:Microscopy [Laboratory Procedure]
   753   C0441722:Force [Phenomenon or Process]
   753   C0563538:Force [Phenomenon or Process]

Phrase: "disrupted by A53T mutant -synuclein."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0332454:Disrupted [Qualitative Concept]
   760   C0596988:Mutant [Cell or Molecular Dysfunction]
Processing 00000000.tx.220: A, POPC/POPS (1:1) bilayer. 

Phrase: "A,"

Phrase: "POPC/POPS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031623:phosphatidylserine [Lipid]
   861   C0301704:Phosphatidyl serine [Lipid]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "bilayer."
Processing 00000000.tx.221: B, 30min after adding the A53T mutant -synuclein at 0.1mg/ml in PBS. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "30min after adding"

Phrase: "the A53T mutant -synuclein at 0.1mg/ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in PBS."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0036082:Saline [Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
Processing 00000000.tx.222: C, 11h post-addition. 

Phrase: "C,"

Phrase: "11h post-addition."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1883712:Addition [Functional Concept]
   755 E C1524062:Additional [Functional Concept]
Processing 00000000.tx.223: D, 15h post-addition. 

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "15h post-addition."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1883712:Addition [Functional Concept]
   755 E C1524062:Additional [Functional Concept]
Processing 00000000.tx.224: Scale bar is 2m. 

Phrase: "Scale bar"

Phrase: "is"

Phrase: "2m."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3171718:2M [Quantitative Concept]
Processing 00000000.tx.225: The A53T mutant -Syn aggregates are shown in the zoomed height image (inset size 500500nm).  

Phrase: "The A53T mutant -Syn aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0205418:aggregates [Qualitative Concept]

Phrase: "are"

Phrase: "shown in the zoomed height image"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0489786:Height [Organism Attribute]
   753   C1704254:Image [Intellectual Product]
   753   C1704922:Image [Entity]
   753   C3542466:Image [Intellectual Product]
   719   C1547282:Show [Intellectual Product]

Phrase: "(inset size 500500nm"

Phrase: ")."
Processing 00000000.tx.226: DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES The primary sequence of -Syn is highly conserved among vertebrates and its NH2-terminal amphipathic -helical domain is similar to the class A2 apolipoproteins. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The primary sequence of -Syn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "highly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205250:Highly [Qualitative Concept]

Phrase: "conserved among vertebrates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0042567:Vertebrates [Vertebrate]

Phrase: "and"

Phrase: "its NH2-terminal amphipathic -helical domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1880389:Domain [Functional Concept]
   804   C1883221:Domain [Conceptual Entity]
   804   C3541951:Domain [Intellectual Product]

Phrase: "is"

Phrase: "similar to the class A2 apolipoproteins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2348205:Similar [Qualitative Concept]
Processing 00000000.tx.227: Apolipoproteins bind and solubilize lipids to form the various plasma lipoprotein particles. 

Phrase: "Apolipoproteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003591:Apolipoproteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "and"

Phrase: "solubilize"

Phrase: "lipids to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023779:Lipids [Lipid]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "the various plasma lipoprotein particles."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   912   C2612456:plasma lipoprotein particle [Cell Component]
   812   C0597177:particles [Chemical Viewed Structurally]
Processing 00000000.tx.228: Class A amphipathic helices have cationic residues near the hydrophobic-hydrophilic interface and anionic residues that oppose the hydrophobic face (51). 

Phrase: "Class"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456387:Class [Intellectual Product]
  1000   C1705943:Class [Classification]

Phrase: "A amphipathic helices"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0018882:Helix [Eukaryote]
   861   C0229304:Helix [Body Part, Organ, or Organ Component]
   861   C1017315:helices [Eukaryote]
   861   C1704821:Helix [Spatial Concept]
   861   C1705682:Helix [Anatomical Structure]

Phrase: "have"

Phrase: "cationic residues near the hydrophobic-hydrophilic interface"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C1709915:Residue [Conceptual Entity]
   714   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "and"

Phrase: "anionic residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "that"

Phrase: "oppose"

Phrase: "the hydrophobic face"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0015450:Face [Body Location or Region]
   861   C1281591:Face [Body Part, Organ, or Organ Component]

Phrase: "(51"

Phrase: ")."
Processing 00000000.tx.229: However, the -Syn sequence is much more conserved across species than the apolipoprotein sequence, suggesting that -Syn is more than just a lipid carrier. 

Phrase: "However,"

Phrase: "the -Syn sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C1519249:Sequence [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "is"

Phrase: "much more"

Phrase: "conserved across species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1705920:Species [Conceptual Entity]

Phrase: "than the apolipoprotein sequence,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C1519249:Sequence [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that -Syn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "more than just"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205172:More [Functional Concept]

Phrase: "a lipid carrier."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007294:Carrier [Finding]
   861   C0560175:Carrier [Finding]
   861   C1706209:Carrier [Medical Device]
   861   C3273162:Carrier [Intellectual Product]
Processing 00000000.tx.230: It is possible that the functions of -Syn, including lipid transport, require the protein to adopt a variety of structures, depending on the availability of binding partners. 

Phrase: "It"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that"

Phrase: "the functions of -Syn,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "lipid transport,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0596846:Lipid Transport [Cell Function]
   861   C0005528:Transport, NOS [Cell Function]
   861   C1317949:Transport [Manufactured Object]
   861   C3495449:transport [Medical Device]

Phrase: "require"

Phrase: "the protein to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "adopt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0425382:adopt [Finding]

Phrase: "a variety of structures,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1883525:Variety [Conceptual Entity]
   770   C2346866:Variety [Conceptual Entity]

Phrase: "depending on the availability of binding partners."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0470187:Availability of [Functional Concept]
           Availability
   748   C0243122:binding [Functional Concept]
   748   C0682323:partners [Family Group]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]
   714   C0725813:depend [Medical Device]
Processing 00000000.tx.231: In order to do so, its sequence needs to be carefully balanced with respect to its conformational propensity for forming -helix, -sheet, and random structure as well as its amphipathicity. 

Phrase: "In order to do so,"

Phrase: "its sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0004793:Sequence [Nucleotide Sequence]
  1000   C0162326:Sequence [Nucleotide Sequence]
  1000   C0162327:Sequence [Nucleotide Sequence]
  1000   C1519249:Sequence [Functional Concept]
   928 E C1548958:Sequential [Idea or Concept]
   928 E C1705294:Sequential [Qualitative Concept]

Phrase: "needs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Need [Qualitative Concept]
  1000   C0686904:need [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "carefully"

Phrase: "balanced with respect to its conformational propensity"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   748   C0205415:Balanced [Functional Concept]
   748   C0679133:respect [Social Behavior]
   714 E C0014653:Balance [Organism Function]
   714 E C0560184:Balance [Finding]

Phrase: "for forming -helix, -"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0018882:Helix [Eukaryote]
   861   C0229304:Helix [Body Part, Organ, or Organ Component]
   861   C1704821:Helix [Spatial Concept]
   861   C1705682:Helix [Anatomical Structure]

Phrase: "sheet,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349187:Sheet [Quantitative Concept]

Phrase: "and"

Phrase: "random structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:Structure [Spatial Concept]

Phrase: "as well as"

Phrase: "its amphipathicity."
Processing 00000000.tx.232: This may explain the specific conservation in the -Syn sequence. 

Phrase: "This"

Phrase: "may"

Phrase: "explain"

Phrase: "the specific conservation in the -Syn sequence."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2347858:Conservation [Qualitative Concept]
Processing 00000000.tx.233: It is also possible that -Syn binds to specific proteins in vivo, such as synphilin-1 (52), which can also explain the highly conserved sequences. 

Phrase: "It"

Phrase: "is"

Phrase: "also possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332149:Possible [Qualitative Concept]
   861   C1705910:Possible [Qualitative Concept]
   861   C2362652:Possible [Qualitative Concept]

Phrase: "that -Syn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "binds to specific proteins"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0205369:Specific [Qualitative Concept]
   770   C1145667:Bind [Activity]
   770   C1167622:bind [Molecular Function]
   770   C1552740:specific [Intellectual Product]

Phrase: "in vivo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "such as synphilin-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1420277:SYNPHILIN 1 [Gene or Genome]
           synphilin
  1000   C3541909:Synphilin-1 [Amino Acid, Peptide, or Protein]

Phrase: "(52"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "can"

Phrase: "also"

Phrase: "explain"

Phrase: "the highly conserved sequences."
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   901   C0009802:Sequences, Conserved [Nucleotide Sequence]
   827   C0162326:Sequences [Nucleotide Sequence]
   793 E C0004793:Sequence [Nucleotide Sequence]
   793 E C0162327:Sequence [Nucleotide Sequence]
   793 E C1519249:Sequence [Functional Concept]
   743 E C1548958:Sequential [Idea or Concept]
   743 E C1705294:Sequential [Qualitative Concept]
Processing 00000000.tx.234: Replacing PC with PE in acidic lipid vesicles increased the binding of -Syn to these vesicles drastically (Fig. 5). 

Phrase: "Replacing PC with PE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C3540812:PC [Gene or Genome]

Phrase: "in acidic lipid vesicles"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0333262:VESICLES [Acquired Abnormality]
   793 E C1622418:vesicle [Cell Component]
   743 E C0205378:Vesicular [Qualitative Concept]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the binding of -Syn to these vesicles drastically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.235: PE has been found to facilitate the interaction between membranes and a few cytoplasmic proteins, including protein kinase C (46). 

Phrase: "PE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031618:Phosphatidyl ethanolamine [Biologically Active Substance,Lipid]
  1000   C1450468:phosphatidylethanolamine [Lipid,Pharmacologic Substance]

Phrase: "has"

Phrase: "been"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "facilitate"

Phrase: "the interaction between membranes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "a few cytoplasmic proteins,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C1333198:Cytoplasmic Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "protein kinase C"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   913   C1168438:Protein C [Laboratory Procedure]
   913   C1418943:PROTEIN C [Gene or Genome]
   913   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(46"

Phrase: ")."
Processing 00000000.tx.236: Although both PE and PC are neutral phospholipids that exhibit similar electrostatic properties, they differ in their head group orientation, lipid bilayer packing, and hydrogen-bonding capacity (45). 

Phrase: "Although"

Phrase: "both PE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031618:Phosphatidyl ethanolamine [Biologically Active Substance,Lipid]
  1000   C1450468:phosphatidylethanolamine [Lipid,Pharmacologic Substance]

Phrase: "and"

Phrase: "PC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540812:PC [Gene or Genome]

Phrase: "are"

Phrase: "neutral phospholipids"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0031676:Phospholipids [Biologically Active Substance,Lipid]
   827 E C0202177:Phospholipid [Laboratory Procedure]

Phrase: "that"

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "similar electrostatic properties,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0871161:properties [Qualitative Concept]
   827   C1292721:properties [Functional Concept]
   793 E C1882134:Property [Conceptual Entity]
   793 E C2347695:Property [Entity]

Phrase: "they"

Phrase: "differ in their head group orientation,"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   753   C0018670:Head [Body Location or Region]
   753   C0029266:Orientation [Mental Process]
   753   C0441833:Group [Idea or Concept]
   753   C0687744:group [Population Group]
   753   C1257890:Group [Population Group]
   753   C1281590:Head [Body Part, Organ, or Organ Component]
   753   C1552516:Group [Health Care Related Organization]
   753   C1704322:orientation [Spatial Concept]
   753   C1704972:Orientation [Spatial Concept]
   753   C1705428:Group [Conceptual Entity]
   753   C1705429:Group [Population Group]
   753   C1706305:Head [Manufactured Object]
   753   C3539923:Orientation [Intellectual Product]

Phrase: "lipid bilayer packing,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0184967:Packing [Therapeutic or Preventive Procedure]
   827   C1289829:Packing [Medical Device]
   827   C2828395:Packing [Activity]
   734   C0023768:Lipid bilayer [Cell Component]

Phrase: "and"

Phrase: "hydrogen-bonding capacity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1516240:Capacity [Quantitative Concept]
   734   C0020276:Hydrogen Bonding [Natural Phenomenon or Process]

Phrase: "(45"

Phrase: ")."
Processing 00000000.tx.237: One of the differences between PE and PC is the size of their head groups. 

Phrase: "One of the differences"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205447:One [Quantitative Concept]

Phrase: "between PE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031618:Phosphatidyl ethanolamine [Biologically Active Substance,Lipid]
  1000   C1450468:phosphatidylethanolamine [Lipid,Pharmacologic Substance]

Phrase: "and"

Phrase: "PC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540812:PC [Gene or Genome]

Phrase: "is"

Phrase: "the size of their head groups."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   851   C0424686:Size of the head [Finding]
           Head size
   783   C0237884:group size [Group Attribute]
   753   C0456389:size [Spatial Concept]
Processing 00000000.tx.238: The surface area of PC head group is 47-54 2 which is compatible with the minimum cross-sectional area of 502 required by two liquid-crystalline hydrocarbon chains (45). 

Phrase: "The surface area of PC head group"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   800   C0817043:Surface of head [Body Location or Region]
           Head surface
   748   C0017446:Area [Geographic Area]
   748   C0205146:Area [Spatial Concept]
   748   C0205148:Surface [Spatial Concept]

Phrase: "is"

Phrase: "47-54 2"

Phrase: "which"

Phrase: "is"

Phrase: "compatible with the minimum cross-sectional area of 502"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0332290:compatible [Idea or Concept]
   742   C1524057:Compatible [Qualitative Concept]

Phrase: "required by two liquid-crystalline hydrocarbon chains"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   748   C0020242:Hydrocarbon [Organic Chemical]
   748   C0205448:Two [Quantitative Concept]
   748   C0302908:Liquid [Substance]
   748   C0337112:chains [Manufactured Object]
   748   C0444626:Crystalline [Chemical Viewed Structurally]
   748   C1304698:Liquid [Finding]
   748   C1514873:Required [Functional Concept]
   748   C1524075:Chains [Idea or Concept]
   748   C1546699:Liquid NOS [Intellectual Product]
   748   C1561501:Liquid NOS [Substance]

Phrase: "(45"

Phrase: ")."
Processing 00000000.tx.239: Conversely, the PE head group has a surface area of 35-42 2 which is smaller than the minimum requirement for two hydrocarbon chains. 

Phrase: "Conversely,"

Phrase: "the PE head group"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   827   C0018670:Head [Body Location or Region]
   827   C0441833:Group [Idea or Concept]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1281590:Head [Body Part, Organ, or Organ Component]
   827   C1552516:Group [Health Care Related Organization]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]
   827   C1706305:Head [Manufactured Object]
   771 E C0205096:Cephalic [Spatial Concept]

Phrase: "has"

Phrase: "a surface area of 35-42 2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0805132:Area 2 [Spatial Concept]
   748   C0017446:Area [Geographic Area]
   748   C0205146:Area [Spatial Concept]
   748   C0205148:Surface [Spatial Concept]

Phrase: "which"

Phrase: "is"

Phrase: "smaller than the minimum requirement"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0547044:Smaller [Qualitative Concept]
   760   C0700321:Smaller [Quantitative Concept]

Phrase: "for two hydrocarbon chains."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0020242:Hydrocarbon [Organic Chemical]
   827   C0337112:chains [Manufactured Object]
   827   C1524075:Chains [Idea or Concept]
Processing 00000000.tx.240: When the zwitterionic head groups are tightly packed, PE forms a lipid monolayer with high negative curvature that eventually leads to the formation of a hexagonal phase (45). 

Phrase: "When"

Phrase: "the zwitterionic head groups"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   827   C0018670:Head [Body Location or Region]
   827   C0441833:Group [Idea or Concept]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1281590:Head [Body Part, Organ, or Organ Component]
   827   C1552516:Group [Health Care Related Organization]
   827   C1552839:groups [Idea or Concept]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]
   827   C1706305:Head [Manufactured Object]
   771 E C0205096:Cephalic [Spatial Concept]

Phrase: "are"

Phrase: "tightly"

Phrase: "packed"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0184967:Packed [Therapeutic or Preventive Procedure]
   966 E C1968515:Pack [Medical Device]
   966 E C2825051:Pack [Drug Delivery Device]
   966 E C2828395:Pack [Activity]

Phrase: ","

Phrase: "PE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031618:Phosphatidyl ethanolamine [Biologically Active Substance,Lipid]
  1000   C1450468:phosphatidylethanolamine [Lipid,Pharmacologic Substance]

Phrase: "forms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "a lipid monolayer with high negative curvature"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0872351:monolayer [Clinical Drug]

Phrase: "that eventually"

Phrase: "leads to the formation of a hexagonal phase"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   744   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   744   C0181586:leads [Medical Device]
   744   C0205390:Phase [Temporal Concept]
   744   C0220781:formation [Biologic Function]
   744   C0439634:formation [Spatial Concept]
   744   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   744   C1522492:Formation [Functional Concept]
   744   C1522538:Lead [Functional Concept]
   744   C1708361:Hexagonal [Qualitative Concept]
   744   C2348269:Lead [Element, Ion, or Isotope]
   744   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "(45"

Phrase: ")."
Processing 00000000.tx.241: It has been reported that the membrane monolayer negative curvature strain is relieved by class A amphipathic helices of the apolipoproteins (51, 53). 

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that"

Phrase: "the membrane monolayer negative curvature strain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0080194:Strain [Injury or Poisoning]
   804   C0456178:strain [Intellectual Product]
   804   C1518614:Strain [Organism]
   804   C2987481:Strain [Mental Process]

Phrase: "is"

Phrase: "relieved by class"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332303:Relieved by [Functional Concept]
   790   C0456387:Class [Intellectual Product]
   790   C1301771:Relieved [Qualitative Concept]
   790   C1705943:Class [Classification]
   756 E C1301676:relieve [Functional Concept]

Phrase: "A amphipathic helices of the apolipoproteins"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0018882:Helix [Eukaryote]
   753   C0229304:Helix [Body Part, Organ, or Organ Component]
   753   C1017315:helices [Eukaryote]
   753   C1704821:Helix [Spatial Concept]
   753   C1705682:Helix [Anatomical Structure]

Phrase: "(51,"

Phrase: "53"

Phrase: ")."
Processing 00000000.tx.242: Since -Syn also contains class A amphipathic helical domains, -Syn in the presence of PE/acidic lipid vesicles is thought to relieve the negative curvature strain and instantaneously stabilize the vesicles, resulting in its drastic binding to these vesicles, whereas -Syn did not bind to PC/acidic lipid vesicles as much (Fig. 5). 

Phrase: "Since -Syn also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "class"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456387:Class [Intellectual Product]
  1000   C1705943:Class [Classification]

Phrase: "A amphipathic helical domains, -Syn"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   771   C1880389:Domain [Functional Concept]
   771   C1883221:Domain [Conceptual Entity]
   771   C3541951:Domain [Intellectual Product]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of PE/acidic lipid vesicles"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0333262:VESICLES [Acquired Abnormality]
   779 E C1622418:vesicle [Cell Component]
   729 E C0205378:Vesicular [Qualitative Concept]

Phrase: "is"

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "relieve"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1301676:relieve [Functional Concept]
   916 E C0332303:relieving [Functional Concept]
   916 E C1301771:Relieved [Qualitative Concept]

Phrase: "the negative curvature strain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0080194:Strain [Injury or Poisoning]
   827   C0456178:strain [Intellectual Product]
   827   C1518614:Strain [Organism]
   827   C2987481:Strain [Mental Process]

Phrase: "and"

Phrase: "instantaneously"

Phrase: "stabilize"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0184512:stabilize [Qualitative Concept]

Phrase: "the vesicles,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0333262:VESICLES [Acquired Abnormality]
   966 E C1622418:vesicle [Cell Component]
   916 E C0205378:Vesicular [Qualitative Concept]

Phrase: "resulting in its drastic binding"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   806   C0332294:Resulting in [Functional Concept]
   760   C0243122:binding [Functional Concept]
   760   C0678226:resulting [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
   726 E C1274040:Result [Functional Concept]
   726 E C1546471:Result [Idea or Concept]
   726 E C2825142:Result [Finding]

Phrase: "to these vesicles,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0333262:VESICLES [Acquired Abnormality]
   966 E C1622418:vesicle [Cell Component]
   916 E C0205378:Vesicular [Qualitative Concept]

Phrase: "whereas -Syn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "bind to PC/acidic lipid vesicles"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0001128:Acidic [Chemical]
   753   C0023779:Lipid [Lipid]
   753   C0333262:VESICLES [Acquired Abnormality]
   753   C1145667:Bind [Activity]
   753   C1167622:bind [Molecular Function]
   753   C3540812:PC [Gene or Genome]
   719 E C1622418:vesicle [Cell Component]

Phrase: "as much"

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.243: The lipid composition of synaptic vesicles has been estimated to be 25-32% PC, 15-24% PE, 4-8% PS, 3-8% sphingomyelin, 2-3% PI, 0-1% PA, and 33-38% cholesterol (31, 54). 

Phrase: "The lipid composition of synaptic vesicles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0486616:Composition [Clinical Attribute]
   753   C1555710:composition [Idea or Concept]

Phrase: "has"

Phrase: "been"

Phrase: "estimated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750572:Estimated [Quantitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "25-32% PC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3540812:PC [Gene or Genome]

Phrase: "15-24% PE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0031618:Phosphatidyl ethanolamine [Biologically Active Substance,Lipid]
   827   C1450468:phosphatidylethanolamine [Lipid,Pharmacologic Substance]

Phrase: "4-8% PS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0031623:phosphatidylserine [Lipid]
   827   C0301704:Phosphatidyl serine [Lipid]

Phrase: "3-8% sphingomyelin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0037906:Sphingomyelin [Biologically Active Substance,Lipid]

Phrase: "2-3% PI,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0031621:Phosphatidyl Inositol [Biologically Active Substance,Lipid]
   827   C2348046:Phosphatidylinositol [Lipid]
   734   C1519042:2-3 [Research Activity]

Phrase: "0-1% PA,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0031610:Phosphatidic Acid [Lipid]
   812   C0001128:Acid [Chemical]
   812   C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "33-38% cholesterol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0008377:Cholesterol [Biologically Active Substance,Steroid]

Phrase: "(31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "54"

Phrase: ")."
Processing 00000000.tx.244: The negative curvature strain caused by the relatively high PE content as well as the surface defect caused by the curved surface of the small synaptic vesicles would favor -Syn binding to these vesicles, and thus stabilizing the membranes. 

Phrase: "The negative curvature strain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0080194:Strain [Injury or Poisoning]
   827   C0456178:strain [Intellectual Product]
   827   C1518614:Strain [Organism]
   827   C2987481:Strain [Mental Process]

Phrase: "caused by the relatively high PE content"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   748   C0031618:Phosphatidyl ethanolamine [Biologically Active Substance,Lipid]
   748   C0205250:High [Qualitative Concept]
   748   C0423896:Content [Mental Process]
   748   C0456205:Content [Conceptual Entity]
   748   C1299351:High [Qualitative Concept]
   748   C1450468:phosphatidylethanolamine [Lipid,Pharmacologic Substance]
   748   C2700149:HIGH [Intellectual Product]
   714   C0015127:cause [Functional Concept]
   714   C1524003:Cause [Conceptual Entity]

Phrase: "as well as"

Phrase: "the surface defect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1457869:Defect [Functional Concept]
   861   C1861101:DEFECT [Disease or Syndrome]

Phrase: "caused by the curved surface of the small synaptic vesicles"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   760   C0039065:Synaptic Vesicles [Cell Component]
   739   C0205134:Curved [Spatial Concept]
   739   C0205148:Surface [Spatial Concept]
   739   C0333262:VESICLES [Acquired Abnormality]
   739   C0700321:Small [Quantitative Concept]
   706   C0015127:cause [Functional Concept]
   706   C1524003:Cause [Conceptual Entity]
   706 E C1622418:vesicle [Cell Component]

Phrase: "would"

Phrase: "favor -Syn binding"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0243122:binding [Functional Concept]
   827   C0309049:FAVOR [Organic Chemical,Pharmacologic Substance,Vitamin]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]

Phrase: "to these vesicles,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0333262:VESICLES [Acquired Abnormality]
   966 E C1622418:vesicle [Cell Component]
   916 E C0205378:Vesicular [Qualitative Concept]

Phrase: "and"

Phrase: "thus"

Phrase: "stabilizing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0184512:stabilizing [Qualitative Concept]

Phrase: "the membranes."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]
Processing 00000000.tx.245: The failure of -Syn to bind to the membranes, possibly caused by its mutations, will break the equilibrium between membrane-bound and free -Syn and may cause the aggregation of free -Syn. 

Phrase: "The failure of -Syn to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "bind to the membranes,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0025255:Membranes [Tissue]
   770   C1145667:Bind [Activity]
   770   C1167622:bind [Molecular Function]
   737 E C0596901:Membrane [Cell Component]
   737 E C1706182:Membrane [Manufactured Object]

Phrase: "possibly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2362652:Possibly [Qualitative Concept]

Phrase: "caused by its mutations,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0026882:Mutations [Genetic Function]
   737   C0015127:cause [Functional Concept]
   737   C1524003:Cause [Conceptual Entity]
   737 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "will"

Phrase: "break"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881704:BREAK [Phenomenon or Process]

Phrase: "the equilibrium between membrane-bound"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0014653:Equilibrium [Organism Function]
   760   C1547026:Equilibrium [Quantitative Concept]

Phrase: "and"

Phrase: "free -Syn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "may"

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "the aggregation of free -Syn."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332621:Aggregation [Functional Concept]
   760   C0439168:% aggregation [Quantitative Concept]
Processing 00000000.tx.246: This possibility is consistent with our AFM data discussed below. 

Phrase: "This possibility"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   928   C0332149:Possible [Qualitative Concept]
   928   C1705910:Possible [Qualitative Concept]
   928   C2362652:Possible [Qualitative Concept]

Phrase: "is"

Phrase: "consistent with our AFM data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "discussed below."
Processing 00000000.tx.247: Our AFM results suggest that the A53T mutant -Syn may be less effective than the wild-type -Syn in binding to or disrupting the membranes. 

Phrase: "Our AFM results"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   779   C1274040:Result [Functional Concept]
   779   C1546471:Result [Idea or Concept]
   779   C2825142:Result [Finding]
   756   C0242849:Microscopy, Atomic Force [Laboratory Procedure]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the A53T mutant -Syn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "may"

Phrase: "be"

Phrase: "less effective than the wild-type -Syn"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280519:effective [Qualitative Concept]
   748   C1704419:Effective [Qualitative Concept]

Phrase: "in binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "to"

Phrase: "or"

Phrase: "disrupting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:disrupting [Qualitative Concept]

Phrase: "the membranes."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]
Processing 00000000.tx.248: This may be a consequence of the more rapid oligomerization kinetics exhibited by the mutant relative to the wild-type protein (55-58). 

Phrase: "This"

Phrase: "may"

Phrase: "be"

Phrase: "a consequence of the more rapid oligomerization kinetics"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0686907:Consequence of [Functional Concept]
           Consequence

Phrase: "exhibited by the mutant relative"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0080103:Relative [Family Group]
   760   C0205345:Relative [Qualitative Concept]
   760   C0596988:Mutant [Cell or Molecular Dysfunction]
   760   C1547039:*Relative [Quantitative Concept]
   726   C0015272:Exhibit [Intellectual Product]

Phrase: "to the wild-type protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "(55-58"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450382:55 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.249: The fibrillar form, which typically has a -sheet structure, is not expected to bind to membranes as effectively as the monomeric form, which has been shown to form -helical structure when bound to membranes. 

Phrase: "The fibrillar form,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0348078:Form [Qualitative Concept]
   861   C0376315:Form [Manufactured Object]
   861   C1522492:Form [Functional Concept]

Phrase: "which typically"

Phrase: "has"

Phrase: "a -sheet structure,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0678594:Structure [Spatial Concept]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "bind to membranes"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0025255:Membranes [Tissue]
   790   C1145667:Bind [Activity]
   790   C1167622:bind [Molecular Function]
   756 E C0596901:Membrane [Cell Component]
   756 E C1706182:Membrane [Manufactured Object]
   706 E C0205287:Membranous [Qualitative Concept]

Phrase: "as"

Phrase: "effectively as the monomeric form,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0348078:Form [Qualitative Concept]
   760   C0376315:Form [Manufactured Object]
   760   C1522492:Form [Functional Concept]

Phrase: "which"

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "form -"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "helical structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:Structure [Spatial Concept]

Phrase: "when"

Phrase: "bound to membranes."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   790   C0025255:Membranes [Tissue]
   790   C0332297:bound [Spatial Concept]
   790   C1145667:Bound [Activity]
   790   C1167622:Bound [Molecular Function]
   790   C1689898:% bound [Quantitative Concept]
   790   C2349209:Bound [Conceptual Entity]
   756 E C0596901:Membrane [Cell Component]
   756 E C1706182:Membrane [Manufactured Object]
   706 E C0205287:Membranous [Qualitative Concept]
Processing 00000000.tx.250: An alternative possibility is that the A53T mutant is structurally defective in binding to the membrane by having threonine at position 53instead of alanine. 

Phrase: "An alternative possibility"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   789   C0332149:Possible [Qualitative Concept]
   789   C1705910:Possible [Qualitative Concept]
   789   C2362652:Possible [Qualitative Concept]

Phrase: "is"

Phrase: "that"

Phrase: "the A53T mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "is"

Phrase: "structurally defective in binding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332452:Defective [Functional Concept]

Phrase: "to the membrane"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025255:Membrane [Tissue]
  1000   C0596901:Membrane [Cell Component]
  1000   C1706182:Membrane [Manufactured Object]
   928 E C0205287:Membranous [Qualitative Concept]

Phrase: "by"

Phrase: "having"

Phrase: "threonine at position 53instead of alanine."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0040005:Threonine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.251: Alanine is one of the strong -helix formers whereas threonine is indifferent in -helical propensity (59). 

Phrase: "Alanine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001898:Alanine [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "one of the strong -helix formers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205447:One [Quantitative Concept]

Phrase: "whereas"

Phrase: "threonine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040005:Threonine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "is"

Phrase: "indifferent in -helical propensity"

Phrase: "(59"

Phrase: ")."
Processing 00000000.tx.252: Considering the correlation between the -helix formation of -Syn and membrane binding, the A53T point mutation may have a negative effect on -helix formation, resulting in reduced membrane binding. 

Phrase: "Considering"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considering [Idea or Concept]

Phrase: "the correlation between the -helix formation of -Syn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1707520:Correlation [Qualitative Concept]

Phrase: "and"

Phrase: "membrane binding,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   861   C0025255:Membrane [Tissue]
   861   C0243122:binding [Functional Concept]
   861   C0596901:Membrane [Cell Component]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "the A53T point mutation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0162735:Point Mutation [Cell or Molecular Dysfunction]
   827   C0026882:Mutation [Genetic Function]
   827   C1552961:Point [Quantitative Concept]
   827   C1705285:Mutation [Cell or Molecular Dysfunction]
   827   C2347617:point [Quantitative Concept]

Phrase: "may"

Phrase: "have"

Phrase: "a negative effect on -helix formation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0220781:formation [Biologic Function]
   804   C0439634:formation [Spatial Concept]
   804   C1522492:Formation [Functional Concept]

Phrase: "resulting in reduced membrane binding."
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   806   C0332294:Resulting in [Functional Concept]
   760   C0025255:Membrane [Tissue]
   760   C0243122:binding [Functional Concept]
   760   C0392756:Reduced [Qualitative Concept]
   760   C0596901:Membrane [Cell Component]
   760   C0678226:resulting [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
   760   C1706182:Membrane [Manufactured Object]
   726 E C1274040:Result [Functional Concept]
   726 E C1546471:Result [Idea or Concept]
   726 E C2825142:Result [Finding]
Processing 00000000.tx.253: However, the binding of the A53T mutant -Syn to phospholipids as determined, for example, by CD spectroscopy was qualitatively identical to the wild-type protein. 

Phrase: "However,"

Phrase: "the binding of the A53T mutant -Syn"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]

Phrase: "to phospholipids"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0031676:Phospholipids [Biologically Active Substance,Lipid]
   966 E C0202177:Phospholipid [Laboratory Procedure]

Phrase: "as"

Phrase: "determined"

Phrase: ","

Phrase: "for example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "by CD spectroscopy"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1519445:Spectroscopy, Circular Dichroism [Natural Phenomenon or Process]
   827   C0037812:spectroscopy [Laboratory Procedure]
   827   C2713504:Spectroscopy [Occupation or Discipline]
   827   C2984732:SPECTROSCOPY [Functional Concept]
   734   C0008813:Circular Dichroism [Laboratory Procedure]

Phrase: "was"

Phrase: "qualitatively identical to the wild-type protein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205280:Identical [Qualitative Concept]
Processing 00000000.tx.254: This may be due to the inability of the spectroscopy technique to quantitate small differences in lipid binding. 

Phrase: "This"

Phrase: "may"

Phrase: "be due to the inability of the spectroscopy technique to"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0678226:Due to [Functional Concept]
           due
   739   C0037812:spectroscopy [Laboratory Procedure]
   739   C0449851:Technique [Functional Concept]
   739   C2713504:Spectroscopy [Occupation or Discipline]
   739   C2984732:SPECTROSCOPY [Functional Concept]
   739   C2987476:Be [Conceptual Entity]
   739   C3146286:Due [Idea or Concept]

Phrase: "quantitate"

Phrase: "small differences in lipid binding."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1705241:*Difference [Quantitative Concept]
   726   C1705242:Difference [Qualitative Concept]
Processing 00000000.tx.255: In contrast, the obvious differences in the extent of membrane disruption of wild-type as compared with mutant -Syn as indicated by AFM appear to be significant. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "the obvious differences in the extent of membrane disruption of wild-type"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   703   C1705241:*Difference [Quantitative Concept]
   703   C1705242:Difference [Qualitative Concept]

Phrase: "as"

Phrase: "compared with mutant -Syn"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0596988:Mutant [Cell or Molecular Dysfunction]
   770   C1707455:Compared [Activity]

Phrase: "as"

Phrase: "indicated by AFM"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   862   C0242849:Microscopy, Atomic Force [Laboratory Procedure]
           Force Microscopy
   760   C0026018:Microscopy [Laboratory Procedure]
   760   C0441722:Force [Phenomenon or Process]
   760   C0563538:Force [Phenomenon or Process]
   760   C1444656:Indicated [Finding]
   704 E C0729333:Dynamic [Functional Concept]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "significant."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0237881:significant [Quantitative Concept]
  1000   C0750502:Significant [Idea or Concept]
  1000   C1546944:Significant [Qualitative Concept]
Processing 00000000.tx.256: The reduced membrane binding of the mutant -Syn in vivo will result in a higher cytosolic concentration of -Syn, leading to fibril formation which is a concentration-dependent process (32, 60). 

Phrase: "The reduced membrane binding of the mutant -Syn"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0025255:Membrane [Tissue]
   744   C0243122:binding [Functional Concept]
   744   C0596901:Membrane [Cell Component]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]
   744   C1706182:Membrane [Manufactured Object]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "will"

Phrase: "result in a higher cytosolic concentration of -Syn,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   744   C0086045:Concentration [Mental Process]
   744   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1274040:Result [Functional Concept]
   744   C1383501:Cytosolic [Cell Component]
   744   C1446561:Concentration [Quantitative Concept]
   744   C1546471:Result [Idea or Concept]
   744   C2825142:Result [Finding]
   711   C0205250:High [Qualitative Concept]
   711   C1299351:High [Qualitative Concept]
   711   C2700149:HIGH [Intellectual Product]

Phrase: "leading to fibril formation"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   770   C0220781:formation [Biologic Function]
   770   C0225328:Fibril [Cell Component]
   770   C0332152:Leading [Temporal Concept]
   770   C0439634:formation [Spatial Concept]
   770   C1522492:Formation [Functional Concept]
   770   C1522538:Leading [Functional Concept]
   770   C1948066:Fibril [Physical Object]
   737 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   737 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   737 E C2348269:Lead [Element, Ion, or Isotope]
   737 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "which"

Phrase: "is"

Phrase: "a concentration-dependent process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1184743:Process [Body Part, Organ, or Organ Component]
   827   C1522240:Process [Phenomenon or Process]

Phrase: "(32,"

Phrase: "60"

Phrase: ")."
Processing 00000000.tx.257: This may explain the pathogenesis of the early-onset familial PD linked to the point mutations in -Syn, at least in part, since fibril formation has been shown to be toxic to neurons (61). 

Phrase: "This"

Phrase: "may"

Phrase: "explain"

Phrase: "the pathogenesis of the early-onset familial PD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0543483:pathogenesis [Functional Concept]
   744   C0699748:Pathogenesis [Pathologic Function]

Phrase: "linked to the point mutations in -Syn,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   778   C0162735:Point Mutations [Cell or Molecular Dysfunction]
   748   C0026882:Mutations [Genetic Function]
   748   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1552961:Point [Quantitative Concept]
   748   C2347617:point [Quantitative Concept]
   714   C1517892:Link [Intellectual Product]
   714   C1704666:Link [Intellectual Product]
   714 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "at least"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0439092:less [Intellectual Product]
   966   C0547044:Less [Qualitative Concept]

Phrase: "in part,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449719:Part [Spatial Concept]
  1000   C1709471:Part [Quantitative Concept]

Phrase: "since"

Phrase: "fibril formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "toxic to neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0600688:toxic [Injury or Poisoning]
   790   C1407029:Toxic [Qualitative Concept]

Phrase: "(61"

Phrase: ")."
Processing 00000000.tx.258: Therefore, we suggest that the normal function of -Syn in synaptic terminals includes its proper interaction with lipids, and the mutation-caused defective interaction of -Syn with lipids is responsible at least for a part of the disease process in the early-onset familial PD.  

Phrase: "Therefore,"

Phrase: "we"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the normal function of -Syn in synaptic terminals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "includes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:Includes [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "its proper interaction with lipids,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "the mutation-caused defective interaction of -Syn with lipids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "responsible at least"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1273518:Responsible [Finding]

Phrase: "for a part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449719:Part [Spatial Concept]
  1000   C1709471:Part [Quantitative Concept]

Phrase: "of the disease process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1184743:Process [Body Part, Organ, or Organ Component]
   861   C1522240:Process [Phenomenon or Process]

Phrase: "in the early-onset familial PD."
Processing 00000000.tx.259: ACKNOWLEDGEMENTS We thank Dr. 

Phrase: "ACKNOWLEDGEMENTS"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.260: Clifford Lingwood for helpful discussions on the TLC overlay study and Francis Lieu for technical assistance.  

Phrase: "Clifford Lingwood for helpful discussions"

Phrase: "on the TLC overlay study"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0557651:Study [Manufactured Object]
   804   C2603343:Study [Research Activity]
   717   C0008569:Thin Layer Chromatography [Laboratory Procedure]

Phrase: "and"

Phrase: "Francis Lieu for technical assistance."
Processing 00000000.tx.261: FOOTNOTES * This work was supported in part by grants from the Medical Research Council of Canada (to P.E.F.and C.M.Y.), Natural Sciences and Engineering Research Council (to C.M.Y.and J.M.), the Ontario Mental Health Foundation (to P.E.F.), the Alzheimer's Society of Ontario (to P.E.F.and J.M.), and the Ontario Research and Development Challenge Fund (to C.M.Y.).

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported in part"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0449719:Part [Spatial Concept]
   790   C1521721:Supported [Conceptual Entity]
   790   C1709471:Part [Quantitative Concept]
   756 E C0183683:Support [Medical Device]

Phrase: "by grants"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0018173:Grants [Quantitative Concept]
   966 E C1548284:Grant [Idea or Concept]

Phrase: "from the Medical Research Council"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0079816:Medical Research [Research Activity]
   901   C1556038:Medical Research [Professional or Occupational Group]
   827   C0035168:research [Research Activity]
   827   C0205476:Medical [Functional Concept]
   827   C0242481:Research [Research Activity]
   827   C1551807:Council [Population Group]

Phrase: "of Canada"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006823:Canada [Geographic Area]

Phrase: "("

Phrase: "to P.E.F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   827   C0439133:(f) [Intellectual Product]
   827   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "C."

Phrase: "M."

Phrase: "Y."

Phrase: ")"

Phrase: ","

Phrase: "Natural Sciences and Engineering Research Council"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   827   C0678530:Natural Sciences [Occupation or Discipline]
   799   C0014279:Engineering [Occupation or Discipline]
   799   C0035168:research [Research Activity]
   799   C0036397:Sciences [Occupation or Discipline]
   799   C0205296:Natural [Functional Concept]
   799   C0242481:Research [Research Activity]
   799   C1551807:Council [Population Group]
   766 E C0878517:Engineer [Professional or Occupational Group]

Phrase: "("

Phrase: "to C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "M."

Phrase: "Y."

Phrase: "and"

Phrase: "J."

Phrase: "M."

Phrase: ")"

Phrase: ","

Phrase: "the Ontario Mental Health Foundation"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   812   C0016617:Foundation [Organization]
   729 E C0002055:base [Inorganic Chemical]
   729 E C0178499:Base [Chemical Viewed Functionally]
   729 E C1626935:Bases [Quantitative Concept]
   729 E C1880279:Base [Biomedical or Dental Material]
   706 E C0205112:Basal [Spatial Concept]

Phrase: "("

Phrase: "to P.E.F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   827   C0439133:(f) [Intellectual Product]
   827   C1553038:[f] [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "the Alzheimer's Society of Ontario"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0037455:society [Organization]

Phrase: "("

Phrase: "to P.E.F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   827   C0439133:(f) [Intellectual Product]
   827   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "J."

Phrase: "M."

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the Ontario Research and Development Challenge Fund"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   876   C0681805:research fund [Research Activity]
   799   C0016820:Fund [Quantitative Concept]

Phrase: "("

Phrase: "to C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "M."

Phrase: "Y."

Phrase: ")."
Processing 00000000.tx.262: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.263: The article must therefore be hereby marked "advertisement" in accordance with 18U.S.C. 

Phrase: "The article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18U.S.C."
Processing 00000000.tx.264: Section 1734solely to indicate this fact.  

Phrase: "Section 1734solely to"

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.265: Supported by a postdoctoral fellowship from the Parkinson Foundation of Canada. 

Phrase: "Supported by a postdoctoral fellowship"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0015770:Fellowship [Educational Activity]
   760   C1521721:Supported [Conceptual Entity]
   726 E C0183683:Support [Medical Device]

Phrase: "from the Parkinson Foundation"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0016617:Foundation [Organization]
   777 E C0002055:base [Inorganic Chemical]
   777 E C0178499:Base [Chemical Viewed Functionally]
   777 E C1626935:Bases [Quantitative Concept]
   777 E C1880279:Base [Biomedical or Dental Material]
   755 E C0205112:Basal [Spatial Concept]

Phrase: "of Canada."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006823:Canada [Geographic Area]
Processing 00000000.tx.266: To whom correspondence should be addressed: Centre for Research in Neurodegenerative Diseases, University of Toronto, 6Queen's Park Crescent West, Toronto, Ontario M5S 3H2, Canada. 

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Centre for Research"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   858   C0683939:center research [Manufactured Object,Organization]
   790   C0205099:Center [Spatial Concept]

Phrase: "in Neurodegenerative Diseases,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0524851:Neurodegenerative Diseases [Disease or Syndrome]
   861   C0012634:Diseases [Disease or Syndrome]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]

Phrase: "University of Toronto,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "6Queen's Park Crescent West,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1705493:West [Spatial Concept]

Phrase: "Toronto,"

Phrase: "Ontario M5S 3H2,"

Phrase: "Canada."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006823:Canada [Geographic Area]
Processing 00000000.tx.267: Tel.: 

Phrase: "Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.268: 416-978-0102; 

Phrase: "416-978-0102"

Phrase: ";"
Processing 00000000.tx.269: Fax: 416-978-1878; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "416-978-1878"

Phrase: ";"
Processing 00000000.tx.270: E-mail: euijung.jo@utoronto.ca. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "euijung.jo@utoronto.ca."
Processing 00000000.tx.271: Published, JBC Papers in Press, July 27,2000,DOI 10.1074/jbc.M004345200  ABBREVIATIONS The abbreviations used are: -Syn, -synuclein; 

Phrase: "Published"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034037:Published [Occupational Activity]
  1000   C1704324:Published [Intellectual Product]

Phrase: ","

Phrase: "JBC Papers in Press,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0030351:Papers [Manufactured Object]
   737 E C1547566:Paper [Idea or Concept]

Phrase: "July 27,"

Phrase: "2000,"

Phrase: "DOI 10.1074/jbc.M004345200  ABBREVIATIONS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0000723:Abbreviations [Intellectual Product]

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ": -Syn, -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.272: AFM, atomic force microscopy; 

Phrase: "AFM,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0242849:Microscopy, Atomic Force [Laboratory Procedure]
           Force Microscopy
   827   C0026018:Microscopy [Laboratory Procedure]
   827   C0441722:Force [Phenomenon or Process]
   827   C0563538:Force [Phenomenon or Process]
   771 E C0729333:Dynamic [Functional Concept]
   755 E C0205288:Microscopic [Qualitative Concept]
   755   C0567415:Atom [Element, Ion, or Isotope]
   755   C1706222:Atom [Conceptual Entity]

Phrase: "atomic force microscopy"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0242849:Microscopy, Atomic Force [Laboratory Procedure]
           Force Microscopy
   827   C0026018:Microscopy [Laboratory Procedure]
   827   C0441722:Force [Phenomenon or Process]
   827   C0563538:Force [Phenomenon or Process]
   771 E C0729333:Dynamic [Functional Concept]
   755 E C0205288:Microscopic [Qualitative Concept]
   755   C0567415:Atom [Element, Ion, or Isotope]
   755   C1706222:Atom [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.273: CD, circular dichroism; 

Phrase: "CD,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0008813:Circular Dichroism [Laboratory Procedure]
   861   C0596436:dichroism [Natural Phenomenon or Process]
   861   C1282913:Circular [Spatial Concept]

Phrase: "circular dichroism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0008813:Circular Dichroism [Laboratory Procedure]
   861   C0596436:dichroism [Natural Phenomenon or Process]
   861   C1282913:Circular [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.274: MLVs, multilamellar vesicles; 

Phrase: "MLVs,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0333262:VESICLES [Acquired Abnormality]
   827 E C1622418:vesicle [Cell Component]
   777 E C0205378:Vesicular [Qualitative Concept]

Phrase: "multilamellar vesicles"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0333262:VESICLES [Acquired Abnormality]
   827 E C1622418:vesicle [Cell Component]
   777 E C0205378:Vesicular [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.275: PBS, phosphate-buffered saline; 

Phrase: "PBS,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0036082:Saline [Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "phosphate-buffered saline"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0036082:Saline [Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.276: PD, Parkinson's disease; 

Phrase: "PD,"

Phrase: "Parkinson's disease"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]

Phrase: ";"
Processing 00000000.tx.277: PE, phosphatidylethanolamine; 

Phrase: "PE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031618:Phosphatidyl ethanolamine [Biologically Active Substance,Lipid]
  1000   C1450468:phosphatidylethanolamine [Lipid,Pharmacologic Substance]

Phrase: "phosphatidylethanolamine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031618:Phosphatidyl ethanolamine [Biologically Active Substance,Lipid]
  1000   C1450468:phosphatidylethanolamine [Lipid,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.278: PI, phosphatidylinositol; 

Phrase: "PI,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031621:Phosphatidyl Inositol [Biologically Active Substance,Lipid]
  1000   C2348046:Phosphatidylinositol [Lipid]

Phrase: "phosphatidylinositol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031621:Phosphatidyl Inositol [Biologically Active Substance,Lipid]
  1000   C2348046:Phosphatidylinositol [Lipid]

Phrase: ";"
Processing 00000000.tx.279: POPA, 1-palmitoyl 2-oleoyl phosphatidic acid; 

Phrase: "POPA,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0031610:Phosphatidic Acid [Lipid]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "1-palmitoyl 2-oleoyl phosphatidic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0031610:Phosphatidic Acid [Lipid]
   799   C0001128:Acid [Chemical]
   799   C0202406:Acid [Laboratory Procedure]

Phrase: ";"
Processing 00000000.tx.280: POPC, 1-palmitoyl 2-oleoyl phosphatidylcholine; 

Phrase: "POPC,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1959616:Phosphatidyl choline [Biologically Active Substance,Lipid,Pharmacologic Substance]
   944 E C0031617:Lecithin [Biologically Active Substance,Lipid,Pharmacologic Substance]
   944 E C0885520:lecithin [Organic Chemical,Pharmacologic Substance]

Phrase: "1-palmitoyl 2-oleoyl phosphatidylcholine"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0044576:1-palmitoyl-2-oleoyl-phosphatidylcholine [Biologically Active Substance,Lipid]
   933   C0058325:1,2-oleoylphosphatidylcholine [Lipid]
   804   C1959616:Phosphatidyl choline [Biologically Active Substance,Lipid,Pharmacologic Substance]
   748 E C0031617:Lecithin [Biologically Active Substance,Lipid,Pharmacologic Substance]
   748 E C0885520:lecithin [Organic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.281: POPS, 1-palmitoyl 2-oleoyl phosphatidylserine; 

Phrase: "POPS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031623:phosphatidylserine [Lipid]
  1000   C0301704:Phosphatidyl serine [Lipid]

Phrase: "1-palmitoyl 2-oleoyl phosphatidylserine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0031623:phosphatidylserine [Lipid]
   804   C0301704:Phosphatidyl serine [Lipid]

Phrase: ";"
Processing 00000000.tx.282: SUVs, small unilamellar vesicles; 

Phrase: "SUVs,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C1881413:Small Unilamellar Vesicles [Chemical Viewed Structurally]
   901   C1721092:Unilamellar Vesicles [Lipid]
   827   C0333262:VESICLES [Acquired Abnormality]
   827   C0700321:Small [Quantitative Concept]
   793 E C1622418:vesicle [Cell Component]
   743 E C0205378:Vesicular [Qualitative Concept]

Phrase: "small unilamellar vesicles"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C1881413:Small Unilamellar Vesicles [Chemical Viewed Structurally]
   901   C1721092:Unilamellar Vesicles [Lipid]
   827   C0333262:VESICLES [Acquired Abnormality]
   827   C0700321:Small [Quantitative Concept]
   793 E C1622418:vesicle [Cell Component]
   743 E C0205378:Vesicular [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.283: PS, phosphatidylserine; 

Phrase: "PS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031623:phosphatidylserine [Lipid]
  1000   C0301704:Phosphatidyl serine [Lipid]

Phrase: "phosphatidylserine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031623:phosphatidylserine [Lipid]
  1000   C0301704:Phosphatidyl serine [Lipid]

Phrase: ";"
Processing 00000000.tx.284: PA, phosphatidic acid; 

Phrase: "PA,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0031610:Phosphatidic Acid [Lipid]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "phosphatidic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0031610:Phosphatidic Acid [Lipid]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: ";"
Processing 00000000.tx.285: TBS, Tris-buffered saline.  

Phrase: "TBS,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0041175:Tris Buffer [Organic Chemical,Pharmacologic Substance]
           TRIS
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0036082:Saline [Substance]
   827   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   827   C0814229:TRI [Intellectual Product]

Phrase: "Tris-buffered saline."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0041175:Tris Buffer [Organic Chemical,Pharmacologic Substance]
           TRIS
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0036082:Saline [Substance]
   827   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   827   C0814229:TRI [Intellectual Product]
Processing 00000000.tx.286: REFERENCES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES 1. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0557061:Discussion [Therapeutic or Preventive Procedure]
   795   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.287: Maroteaux, L., Campanelli, J. 

Phrase: "Maroteaux,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Campanelli,"

Phrase: "J."
Processing 00000000.tx.288: T., and Scheller, R. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Scheller,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.289: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.290: (1988) J. 

Phrase: "(1988"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.291: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.292: 8, 2804-2815[Abstract] 2. 

Phrase: "8,"

Phrase: "2804-2815"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.293: Nakajo, S., Omata, K., Aiuchi, T., Shibayama, T., Okahashi, I., Ochiai, H., Nakai, Y., Nakaya, K., and Nakamura, Y. 

Phrase: "Nakajo,"

Phrase: "S."

Phrase: ","

Phrase: "Omata,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Aiuchi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Shibayama,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Okahashi,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Ochiai,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Nakai,"

Phrase: "Y.,"

Phrase: "Nakaya,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Nakamura,"

Phrase: "Y."
Processing 00000000.tx.294: (1990) J. 

Phrase: "(1990"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.295: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.296: 55, 2031-2038[Medline] [OrderarticleviaInfotrieve] 3. 

Phrase: "55,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: "2031-2038"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.297: Maroteaux, L., and Scheller, R. 

Phrase: "Maroteaux,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Scheller,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.298: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.299: (1991) Brain Res. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.300: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.301: Brain Res. 

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.302: 11, 335-343[Medline] [OrderarticleviaInfotrieve] 4. 

Phrase: "11,"

Phrase: "335-343"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 4."
Processing 00000000.tx.303: Ueda, K., Fukushima, H., Masliah, E., Xia, Y., Iwai, A., Yoshimoto, M., Otero, D. 

Phrase: "Ueda,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Fukushima,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Masliah,"

Phrase: "E.,"

Phrase: "Xia,"

Phrase: "Y.,"

Phrase: "Iwai,"

Phrase: "A.,"

Phrase: "Yoshimoto,"

Phrase: "M."

Phrase: ","

Phrase: "Otero,"

Phrase: "D."
Processing 00000000.tx.304: A., Kondo, J., Ihara, Y., and Saitoh, T. 

Phrase: "A.,"

Phrase: "Kondo,"

Phrase: "J.,"

Phrase: "Ihara,"

Phrase: "Y.,"

Phrase: "and"

Phrase: "Saitoh,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.305: (1993) Proc. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.306: Natl. 

Phrase: "Natl."
Processing 00000000.tx.307: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.308: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.309: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.310: 90, 11282-11286[Abstract] 5. 

Phrase: "90,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: "11282-11286"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.311: Jakes, R., Spillantini, M. 

Phrase: "Jakes,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Spillantini,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.312: G., and Goedert, M. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Goedert,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.313: (1994) FEBS Lett. 

Phrase: "(1994"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.314: 345, 27-32[CrossRef][Medline] [OrderarticleviaInfotrieve] 6. 

Phrase: "345,"

Phrase: "27-32"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 6."
Processing 00000000.tx.315: George, J. 

Phrase: "George,"

Phrase: "J."
Processing 00000000.tx.316: M., Jin, H., Woods, W. 

Phrase: "M."

Phrase: ","

Phrase: "Jin,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Woods,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0043217:Woods [Substance]
  1000   C0442548:Woods [Geographic Area]
   928 E C0144237:Sylvan [Organic Chemical]

Phrase: "W."
Processing 00000000.tx.317: S., and Clayton, D. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Clayton,"

Phrase: "D."
Processing 00000000.tx.318: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.319: (1995) Neuron 15, 361-372[Medline] [OrderarticleviaInfotrieve] 7. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Neuron 15,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "361-372"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 7."
Processing 00000000.tx.320: Clayton, D. 

Phrase: "Clayton,"

Phrase: "D."
Processing 00000000.tx.321: F., and George, J. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "George,"

Phrase: "J."
Processing 00000000.tx.322: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.323: (1998) Trends Neurosci. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Neurosci."
Processing 00000000.tx.324: 21, 249-254[CrossRef][Medline] [OrderarticleviaInfotrieve] 8. 

Phrase: "21,"

Phrase: "249-254"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 8."
Processing 00000000.tx.325: Thal, L. 

Phrase: "Thal,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039736:THAL [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.326: J., Saitoh, T., and Masliah, E. 

Phrase: "J.,"

Phrase: "Saitoh,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Masliah,"

Phrase: "E."
Processing 00000000.tx.327: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.328: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.329: 71, 338-344[Medline] [OrderarticleviaInfotrieve] 9. 

Phrase: "71,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450389:71 [Intellectual Product]

Phrase: "338-344"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 9."
Processing 00000000.tx.330: Polymeropoulos, M. 

Phrase: "Polymeropoulos,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.331: H., Lavedan, C., Leroy, E., Ide, S. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Lavedan,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Leroy,"

Phrase: "E.,"

Phrase: "Ide,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0328104:Ide [Fish]
  1000   C1415875:IDE [Gene or Genome]
  1000   C2826366:IDE [Idea or Concept]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.332: E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., Stenroos, E. 

Phrase: "E.,"

Phrase: "Dehejia,"

Phrase: "A.,"

Phrase: "Dutra,"

Phrase: "A.,"

Phrase: "Pike,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014878:Pike [Fish]
  1000   C0522667:Pike [Manufactured Object]
  1000   C0730321:PIC [Disease or Syndrome]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Root,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0040452:Root [Body Part, Organ, or Organ Component]
  1000   C0242726:Root [Plant]
  1000   C1318154:Root [Body Part, Organ, or Organ Component]
  1000   C1705917:Root [Idea or Concept]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Rubenstein,"

Phrase: "J.,"

Phrase: "Boyer,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Stenroos,"

Phrase: "E."
Processing 00000000.tx.333: S., Chandrasekharappa, S., Athanassiadou, A., Papapetropoulos, T., Johnson, W. 

Phrase: "S."

Phrase: ","

Phrase: "Chandrasekharappa,"

Phrase: "S."

Phrase: ","

Phrase: "Athanassiadou,"

Phrase: "A.,"

Phrase: "Papapetropoulos,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Johnson,"

Phrase: "W."
Processing 00000000.tx.334: G., Lazzarini, A. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Lazzarini,"

Phrase: "A."
Processing 00000000.tx.335: M., Duvoisin, R. 

Phrase: "M."

Phrase: ","

Phrase: "Duvoisin,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.336: C., Di Iorio, G., Golbe, L. 

Phrase: "C., Di Iorio,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Golbe,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.337: I., and Nussbaum, R. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Nussbaum,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.338: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.339: (1997) Science 276, 2045-2047[Abstract/Free FullText] 10. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Science 276,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "2045-2047"

Phrase: "[Abstract/Free FullText"

Phrase: "] 10."
Processing 00000000.tx.340: Polymeropoulos, M. 

Phrase: "Polymeropoulos,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.341: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.342: (1998) Ann. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Ann."
Processing 00000000.tx.343: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.344: 44, S63-S64[Medline] [OrderarticleviaInfotrieve] 11. 

Phrase: "44,"

Phrase: "S63-S64"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 11."
Processing 00000000.tx.345: Kruger, R., Kuhn, W., Muller, T., Woitalla, D., Graeber, M., Kosel, S., Przuntek, H., Epplen, J. 

Phrase: "Kruger,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Kuhn,"

Phrase: "W.,"

Phrase: "Muller,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Woitalla,"

Phrase: "D."

Phrase: ","

Phrase: "Graeber,"

Phrase: "M."

Phrase: ","

Phrase: "Kosel,"

Phrase: "S."

Phrase: ","

Phrase: "Przuntek,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Epplen,"

Phrase: "J."
Processing 00000000.tx.346: T., Schols, L., and Riess, O. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Schols,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Riess,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.347: (1998) Nat. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.348: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.349: 18, 106-108[Medline] [OrderarticleviaInfotrieve] 12. 

Phrase: "18,"

Phrase: "106-108"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 12."
Processing 00000000.tx.350: Iwai, A., Yoshimoto, M., Masliah, E., and Saitoh, T. 

Phrase: "Iwai,"

Phrase: "A.,"

Phrase: "Yoshimoto,"

Phrase: "M."

Phrase: ","

Phrase: "Masliah,"

Phrase: "E.,"

Phrase: "and"

Phrase: "Saitoh,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.351: (1995a) Biochemistry 34, 10139-10145[Medline] [OrderarticleviaInfotrieve] 13. 

Phrase: "(1995a"

Phrase: ")"

Phrase: "Biochemistry 34,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "10139-10145"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 13."
Processing 00000000.tx.352: Spillantini, M. 

Phrase: "Spillantini,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.353: G., Schmidt, M. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Schmidt,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.354: L., Lee, V. 

Phrase: "L., Lee,"

Phrase: "V."
Processing 00000000.tx.355: M., Trojanowski, J. 

Phrase: "M."

Phrase: ","

Phrase: "Trojanowski,"

Phrase: "J."
Processing 00000000.tx.356: Q., Jakes, R., and Goedert, M. 

Phrase: "Q., Jakes,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Goedert,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.357: (1997) Nature 388, 839-840[CrossRef][Medline] [OrderarticleviaInfotrieve] 14. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Nature 388,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "839-840"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 14."
Processing 00000000.tx.358: Mezey, E., Dehejia, A. 

Phrase: "Mezey,"

Phrase: "E.,"

Phrase: "Dehejia,"

Phrase: "A."
Processing 00000000.tx.359: M., Harta, G., Tresser, N., Suchy, S. 

Phrase: "M."

Phrase: ","

Phrase: "Harta,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Tresser,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Suchy,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.360: F., Nussbaum, R. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Nussbaum,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.361: L., Brownstein, M. 

Phrase: "L., Brownstein,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.362: J., and Polymeropoulos, M. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Polymeropoulos,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.363: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.364: (1998a) Mol. 

Phrase: "(1998a"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.365: Psychiatry 3, 493-499[CrossRef][Medline] [OrderarticleviaInfotrieve] 15. 

Phrase: "Psychiatry 3,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0033872:Psychiatry [Professional or Occupational Group]
   861   C0033873:Psychiatry [Biomedical Occupation or Discipline]
   789 E C0205487:Psychiatric [Functional Concept]

Phrase: "493-499"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 15."
Processing 00000000.tx.366: Wakabayashi, K., Matsumoto, K., Takayama, K., Yoshimoto, M., and Takahashi, H. 

Phrase: "Wakabayashi,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Matsumoto,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Takayama,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1491778:Takayama [Eukaryote]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Yoshimoto,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Takahashi,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.367: (1997) Neurosci. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Neurosci."
Processing 00000000.tx.368: Lett. 

Phrase: "Lett."
Processing 00000000.tx.369: 239, 45-48[CrossRef][Medline] [OrderarticleviaInfotrieve] 16. 

Phrase: "239,"

Phrase: "45-48"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 16."
Processing 00000000.tx.370: Trojanowski, J. 

Phrase: "Trojanowski,"

Phrase: "J."
Processing 00000000.tx.371: Q., and Lee, V. 

Phrase: "Q.,"

Phrase: "and"

Phrase: "Lee,"

Phrase: "V."
Processing 00000000.tx.372: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.373: (1998) Arch. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Arch."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0230467:arch [Body Location or Region]
  1000   C0741204:ARCH [Body Space or Junction]
Processing 00000000.tx.374: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.375: 55, 151-152[Free FullText] 17. 

Phrase: "55,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: "151-152"

Phrase: "[Free FullText"

Phrase: "] 17."
Processing 00000000.tx.376: Baba, M., Nakajo, S., Tu, P. 

Phrase: "Baba,"

Phrase: "M."

Phrase: ","

Phrase: "Nakajo,"

Phrase: "S."

Phrase: ","

Phrase: "Tu,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1532464:TU [Quantitative Concept]
  1000   C2700314:TU [Fish]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.377: H., Tomita, T., Nakaya, K., Lee, V. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Tomita,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Nakaya,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Lee,"

Phrase: "V."
Processing 00000000.tx.378: M., Trojanowski, J. 

Phrase: "M."

Phrase: ","

Phrase: "Trojanowski,"

Phrase: "J."
Processing 00000000.tx.379: Q., and Iwatsubo, T. 

Phrase: "Q.,"

Phrase: "and"

Phrase: "Iwatsubo,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.380: (1998) Am. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Am."
Processing 00000000.tx.381: J.Pathol. 

Phrase: "J.Pathol."
Processing 00000000.tx.382: 152, 879-884[Abstract] 18. 

Phrase: "152,"

Phrase: "879-884"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 18."
Processing 00000000.tx.383: Goedert, M., Jakes, R., Crowther, R. 

Phrase: "Goedert,"

Phrase: "M."

Phrase: ","

Phrase: "Jakes,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Crowther,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.384: A., Hasegawa, M., Smith, M. 

Phrase: "A.,"

Phrase: "Hasegawa,"

Phrase: "M."

Phrase: ","

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.385: J., and Spillantini, M. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Spillantini,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.386: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.387: (1998) Biochem. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.388: Soc. 

Phrase: "Soc."
Processing 00000000.tx.389: Trans. 

Phrase: "Trans."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2826298:TRANS [Idea or Concept]
Processing 00000000.tx.390: 26, 463-471[Medline] [OrderarticleviaInfotrieve] 19. 

Phrase: "26,"

Phrase: "463-471"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 19."
Processing 00000000.tx.391: Arima, K., Ueda, K., Sunohara, N., Hirai, S., Izumiyama, Y., Tonozuka-Uehara, H., and Kawai, M. 

Phrase: "Arima,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1563875:Arima [Organic Chemical,Pharmacologic Substance]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Ueda,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Sunohara,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Hirai,"

Phrase: "S."

Phrase: ","

Phrase: "Izumiyama,"

Phrase: "Y.,"

Phrase: "Tonozuka-Uehara,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Kawai,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.392: (1998a) Brain Res. 

Phrase: "(1998a"

Phrase: ")"

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.393: 808, 93-100[CrossRef][Medline] [OrderarticleviaInfotrieve] 20. 

Phrase: "808,"

Phrase: "93-100"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 20."
Processing 00000000.tx.394: Wakabayashi, K., Hayashi, S., Yoshimoto, M., Kudo, H., and Takahashi, H. 

Phrase: "Wakabayashi,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Hayashi,"

Phrase: "S."

Phrase: ","

Phrase: "Yoshimoto,"

Phrase: "M."

Phrase: ","

Phrase: "Kudo,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Takahashi,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.395: (2000) Acta Neuropathol. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Acta Neuropathol."
Processing 00000000.tx.396: (Berl.) 

Phrase: "(Berl."

Phrase: ")"
Processing 00000000.tx.397: 99, 14-20[Medline] [OrderarticleviaInfotrieve] 21. 

Phrase: "99,"

Phrase: "14-20"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 21."
Processing 00000000.tx.398: Arai, T., Ueda, K., Ikeda, K., Akiyama, H., Haga, C., Kondo, H., Kuroki, N., Niizato, K., Iritani, S., and Tsuchiya, K. 

Phrase: "Arai,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Ueda,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Ikeda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3613423:Ikeda [Eukaryote]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Akiyama,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Haga,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Kondo,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Kuroki,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Niizato,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Iritani,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Tsuchiya,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.399: (1999) Neurosci. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Neurosci."
Processing 00000000.tx.400: Lett. 

Phrase: "Lett."
Processing 00000000.tx.401: 259, 83-86[CrossRef][Medline] [OrderarticleviaInfotrieve] 22. 

Phrase: "259,"

Phrase: "83-86"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 22."
Processing 00000000.tx.402: Spillantini, M. 

Phrase: "Spillantini,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.403: G., Crowther, R. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Crowther,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.404: A., Jakes, R., Cairns, N. 

Phrase: "A.,"

Phrase: "Jakes,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Cairns,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.405: J., Lantos, P. 

Phrase: "J.,"

Phrase: "Lantos,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.406: L., and Goedert, M. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Goedert,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.407: (1998) Neurosci. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Neurosci."
Processing 00000000.tx.408: Lett. 

Phrase: "Lett."
Processing 00000000.tx.409: 251, 205-208[CrossRef][Medline] [OrderarticleviaInfotrieve] 23. 

Phrase: "251,"

Phrase: "205-208"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 23."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]
Processing 00000000.tx.410: Tu, P. 

Phrase: "Tu,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1532464:TU [Quantitative Concept]
  1000   C2700314:TU [Fish]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.411: H., Galvin, J. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Galvin,"

Phrase: "J."
Processing 00000000.tx.412: E., Baba, M., Giasson, B., Tomita, T., Leight, S., Nakajo, S., Iwatsubo, T., Trojanowski, J. 

Phrase: "E.,"

Phrase: "Baba,"

Phrase: "M."

Phrase: ","

Phrase: "Giasson,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Tomita,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Leight,"

Phrase: "S."

Phrase: ","

Phrase: "Nakajo,"

Phrase: "S."

Phrase: ","

Phrase: "Iwatsubo,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Trojanowski,"

Phrase: "J."
Processing 00000000.tx.413: Q., and Lee, V. 

Phrase: "Q.,"

Phrase: "and"

Phrase: "Lee,"

Phrase: "V."
Processing 00000000.tx.414: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.415: (1998) Ann. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Ann."
Processing 00000000.tx.416: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.417: 44, 415-422[Medline] [OrderarticleviaInfotrieve] 24. 

Phrase: "44,"

Phrase: "415-422"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 24."
Processing 00000000.tx.418: Wakabayashi, K., Hayashi, S., Kakita, A., Yamada, M., Toyoshima, Y., Yoshimoto, M., and Takahashi, H. 

Phrase: "Wakabayashi,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Hayashi,"

Phrase: "S."

Phrase: ","

Phrase: "Kakita,"

Phrase: "A.,"

Phrase: "Yamada,"

Phrase: "M."

Phrase: ","

Phrase: "Toyoshima,"

Phrase: "Y.,"

Phrase: "Yoshimoto,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Takahashi,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.419: (1998) Acta Neuropathol. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Acta Neuropathol."
Processing 00000000.tx.420: (Berl.) 

Phrase: "(Berl."

Phrase: ")"
Processing 00000000.tx.421: 96, 445-452[CrossRef][Medline] [OrderarticleviaInfotrieve] 25. 

Phrase: "96,"

Phrase: "445-452"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 25."
Processing 00000000.tx.422: Arima, K., Ueda, K., Sunohara, N., Arakawa, K., Hirai, S., Nakamura, M., Tonozuka-Uehara, H., and Kawai, M. 

Phrase: "Arima,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1563875:Arima [Organic Chemical,Pharmacologic Substance]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Ueda,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Sunohara,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Arakawa,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Hirai,"

Phrase: "S."

Phrase: ","

Phrase: "Nakamura,"

Phrase: "M."

Phrase: ","

Phrase: "Tonozuka-Uehara,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Kawai,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.423: (1998) Acta Neuropathol. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Acta Neuropathol."
Processing 00000000.tx.424: (Berl.) 

Phrase: "(Berl."

Phrase: ")"
Processing 00000000.tx.425: 96, 439-444[CrossRef][Medline] [OrderarticleviaInfotrieve] 26. 

Phrase: "96,"

Phrase: "439-444"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 26."
Processing 00000000.tx.426: Goedert, M., and Spillantini, M. 

Phrase: "Goedert,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Spillantini,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.427: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.428: (1998) Mol. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.429: Psychiatry 3, 462-465[CrossRef][Medline] [OrderarticleviaInfotrieve] 27. 

Phrase: "Psychiatry 3,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0033872:Psychiatry [Professional or Occupational Group]
   861   C0033873:Psychiatry [Biomedical Occupation or Discipline]
   789 E C0205487:Psychiatric [Functional Concept]

Phrase: "462-465"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 27."
Processing 00000000.tx.430: Takeda, A., Mallory, M., Sundsmo, M., Honer, W., Hansen, L., and Masliah, E. 

Phrase: "Takeda,"

Phrase: "A.,"

Phrase: "Mallory,"

Phrase: "M."

Phrase: ","

Phrase: "Sundsmo,"

Phrase: "M."

Phrase: ","

Phrase: "Honer,"

Phrase: "W.,"

Phrase: "Hansen,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Masliah,"

Phrase: "E."
Processing 00000000.tx.431: (1998) Am. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Am."
Processing 00000000.tx.432: J.Pathol. 

Phrase: "J.Pathol."
Processing 00000000.tx.433: 152, 367-372[Abstract] 28. 

Phrase: "152,"

Phrase: "367-372"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 28."
Processing 00000000.tx.434: Mezey, E., Dehejia, A., Harta, G., Papp, M. 

Phrase: "Mezey,"

Phrase: "E.,"

Phrase: "Dehejia,"

Phrase: "A.,"

Phrase: "Harta,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Papp,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0135262:PAPP [Organic Chemical,Pharmacologic Substance]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.435: I., Polymeropoulos, M. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Polymeropoulos,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.436: H., and Brownstein, M. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Brownstein,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.437: J. 

Phrase: "J."
Processing 00000000.tx.438: (1998) Nat. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.439: Med. 

Phrase: "Med."
Processing 00000000.tx.440: 4, 755-757[Medline] [OrderarticleviaInfotrieve] 29. 

Phrase: "4,"

Phrase: "755-757"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 29."
Processing 00000000.tx.441: Borden, K. 

Phrase: "Borden,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.442: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.443: (1998) Ann. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Ann."
Processing 00000000.tx.444: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.445: 44, S65-S71[Medline] [OrderarticleviaInfotrieve] 30. 

Phrase: "44,"

Phrase: "S65-S71"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 30."
Processing 00000000.tx.446: Weinreb, P. 

Phrase: "Weinreb,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.447: H., Zhen, W., Poon, A. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Zhen,"

Phrase: "W.,"

Phrase: "Poon,"

Phrase: "A."
Processing 00000000.tx.448: W., Conway, K. 

Phrase: "W., Conway,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.449: A., and Lansbury, P. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Lansbury,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.450: T., Jr. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Jr."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]
Processing 00000000.tx.451: (1996) Biochemistry 35, 13709-13715[CrossRef][Medline] [OrderarticleviaInfotrieve] 31. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Biochemistry 35,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "13709-13715"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 31."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]
Processing 00000000.tx.452: Davidson, W. 

Phrase: "Davidson,"

Phrase: "W."
Processing 00000000.tx.453: S., Jonas, A., Clayton, D. 

Phrase: "S."

Phrase: ","

Phrase: "Jonas,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1652689:Jonas [Eukaryote]

Phrase: "A.,"

Phrase: "Clayton,"

Phrase: "D."
Processing 00000000.tx.454: F., and George, J. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "George,"

Phrase: "J."
Processing 00000000.tx.455: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.456: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.457: Biol. 

Phrase: "Biol."
Processing 00000000.tx.458: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.459: 273, 9443-9449[Abstract/Free FullText] 32. 

Phrase: "273,"

Phrase: "9443-9449"

Phrase: "[Abstract/Free FullText"

Phrase: "] 32."
Processing 00000000.tx.460: Giasson, B. 

Phrase: "Giasson,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.461: I., Uryu, K., Trojanowski, J. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Uryu,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Trojanowski,"

Phrase: "J."
Processing 00000000.tx.462: Q., and Lee, V. 

Phrase: "Q.,"

Phrase: "and"

Phrase: "Lee,"

Phrase: "V."
Processing 00000000.tx.463: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.464: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.465: Biol. 

Phrase: "Biol."
Processing 00000000.tx.466: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.467: 274, 7619-7622[Abstract/Free FullText] 33. 

Phrase: "274,"

Phrase: "7619-7622"

Phrase: "[Abstract/Free FullText"

Phrase: "] 33."
Processing 00000000.tx.468: Goedert, M. 

Phrase: "Goedert,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.469: (1997) Nature 388, 232-233[CrossRef][Medline] [OrderarticleviaInfotrieve] 34. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Nature 388,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "232-233"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 34."
Processing 00000000.tx.470: Epand, R. 

Phrase: "Epand,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.471: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.472: (1993) The Amphipathic Helix , CRC Press, Boca Raton, FL 35. 

Phrase: "(1993"

Phrase: ")"

Phrase: "The Amphipathic Helix ,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0018882:Helix [Eukaryote]
   861   C0229304:Helix [Body Part, Organ, or Organ Component]
   861   C1704821:Helix [Spatial Concept]
   861   C1705682:Helix [Anatomical Structure]

Phrase: "CRC Press,"

Phrase: "Boca Raton,"

Phrase: "FL 35."
Processing 00000000.tx.473: Jensen, P. 

Phrase: "Jensen,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.474: H., Nielsen, M. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Nielsen,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.475: S., Jakes, R., Dotti, C. 

Phrase: "S."

Phrase: ","

Phrase: "Jakes,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Dotti,"

Phrase: "C."
Processing 00000000.tx.476: G., and Goedert, M. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Goedert,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.477: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.478: Biol. 

Phrase: "Biol."
Processing 00000000.tx.479: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.480: 273, 26292-26294[Abstract/Free FullText] 36. 

Phrase: "273,"

Phrase: "26292-26294"

Phrase: "[Abstract/Free FullText"

Phrase: "] 36."
Processing 00000000.tx.481: Jenco, J. 

Phrase: "Jenco,"

Phrase: "J."
Processing 00000000.tx.482: M., Rawlingson, A., Daniels, B., and Morris, A. 

Phrase: "M."

Phrase: ","

Phrase: "Rawlingson,"

Phrase: "A.,"

Phrase: "Daniels,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331799:Daniels [Health Care Related Organization]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Morris,"

Phrase: "A."
Processing 00000000.tx.483: J. 

Phrase: "J."
Processing 00000000.tx.484: (1998) Biochemistry 37, 4901-4909[CrossRef][Medline] [OrderarticleviaInfotrieve] 37. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Biochemistry 37,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "4901-4909"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 37."
Processing 00000000.tx.485: Clayton, D. 

Phrase: "Clayton,"

Phrase: "D."
Processing 00000000.tx.486: F., and George, J. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "George,"

Phrase: "J."
Processing 00000000.tx.487: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.488: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.489: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.490: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.491: 58, 120-129[CrossRef][Medline] [OrderarticleviaInfotrieve] 38. 

Phrase: "58,"

Phrase: "120-129"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 38."
Processing 00000000.tx.492: Iwai, A., Masliah, E., Yoshimoto, M., Ge, N., Flanagan, L., de Silva, H. 

Phrase: "Iwai,"

Phrase: "A.,"

Phrase: "Masliah,"

Phrase: "E.,"

Phrase: "Yoshimoto,"

Phrase: "M."

Phrase: ","

Phrase: "Ge,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538705:GE [Gene or Genome]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Flanagan,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "de Silva,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   789   C0144237:Silvan [Organic Chemical]
   768 E C0043217:Wood [Substance]
   768 E C0442548:Woods [Geographic Area]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.493: A., Kittel, A., and Saitoh, T. 

Phrase: "A.,"

Phrase: "Kittel,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Saitoh,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.494: (1995) Neuron 14, 467-475[Medline] [OrderarticleviaInfotrieve] 39. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Neuron 14,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "467-475"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 39."
Processing 00000000.tx.495: Irizarry, M. 

Phrase: "Irizarry,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.496: C., Kim, T. 

Phrase: "C., Kim,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.497: W., McNamara, M., Tanzi, R. 

Phrase: "W., McNamara,"

Phrase: "M."

Phrase: ","

Phrase: "Tanzi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.498: E., George, J. 

Phrase: "E.,"

Phrase: "George,"

Phrase: "J."
Processing 00000000.tx.499: M., Clayton, D. 

Phrase: "M."

Phrase: ","

Phrase: "Clayton,"

Phrase: "D."
Processing 00000000.tx.500: F., and Hyman, B. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Hyman,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.501: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.502: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.503: Neuropathol. 

Phrase: "Neuropathol."
Processing 00000000.tx.504: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.505: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.506: 55, 889-895[Medline] [OrderarticleviaInfotrieve] 40. 

Phrase: "55,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: "889-895"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 40."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]
Processing 00000000.tx.507: Withers, G. 

Phrase: "Withers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0230107:Withers [Body Part, Organ, or Organ Component]

Phrase: ","

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.508: S., George, J. 

Phrase: "S."

Phrase: ","

Phrase: "George,"

Phrase: "J."
Processing 00000000.tx.509: M., Banker, G. 

Phrase: "M."

Phrase: ","

Phrase: "Banker,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.510: A., and Clayton, D. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Clayton,"

Phrase: "D."
Processing 00000000.tx.511: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.512: (1997) Brain Res. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.513: Dev. 

Phrase: "Dev."
Processing 00000000.tx.514: Brain Res. 

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.515: 99, 87-94[CrossRef][Medline] [OrderarticleviaInfotrieve] 41. 

Phrase: "99,"

Phrase: "87-94"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 41."
Processing 00000000.tx.516: Murphy, D. 

Phrase: "Murphy,"

Phrase: "D."
Processing 00000000.tx.517: D., Rueter, S. 

Phrase: "D."

Phrase: ","

Phrase: "Rueter,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.518: M., Trojanowski, J. 

Phrase: "M."

Phrase: ","

Phrase: "Trojanowski,"

Phrase: "J."
Processing 00000000.tx.519: Q., and Lee, V. 

Phrase: "Q.,"

Phrase: "and"

Phrase: "Lee,"

Phrase: "V."
Processing 00000000.tx.520: M.Y. 

Phrase: "M."

Phrase: "Y."
Processing 00000000.tx.521: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.522: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.523: 20, 3214-3220[Abstract/Free FullText] 42. 

Phrase: "20,"

Phrase: "3214-3220"

Phrase: "[Abstract/Free FullText"

Phrase: "] 42."
Processing 00000000.tx.524: Barenholz, Y., Gibbes, D., Litman, B. 

Phrase: "Barenholz,"

Phrase: "Y.,"

Phrase: "Gibbes,"

Phrase: "D."

Phrase: ","

Phrase: "Litman,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.525: J., Goll, J., Thompson, T. 

Phrase: "J.,"

Phrase: "Goll,"

Phrase: "J.,"

Phrase: "Thompson,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.526: E., and Carlson, R. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Carlson,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.527: D. 

Phrase: "D."
Processing 00000000.tx.528: (1977) Biochemistry 16, 2806-2810[Medline] [OrderarticleviaInfotrieve] 43. 

Phrase: "(1977"

Phrase: ")"

Phrase: "Biochemistry 16,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "2806-2810"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 43."
Processing 00000000.tx.529: Ganser, A. 

Phrase: "Ganser,"

Phrase: "A."
Processing 00000000.tx.530: L., Kerner, A. 

Phrase: "L., Kerner,"

Phrase: "A."
Processing 00000000.tx.531: L., Brown, B. 

Phrase: "L., Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.532: J., Davisson, M. 

Phrase: "J.,"

Phrase: "Davisson,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.533: T., and Kirschner, D. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Kirschner,"

Phrase: "D."
Processing 00000000.tx.534: A. 

Phrase: "A."
Processing 00000000.tx.535: (1988) Dev. 

Phrase: "(1988"

Phrase: ")"

Phrase: "Dev."
Processing 00000000.tx.536: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.537: 10, 99-122[Medline] [OrderarticleviaInfotrieve] 44. 

Phrase: "10,"

Phrase: "99-122"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 44."
Processing 00000000.tx.538: Yiu, S. 

Phrase: "Yiu,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.539: C., and Lingwood, C. 

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Lingwood,"

Phrase: "C."
Processing 00000000.tx.540: A. 

Phrase: "A."
Processing 00000000.tx.541: (1992) Anal. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Anal."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003461:Anal [Body Part, Organ, or Organ Component]
  1000   C2939124:Anal [Spatial Concept]
Processing 00000000.tx.542: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.543: 202, 188-192[Medline] [OrderarticleviaInfotrieve] 45. 

Phrase: "202,"

Phrase: "188-192"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 45."
Processing 00000000.tx.544: Hauser, H., Pascher, I., Pearson, R. 

Phrase: "Hauser,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Pascher,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Pearson,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.545: H., and Sundell, S. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Sundell,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.546: (1981) Biochim. 

Phrase: "(1981"

Phrase: ")"

Phrase: "Biochim."
Processing 00000000.tx.547: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.548: Acta 650, 21-51[Medline] [OrderarticleviaInfotrieve] 46. 

Phrase: "Acta 650,"

Phrase: "21-51"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 46."
Processing 00000000.tx.549: Bazzi, M. 

Phrase: "Bazzi,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.550: D., Youakim, M. 

Phrase: "D."

Phrase: ","

Phrase: "Youakim,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.551: A., and Nelsestuen, G. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Nelsestuen,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.552: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.553: (1992) Biochemistry 31, 1125-1134[Medline] [OrderarticleviaInfotrieve] 47. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Biochemistry 31,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0005477:Biochemistry [Occupation or Discipline]
   861   C0450355:31 [Intellectual Product]

Phrase: "1125-1134"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 47."
Processing 00000000.tx.554: Winkler, R. 

Phrase: "Winkler,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.555: G., Spatz, J. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Spatz,"

Phrase: "J."
Processing 00000000.tx.556: P., Sheiko, S., Moller, M., Reineker, P., and Marti, O. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Sheiko,"

Phrase: "S."

Phrase: ","

Phrase: "Moller,"

Phrase: "M."

Phrase: ","

Phrase: "Reineker,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Marti,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.557: (1996) Phys. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Phys."
Processing 00000000.tx.558: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.559: B 54, 8908-8912[CrossRef] 48. 

Phrase: "B 54,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347469:/B [Quantitative Concept]

Phrase: "8908-8912"

Phrase: "[CrossRef"

Phrase: "] 48."
Processing 00000000.tx.560: Noy, A. 

Phrase: "Noy,"

Phrase: "A."
Processing 00000000.tx.561: C., Sanders, H., Vezenov, D. 

Phrase: "C., Sanders,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1504648:Sander [Fish]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Vezenov,"

Phrase: "D."
Processing 00000000.tx.562: V., Wong, S. 

Phrase: "V., Wong,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.563: S., and Lieber, C. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Lieber,"

Phrase: "C."
Processing 00000000.tx.564: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.565: (1998) Langmuir 14, 1508-1511[CrossRef] 49. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Langmuir 14,"

Phrase: "1508-1511"

Phrase: "[CrossRef"

Phrase: "] 49."
Processing 00000000.tx.566: Cleveland, J. 

Phrase: "Cleveland,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0454845:Cleveland [Geographic Area]

Phrase: "J."
Processing 00000000.tx.567: P., Anczyknowski, B., Schmid, A. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Anczyknowski,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Schmid,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331895:Schmid [Health Care Related Organization]

Phrase: "A."
Processing 00000000.tx.568: E., and Elings, V. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Elings,"

Phrase: "V."
Processing 00000000.tx.569: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.570: (1998) Appl. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Appl."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1858559:APPL [Gene or Genome]
Processing 00000000.tx.571: Phys. 

Phrase: "Phys."
Processing 00000000.tx.572: Lett. 

Phrase: "Lett."
Processing 00000000.tx.573: 72, 2613-2615[CrossRef] 50. 

Phrase: "72,"

Phrase: "2613-2615"

Phrase: "[CrossRef"

Phrase: "] 50."
Processing 00000000.tx.574: Brandsch, R. 

Phrase: "Brandsch,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.575: G., Bar, G., and Whangbo, M-H. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Bar,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0687760:bar [Manufactured Object]
  1000   C1551065:bar [Quantitative Concept]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Whangbo,"

Phrase: "M-"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.576: (1997) Langmuir 13, 6349-6353[CrossRef] 51. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Langmuir 13,"

Phrase: "6349-6353"

Phrase: "[CrossRef"

Phrase: "] 51."
Processing 00000000.tx.577: Epand, R. 

Phrase: "Epand,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.578: M., Shai, Y., Segrest, J. 

Phrase: "M."

Phrase: ","

Phrase: "Shai,"

Phrase: "Y.,"

Phrase: "Segrest,"

Phrase: "J."
Processing 00000000.tx.579: P., and Anantharamaiah, G. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Anantharamaiah,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.580: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.581: (1995) Biopolymers 37, 319-338[Medline] [OrderarticleviaInfotrieve] 52. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Biopolymers 37,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005554:Biopolymers [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "319-338"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 52."
Processing 00000000.tx.582: Engelender, S., Kaminsky, Z., Guo, X., Sharp, A. 

Phrase: "Engelender,"

Phrase: "S."

Phrase: ","

Phrase: "Kaminsky,"

Phrase: "Z.,"

Phrase: "Guo,"

Phrase: "X.,"

Phrase: "Sharp,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1444775:Sharp [Finding]
  1000   C1539835:SHARP [Gene or Genome]

Phrase: "A."
Processing 00000000.tx.583: H., Amaravi, R. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Amaravi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.584: K., Kleiderlein, J. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Kleiderlein,"

Phrase: "J."
Processing 00000000.tx.585: J., Margolis, R. 

Phrase: "J.,"

Phrase: "Margolis,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.586: L., Troncoso, J. 

Phrase: "L., Troncoso,"

Phrase: "J."
Processing 00000000.tx.587: C., Lanahan, A. 

Phrase: "C., Lanahan,"

Phrase: "A."
Processing 00000000.tx.588: A., Worley, P. 

Phrase: "A.,"

Phrase: "Worley,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.589: F., Dawson, V. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Dawson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Dawson [Language]

Phrase: "V."
Processing 00000000.tx.590: L., Dawson, T. 

Phrase: "L., Dawson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1551910:Dawson [Language]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.591: M., and Ross, C. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Ross,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0331968:Ross [Health Care Related Organization]
  1000   C2699100:Ross [Bird]

Phrase: "C."
Processing 00000000.tx.592: A. 

Phrase: "A."
Processing 00000000.tx.593: (1999) Nat. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.594: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.595: 22, 110-114[CrossRef][Medline] [OrderarticleviaInfotrieve] 53. 

Phrase: "22,"

Phrase: "110-114"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 53."
Processing 00000000.tx.596: Tytler, E. 

Phrase: "Tytler,"

Phrase: "E."
Processing 00000000.tx.597: M., Segrest, J. 

Phrase: "M."

Phrase: ","

Phrase: "Segrest,"

Phrase: "J."
Processing 00000000.tx.598: P., Epand, R. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Epand,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.599: M., Nie, S. 

Phrase: "M."

Phrase: ","

Phrase: "Nie,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.600: Q., Epand, R. 

Phrase: "Q., Epand,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.601: F., Mishra, V. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Mishra,"

Phrase: "V."
Processing 00000000.tx.602: K., Venkatachalapathi, Y. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Venkatachalapathi,"

Phrase: "Y."
Processing 00000000.tx.603: V., and Anantharamaiah, G. 

Phrase: "V.,"

Phrase: "and"

Phrase: "Anantharamaiah,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.604: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.605: (1993) J. 

Phrase: "(1993"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.606: Biol. 

Phrase: "Biol."
Processing 00000000.tx.607: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.608: 268, 22112-22118[Abstract/Free FullText] 54. 

Phrase: "268,"

Phrase: "22112-22118"

Phrase: "[Abstract/Free FullText"

Phrase: "] 54."
Processing 00000000.tx.609: Michaelson, D. 

Phrase: "Michaelson,"

Phrase: "D."
Processing 00000000.tx.610: M., Barkai, G., and Barenholz, Y. 

Phrase: "M."

Phrase: ","

Phrase: "Barkai,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Barenholz,"

Phrase: "Y."
Processing 00000000.tx.611: (1983) Biochem. 

Phrase: "(1983"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.612: J. 

Phrase: "J."
Processing 00000000.tx.613: 211, 155-162[Medline] [OrderarticleviaInfotrieve] 55. 

Phrase: "211,"

Phrase: "155-162"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 55."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]
Processing 00000000.tx.614: Conway, K. 

Phrase: "Conway,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.615: A., Harper, J. 

Phrase: "A.,"

Phrase: "Harper,"

Phrase: "J."
Processing 00000000.tx.616: D., and Lansbury, P. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Lansbury,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.617: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.618: (1998) Nat. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.619: Med. 

Phrase: "Med."
Processing 00000000.tx.620: 4, 1318-1320[CrossRef][Medline] [OrderarticleviaInfotrieve] 56. 

Phrase: "4,"

Phrase: "1318-1320"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 56."
Processing 00000000.tx.621: El Agnaf, O. 

Phrase: "El Agnaf,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.622: M., Jakes, R., Curran, M. 

Phrase: "M."

Phrase: ","

Phrase: "Jakes,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Curran,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.623: D., and Wallace, A. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Wallace,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331925:Wallace [Health Care Related Organization]

Phrase: "A."
Processing 00000000.tx.624: (1998) FEBS Lett. 

Phrase: "(1998"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.625: 440, 67-70[CrossRef][Medline] [OrderarticleviaInfotrieve] 57. 

Phrase: "440,"

Phrase: "67-70"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 57."
Processing 00000000.tx.626: Narhi, L., Wood, S. 

Phrase: "Narhi,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Wood,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0043217:Wood [Substance]
   944 E C0144237:Sylvan [Organic Chemical]
   916 E C0442548:Woods [Geographic Area]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.627: J., Steavenson, S., Jiang, Y., Wu, G. 

Phrase: "J.,"

Phrase: "Steavenson,"

Phrase: "S."

Phrase: ","

Phrase: "Jiang,"

Phrase: "Y.,"

Phrase: "Wu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1431628:wu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.628: M., Anafi, D., Kaufman, S. 

Phrase: "M."

Phrase: ","

Phrase: "Anafi,"

Phrase: "D."

Phrase: ","

Phrase: "Kaufman,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.629: A., Martin, F., Sitney, K., Denis, P., Louis, J. 

Phrase: "A.,"

Phrase: "Martin,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Sitney,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Denis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332319:denis [Qualitative Concept]

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Louis,"

Phrase: "J."
Processing 00000000.tx.630: C., Wypych, J., Biere, A. 

Phrase: "C., Wypych,"

Phrase: "J.,"

Phrase: "Biere,"

Phrase: "A."
Processing 00000000.tx.631: L., and Citron, M. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Citron,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0759909:CITRON [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1135895:citron [Plant]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.632: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.633: Biol. 

Phrase: "Biol."
Processing 00000000.tx.634: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.635: 274, 9843-9846[Abstract/Free FullText] 58. 

Phrase: "274,"

Phrase: "9843-9846"

Phrase: "[Abstract/Free FullText"

Phrase: "] 58."
Processing 00000000.tx.636: Serpell, L. 

Phrase: "Serpell,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.637: C., Berriman, J., Jakes, R., Goedert, M., and Crowther, R. 

Phrase: "C., Berriman,"

Phrase: "J.,"

Phrase: "Jakes,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Goedert,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Crowther,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.638: A. 

Phrase: "A."
Processing 00000000.tx.639: (2000) Proc. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.640: Natl. 

Phrase: "Natl."
Processing 00000000.tx.641: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.642: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.643: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.644: 97, 4897-4902[Abstract/Free FullText] 59. 

Phrase: "97,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439073:97 [Intellectual Product]
  1000   C0439082:>97 [Quantitative Concept]

Phrase: "4897-4902"

Phrase: "[Abstract/Free FullText"

Phrase: "] 59."
Processing 00000000.tx.645: Chou, P. 

Phrase: "Chou,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.646: Y., and Fasman, G. 

Phrase: "Y.,"

Phrase: "and"

Phrase: "Fasman,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.647: D. 

Phrase: "D."
Processing 00000000.tx.648: (1978) Annu. 

Phrase: "(1978"

Phrase: ")"

Phrase: "Annu."
Processing 00000000.tx.649: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.650: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.651: 47, 251-276[CrossRef][Medline] [OrderarticleviaInfotrieve] 60. 

Phrase: "47,"

Phrase: "251-276"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 60."
Processing 00000000.tx.652: Wood, S. 

Phrase: "Wood,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0043217:Wood [Substance]
   944 E C0144237:Sylvan [Organic Chemical]
   916 E C0442548:Woods [Geographic Area]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.653: J., Wypych, J., Steavenson, S., Louis, J. 

Phrase: "J.,"

Phrase: "Wypych,"

Phrase: "J.,"

Phrase: "Steavenson,"

Phrase: "S."

Phrase: ","

Phrase: "Louis,"

Phrase: "J."
Processing 00000000.tx.654: C., Citron, M., and Biere, A. 

Phrase: "C., Citron,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0759909:CITRON [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1135895:citron [Plant]

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Biere,"

Phrase: "A."
Processing 00000000.tx.655: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.656: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.657: Biol. 

Phrase: "Biol."
Processing 00000000.tx.658: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.659: 274, 19509-19512[Abstract/Free FullText] 61. 

Phrase: "274,"

Phrase: "19509-19512"

Phrase: "[Abstract/Free FullText"

Phrase: "] 61."
Processing 00000000.tx.660: El Agnaf, O. 

Phrase: "El Agnaf,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.661: M., Jakes, R., Curran, M. 

Phrase: "M."

Phrase: ","

Phrase: "Jakes,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Curran,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.662: D., Middleton, D., Ingenito, R., Bianchi, E., Pessi, A., Neill, D., and Wallace, A. 

Phrase: "D."

Phrase: ","

Phrase: "Middleton,"

Phrase: "D."

Phrase: ","

Phrase: "Ingenito,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Bianchi,"

Phrase: "E.,"

Phrase: "Pessi,"

Phrase: "A.,"

Phrase: "Neill,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Wallace,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331925:Wallace [Health Care Related Organization]

Phrase: "A."
Processing 00000000.tx.663: (1998) FEBS Lett. 

Phrase: "(1998"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.664: 440, 71-75[CrossRef][Medline] [OrderarticleviaInfotrieve] Copyright  2000 by The American Society for Biochemistry and Molecular Biology, Inc.

Phrase: "440,"

Phrase: "71-75"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450389:71 [Intellectual Product]

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Copyright  2000 by The American Society"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0009993:Copyright [Intellectual Product]
   753   C0037455:society [Organization]
   753   C0596070:American [Population Group]
   753   C1552856:copyright [Idea or Concept]

Phrase: "for Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "and"

Phrase: "Molecular Biology,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C0567416:Molecule [Substance]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "Inc."

